
<html lang="en"     class="pb-page"  data-request-id="9999d4cb-da77-40fa-b2db-e12c2653b1dc"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2021.64.issue-9;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.0c02237;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Stapled Wasp Venom-Derived Oncolytic Peptides with Side Chains Induce Rapid Membrane Lysis and Prolonged Immune Responses in Melanoma" /></meta><meta name="dc.Creator" content="Ye  Wu" /></meta><meta name="dc.Creator" content="Dong  Lu" /></meta><meta name="dc.Creator" content="Yixin  Jiang" /></meta><meta name="dc.Creator" content="Jinmei  Jin" /></meta><meta name="dc.Creator" content="Sanhong  Liu" /></meta><meta name="dc.Creator" content="Lili  Chen" /></meta><meta name="dc.Creator" content="Hong  Zhang" /></meta><meta name="dc.Creator" content="Yudong  Zhou" /></meta><meta name="dc.Creator" content="Hongzhuan  Chen" /></meta><meta name="dc.Creator" content="Dale G.  Nagle" /></meta><meta name="dc.Creator" content="Xin  Luan" /></meta><meta name="dc.Creator" content="Weidong  Zhang" /></meta><meta name="dc.Description" content="Peptide stapling chemistry represents an attractive strategy to promote the clinical translation of protein epitope mimetics, but its use has not been applied to natural cytotoxic peptides (NCPs) t..." /></meta><meta name="Description" content="Peptide stapling chemistry represents an attractive strategy to promote the clinical translation of protein epitope mimetics, but its use has not been applied to natural cytotoxic peptides (NCPs) t..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 12, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c02237" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c02237" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c02237" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c02237" /></link>
        
    
    

<title>Stapled Wasp Venom-Derived Oncolytic Peptides with Side Chains Induce Rapid Membrane Lysis and Prolonged Immune Responses in Melanoma | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c02237" /></meta><meta property="og:title" content="Stapled Wasp Venom-Derived Oncolytic Peptides with Side Chains Induce Rapid Membrane Lysis and Prolonged Immune Responses in Melanoma" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0011.jpeg" /></meta><meta property="og:description" content="Peptide stapling chemistry represents an attractive strategy to promote the clinical translation of protein epitope mimetics, but its use has not been applied to natural cytotoxic peptides (NCPs) to produce new oncolytic peptides. Based on a wasp venom peptide, a series of stapled anoplin peptides (StAnos) were prepared. The optimized stapled Ano-3/3s were shown to be protease-resistant and exerted superior tumor cell-selective cytotoxicity by rapid membrane disruption. In addition, Ano-3/3s induced tumor ablation in mice through the direct oncolytic effect and subsequent stimulation of immunogenic cell death. This synergistic oncolytic-immunotherapy effect is more remarkable on melanoma than on triple-negative breast cancer in vivo. The efficacies exerted by Ano-3/3s on melanoma were further characterized by CD8+ T cell infiltration, and the addition of anti-CD8 antibodies diminished the long-term antitumor effects. In summary, these results support stapled peptide chemistry as an advantageous method to enhance the NCP potency for oncolytic therapy." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c02237"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02237">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c02237&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c02237&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c02237&amp;href=/doi/10.1021/acs.jmedchem.0c02237" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 5802-5815</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c02232" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c02252" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Stapled Wasp Venom-Derived Oncolytic Peptides with Side Chains Induce Rapid Membrane Lysis and Prolonged Immune Responses in Melanoma</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Ye Wu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ye Wu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ye++Wu">Ye Wu</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Dong Lu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dong Lu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dong++Lu">Dong Lu</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Yixin Jiang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yixin Jiang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yixin++Jiang">Yixin Jiang</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Jinmei Jin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jinmei Jin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jinmei++Jin">Jinmei Jin</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Sanhong Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sanhong Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sanhong++Liu">Sanhong Liu</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Lili Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lili Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lili++Chen">Lili Chen</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Hong Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hong Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hong++Zhang">Hong Zhang</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Yudong Zhou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yudong Zhou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China</div><div class="loa-info-affiliations-info">Department of Chemistry and Biochemistry, College of Liberal Arts, University of Mississippi, University, Mississippi 38677-1848, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yudong++Zhou">Yudong Zhou</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Hongzhuan Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hongzhuan Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hongzhuan++Chen">Hongzhuan Chen</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Dale G. Nagle</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dale G. Nagle</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China</div><div class="loa-info-affiliations-info">Department of Biomolecular Sciences and Research of Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi, University, Mississippi 38677-1848, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dale+G.++Nagle">Dale G. Nagle</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Xin Luan</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xin Luan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#a4c8d1c5cadccdcae4d7ccd1d0c7c98ac1c0d18ac7ca"><span class="__cf_email__" data-cfemail="375b4256594f5e5977445f4243545a19525342195459">[emailÂ protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xin++Luan">Xin Luan</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3674-256X" title="Orcid link">http://orcid.org/0000-0003-3674-256X</a></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">Weidong Zhang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Weidong Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China</div><div class="loa-info-affiliations-info">School of Pharmacy, Second Military Medical University, Shanghai 201203, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#47233d2f2629203e072f28332a262e2b6924282a"><span class="__cf_email__" data-cfemail="0e6a74666f6069774e66617a636f6762206d6163">[emailÂ protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Weidong++Zhang">Weidong Zhang</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c02237&amp;href=/doi/10.1021%2Facs.jmedchem.0c02237" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 5802â5815</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 12, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>24 December 2020</li><li><span class="item_label"><b>Published</b> online</span>12 April 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 May 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c02237" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02237</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5802%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYe%2BWu%252C%2BDong%2BLu%252C%2BYixin%2BJiang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D9%26contentID%3Dacs.jmedchem.0c02237%26title%3DStapled%2BWasp%2BVenom-Derived%2BOncolytic%2BPeptides%2Bwith%2BSide%2BChains%2BInduce%2BRapid%2BMembrane%2BLysis%2Band%2BProlonged%2BImmune%2BResponses%2Bin%2BMelanoma%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5815%26publicationDate%3DMay%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c02237"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">850</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c02237" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Stapled Wasp Venom-Derived Oncolytic Peptides with Side Chains Induce Rapid Membrane Lysis and Prolonged Immune Responses in Melanoma&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ye&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Dong&quot;,&quot;last_name&quot;:&quot;Lu&quot;},{&quot;first_name&quot;:&quot;Yixin&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;Jinmei&quot;,&quot;last_name&quot;:&quot;Jin&quot;},{&quot;first_name&quot;:&quot;Sanhong&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Lili&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Yudong&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Hongzhuan&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Dale&quot;,&quot;last_name&quot;:&quot;G. Nagle&quot;},{&quot;first_name&quot;:&quot;Xin&quot;,&quot;last_name&quot;:&quot;Luan&quot;},{&quot;first_name&quot;:&quot;Weidong&quot;,&quot;last_name&quot;:&quot;Zhang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;5802-5815&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c02237&quot;},&quot;abstract&quot;:&quot;Peptide stapling chemistry represents an attractive strategy to promote the clinical translation of protein epitope mimetics, but its use has not been applied to natural cytotoxic peptides (NCPs) to produce new oncolytic peptides. Based on a wasp venom peptide, a series of stapled anoplin peptides (StAnos) were prepared. The optimized stapled Ano-3/3s were shown to be protease-resistant and exerted superior tumor cell-selective cytotoxicity by rapid membrane disruption. In addition, Ano-3/3s induced tumor ablation in mice through the direct oncolytic effect and subsequent stimulation of immunogenic cell death. This synergistic oncolytic-immunotherapy effect is more remarkable on melanoma than on triple-negative breast cancer in vivo. The efficacies exerted by Ano-3/3s on melanoma were further characterized by CD8+ T cell infiltration, and the addition of anti-CD8 antibodies diminished the long-term antitumor effects. In summary, these results support stapled peptide chemistry as an advantageous method to enha&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02237&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02237" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02237&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02237" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02237&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02237" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c02237&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02237&amp;href=/doi/10.1021/acs.jmedchem.0c02237" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c02237" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c02237" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c02237%26sid%3Dliteratum%253Aachs%26pmid%3D33844923%26genre%3Darticle%26aulast%3DWu%26date%3D2021%26atitle%3DStapled%2BWasp%2BVenom-Derived%2BOncolytic%2BPeptides%2Bwith%2BSide%2BChains%2BInduce%2BRapid%2BMembrane%2BLysis%2Band%2BProlonged%2BImmune%2BResponses%2Bin%2BMelanoma%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D9%26spage%3D5802%26epage%3D5815%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/jmcmar.2021.64.issue-9/20210513/jmcmar.2021.64.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/medium/jm0c02237_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02237&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Peptide stapling chemistry represents an attractive strategy to promote the clinical translation of protein epitope mimetics, but its use has not been applied to natural cytotoxic peptides (NCPs) to produce new oncolytic peptides. Based on a wasp venom peptide, a series of stapled anoplin peptides (StAnos) were prepared. The optimized stapled Ano-3/3s were shown to be protease-resistant and exerted superior tumor cell-selective cytotoxicity by rapid membrane disruption. In addition, Ano-3/3s induced tumor ablation in mice through the direct oncolytic effect and subsequent stimulation of immunogenic cell death. This synergistic oncolytic-immunotherapy effect is more remarkable on melanoma than on triple-negative breast cancer <i>in vivo</i>. The efficacies exerted by Ano-3/3s on melanoma were further characterized by CD8+ T cell infiltration, and the addition of anti-CD8 antibodies diminished the long-term antitumor effects. In summary, these results support stapled peptide chemistry as an advantageous method to enhance the NCP potency for oncolytic therapy.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27354" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27354" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cancer is a major cause of morbidity and mortality worldwide and an important economic burden on health care systems.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> To address this global threat, unrelenting efforts have been committed to cancer therapeutic modality development. Modern cancer treatment options have shifted from their reliance on surgery and radiation therapy to an increased emphasis on systemic therapies, such as hormonal therapy, chemotherapy, and immunotherapy. Among these treatment options, chemotherapy remains the primary systemic treatment for advanced and metastatic stages of common cancers.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> However, conventional chemotherapeutics are often subjected to a considerable loss of efficacy due to drug resistance, lack of tumor-specific selectivity, and potential toxicity.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> In this context, the application of natural cytotoxic peptides (NCPs) represents a promising alternative approach for cancer prevention and treatments.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5â7)</a></div><div class="NLM_p">In nature, NCPs are expressed to capture prey, fend off predators, and boost innate immunity.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Cationic NCPs exhibit strong oncolytic activity by lysing cancer cell membranes, a mechanism of action with a decreased tendency to induce resistance.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9â11)</a> Along with the structural characterization of NCPs, certain NCPs and their derivates are the focus of drug development as novel antitumor agents.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11â13)</a> As the shortest (10-amino acids), amphipathic, linear Î±-helical NCP from the venom sac of the spider wasp, <i>Anoplius samariensis</i>, anoplin has attracted much attention on the account of its simple structure, broad spectrum of activities, and lack of hemolytic toxicity.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> However, further development of the linear form of anoplin has been hindered by its conformational instability, susceptibility to proteolytic degradation, and suboptimal therapeutic activity.<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15â17)</a> All-hydrocarbon stapling has been considered one of the most promising strategies for constraining peptides in an Î±-helical conformation to form protein epitope mimetics with improved bioactivity and increased proteolytic stability.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18â20)</a> However, all-hydrocarbon stapling has never been applied to oncolytic NCP design. The tumor membrane lytic capacity of anoplin exhibits high dependency on its Î±-helical structure,<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> making anoplin an ideal template for modification by peptide stapling.</div><div class="NLM_p">Synthetic StAnos peptides were prepared (Ano-1 to 6), and the structureâactivity relationships were examined. The side-chain-retention stapling methodology was used to produce the lead StAno structure (Ano-3s). Mechanistic studies revealed that Ano-3s cause rapid tumor cell membrane lysis in 4T1 and B16F10 cells with significantly improved water solubility and hemolytic safety. In addition, Ano-3/3s induced immunogenic cell death (ICD) of different tumor cell lines, which suggests the potential synergy between oncolytic therapy and the immunotherapeutic function. Ano-3/3s displayed pronounced antitumor activity in an immunologically âhotâ tumor model (melanoma) following a rapid tumor cell killing effect and protective immune response but not in the âcoldâ tumor model [triple-negative breast cancer (TNBC)]. The significant difference in the therapeutic outcome exhibited high correlation with the significantly increased CD8+ T cell infiltration in melanoma, evidenced by the depletion effect of anti-CD8 antibodies (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Therefore, this work not only broadens the application of the stapled chemistry in the development of natural oncolytic peptides but also provides an interesting insight into the subsequent long-term immune response.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/medium/jm0c02237_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic illustration of the StAnos design and the proposed mechanism of action for StAnos-based oncolytic immunotherapy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02237&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86011" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86011" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Staple Scan Design and Functional Screening</h3><div class="NLM_p">When designing bioactive stapled peptides, one of the challenges is where to install the staple.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The ultrashort structure of anoplin, ten amino acids in total, is favorable for the design and production of a library of StAnos by performing a âstaple scanâ that sequentially places the staple along the sequence of anoplin, yielding 6 <i>i</i>, <i>i</i> + 4, and 3 <i>i</i>, <i>i</i> + 7 stapled peptides, termed Ano (<i>i</i> + 4) and Ano (<i>i</i> + 7) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A and <a href="/doi/suppl/10.1021/acs.jmedchem.0c02237/suppl_file/jm0c02237_si_002.pdf" class="ext-link">S1A</a>). For programmatic expediency, we prepared entire staple-scanning anoplin libraries using standard Fmoc solid-phase peptide synthesis (SPPS) procedures and ring-closing metathesis on the resin (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). To verify the conformational changes induced by the all-hydrocarbon crosslinking strategy, we calculated the percent helicity of all the StAnos through analysis of their circular dichroism (CD) spectra (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A, <a href="/doi/suppl/10.1021/acs.jmedchem.0c02237/suppl_file/jm0c02237_si_002.pdf" class="ext-link">S1</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c02237/suppl_file/jm0c02237_si_002.pdf" class="ext-link">S2</a>). The Ano-libraries demonstrated Î±-helicity with a 1.3- to 15.8-fold increase compared to the parent anoplin, suggesting that the structural constraint is a feasible method for Î±-helical stabilization of anoplin. These stapled peptides were evaluated for <i>in vitro</i> cytotoxicity in two highly malignant tumor cell lines with multiple mechanisms of drug resistance: mouse TNBC 4T1 and mouse melanoma B16F10 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A and <a href="/doi/suppl/10.1021/acs.jmedchem.0c02237/suppl_file/jm0c02237_si_002.pdf" class="ext-link">S1</a>).<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> The antiproliferative activity of the whole StAnos panel showed remarkable enhancement against both cancer cell lines. The half-maximal inhibitory concentration (IC<sub>50</sub>) of the Ano-libraries ranges from 4 to 66 Î¼M, corresponding to a 5.8- to 47.8-fold enhanced potency. These results also suggest that conformational constraint is preferable to increase the bioactivity of these oncolytic peptides.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/medium/jm0c02237_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Sequence, charge, C<sub>18</sub>-HPLC retention time (<i>T</i><sub>R</sub>), Î±-helicity, and antitumor activities of <i>i</i>, <i>i</i> + 4-stapled Anoplin library. The reported IC<sub>50</sub> values are the mean Â± standard deviation of three or more independent experiments. (B) Synthetic route for the production of Ano (<i>i</i> + 4). (C) Surface and ribbon views of the hydrophobic (left) and hydrophilic (right) faces of the amphipathic anoplin Î±-helix (protein data bank ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2MJQ">2MJQ</a>). Helical wheel diagram of anoplin (middle) shows the polar and nonpolar faces of the helix. Yellow symbols represent highly hydrophobic residues. Gray symbols represent low hydrophobic residues. Green symbols represent polar, uncharged residues. Blue symbols represent basic residues. (D) Surface views of the Ano (<i>i</i> + 4) (hydrocarbon staple represented by a black oval symbol). Staple locations for each StAons are indicated on the helical wheel.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02237&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To identify determinants for the variable trends in structureâactivity relationships of StAnos, we analyzed several biophysical parameters that include charge, C<sub>18</sub>-HPLC retention time, staple placement, and Î±-helicity (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A and <a href="/doi/suppl/10.1021/acs.jmedchem.0c02237/suppl_file/jm0c02237_si_002.pdf" class="ext-link">S1</a>). No single determinant uniformly correlates with the IC<sub>50</sub> values of the Ano (<i>i</i> + 7) library. To make matters more complicated, Ano-8 and Ano-9 included two (<i>E</i>/<i>Z</i>)-steric configurations in a hydrocarbon staple. For example, Ano-8-1 and Ano-8-2 that derived from the same amino acid sequence showed nearly identical HPLC retention times, yet their helical contents and antitumor selectivity were significantly different, and it is technically difficult to confirm the absolute configuration of diastereoisomeric stapled peptides. In contrast, the IC<sub>50</sub> values for the Ano (<i>i</i> + 4) library revealed a traceable correlation among the examined variables. On the whole, the stable Î±-helix topology effectively increases the interaction with cancer cells, and the hydrophobicity of the hydrophobic face determines the level of oncolytic efficacy. To be more specific, the hydrophobic ring-closing amino acids S<sub>5</sub> sacrifice peptide cationic charges (Arg and Lys) in some stapling positions and increase their HPLC retention time. To visualize the consequence of staple placement along the anoplin helix, we plotted and compared a variety of StAnos surfaces, generated in PyMol according to the NOE-based NMR structure of anoplin in dodecylphosphocholine micelles (protein data bank ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2MJQ">2MJQ</a>) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The secondary structure model of anoplin is an idealized amphipathic conformation with nonpolar residues (Leu2, Leu3, Ile6, Leu9, and Leu10; in yellow) on the one side and basic residues (Lys4, Arg5, and Lys7; in blue) on the opposite side that is joined by a polar, uncharged Thr8 (green). When the staple is inserted at the amphipathic boundary, as in Ano-1, -3, and -5 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>D), there was a maximal increase in antitumor activity compared to anoplin. Placing the staple within the highly hydrophobicity regions, such as in Ano-2 and Ano-6, or the hydrophilic face (<i>e.g.,</i> Ano-4) of the anoplin helix surrounded by positively charged residues, the antitumor effect of the StAnos has a reduced activity relative to Ano-1, -3, and -5. Further, staple placements that expand the hydrophobic network on the hydrophobic face improved the strength of the interaction with cancer cells, whereas inspection of the Ano-2, -4, and -6 structures revealed that the localization of the staple only increased the overall hydrophobicity without changing the landscape of the hydrophobic surface, thus diminishing the increase in bioactivity.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> StAno Peptides Rapidly Kill Cancer Cells by Membrane Lysis</h3><div class="NLM_p">Despite the remarkable promise of StAnos as a novel class of antitumor compounds, stapled natural peptides can lead to nonspecific hemolysis.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> To detect stapled peptide structureâtoxicity relationships, Walensky and coworkers<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> devised a predictive algorithm to generate âhydrophobicity network maps (HNMs)â and lyticity indices of stapled antimicrobial peptides. Inspired by this algorithm, we developed HNMs of the better-performing Ano-1, -3, and -5 to systematically visualize and quantitate the hydrophobic interactions on the three-dimensional Î±-helical surface (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). The HNMs of StAnos showed a greater number and thickness of linkages within the networks compared to anoplin, which reflected an increased surface area of the hydrophobic interactions. The nonspecific predicted lyticity index (LI), depending on a computational algorithm, demonstrated that Ano-3 has the lowest calculated value (LI 304.4) among the three StAnos with optimum antitumor activity, an LI value far below the threshold of 600 set by authors at the supratherapeutic dosing level <i>in vivo</i>. This is probably because the Ano-3 HNM is not that structurally dissimilar from the anoplin parent structure. To confirm the predicted LI relationships, red blood cell (RBC) hemolysis assays were performed to determine the actual hemolytic activity of the three StAnos (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). Consistent with the predictions, StAnos with higher LI values exhibited a greater percentage of RBC hemolysis, and Ano-3 had the best therapeutic index, even the most hemolytic Ano-1 provided a relatively wide therapeutic window of selectivity for cancer cells versus nontumor mammalian cell membranes. These results indicate that anoplin can serve as an idealized template for stapling modification. To investigate the oncolytic mechanism of StAnos, Ano-3 was used as a representative and examined in StAnos-sensitive 4T1 cells. The 9-mer amphipathic helical peptide LTX-315 (Ruxotemitide, Oncopore), a potential first in class oncolytic peptide in the phase II clinical trial (clinical trials. gov identifier: NCT03725605),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> served as a standard positive control for cytotoxic activity in the two cancer cell lines (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02237/suppl_file/jm0c02237_si_002.pdf" class="ext-link">Figure S3</a>); it can kill cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> In the lactate dehydrogenase (LDH) release assay that monitors the release of intracellular contents, treatment of cells with Ano-3, LTX-315, and anoplin each leads to a loss of membrane integrity in a concentration-dependent manner (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C and <a href="/doi/suppl/10.1021/acs.jmedchem.0c02237/suppl_file/jm0c02237_si_002.pdf" class="ext-link">S4</a>). The ability to disrupt cell membranes was in line with cell viability assay results. A time-course study on the release of ATP revealed that ATP was detected in the supernatant as early as 5 min after the cells were exposed to the peptides (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D). Live cell imaging [three-dimensional (3D) cell explorer] was used to observe the morphology of Ano-3-treated 4T1 cells in the bright field; the time-lapse movie displayed a rapid change from a completely adherent morphology to a total collapse. Broken disrupted cell particles were clearly visible, and these changes occurred within less than 5 min (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>E). In addition, peptide-lysed cell membranes were observed by confocal imaging. As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>F, a significant difference in membrane profiles was observed between the treated and control cells. Peptides FITC-Ano-3 and FITC-LTX-315 caused disruption of the complete membrane and cytoplasmic staining, whereas the plasma membrane of untreated and FITC-Anoplin-treated cells remained intact. A similar outcome was obtained in the calcein-AM and propidium iodide (PI) dual staining assay. Treatment with Ano-3 and LTX-315 produced an increase in cells displaying red fluorescence that became the dominant cell type over time, suggesting that a large number of cells were disrupted (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>G). In contrast, the subtherapeutic anoplin did not incur such a change (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02237/suppl_file/jm0c02237_si_002.pdf" class="ext-link">Figure S5</a>). Taken together, these results indicate that StAnos-mediated membrane lysis of cancer cells is a rapid process that is both concentration- and time-dependent and that Ano-3 exerts superior oncolytic activity relative to LTX-315.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/medium/jm0c02237_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) HNMs and the corresponding lyticity indices of anoplin, Ano-1, -3, and -5. (B) RBC hemolytic activity of anoplin, Ano-1, -3, and -5 (<i>n</i> = 3). (C) LDH release of 4T1 following treatment with Ano-3 and LTX-315 (<i>n</i> = 3). (D) Extracellular ATP levels of 4T1 following Ano-3 and LTX-315 treatment (50 Î¼M) (<i>n</i> = 3). (E) Bright field microscopy images of Ano-3-treated 4T1. (F) Peptide effects on 4T1 cells, as observed by a confocal microscope (16 Î¼M). (G) 4T1 cells after treatment with Ano-3 and LTX-315 and stained with the LIVE/DEAD cell viability/cytotoxicity kit. The representative photographs of the cells were shown. Statistical significance: **<i>P</i> < 0.01 and ***<i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02237&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Increasing StAno Hydrophilicity and Tumor Cell Selectivity with Side Chains</h3><div class="NLM_p">Despite previous success, a potential drawback of StAnos is the lack of the natural side chains in the stapling position. For example, a staple-induced hydrophobic network could improve the ability of Ano-3 to interact with cancer cells but at the cost of original cationic Lys side chains. We envisioned that the retention of a parental side chain would further increase the water solubility and tumor cell selectivity of Ano-3 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). In an earlier study, we synthesized a series of amino acids which contain both native side chains and stapling groups and used them to expand the scope of the all-hydrocarbon stapled peptide strategy (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Thus, with these novel stapling amino acids (Fmoc-Leu*-OH and Fmoc-Lys*(Boc)-OH) in hand, Ano-3s, the side-chain-retention stapled anoplin peptide based on Ano-3, was rapidly assembled <i>via</i> SPPS (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C). As anticipated, the introduction of a hydrophilic side chain shortened the HPLC retention time of Ano-3s when compared to Ano-3 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D). Therefore, the side-chain-retention stapling strategy produced a more water soluble Ano-3s peptide. The Ano-3s maintained IC<sub>50</sub> values for cancer cells comparable to Ano-3 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C). At a relatively high concentration of 80 Î¼M, there was less than 10% hemolysis, reflecting a potentially broad membrane-specificity window of Ano-3s (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>E). However, Ano-3s cannot keep the same degree of helicity as Ano-3 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>F). A logical explanation is that the steric hindrance of the Î±,Î±-disubstituted amino acids results in the helix-kinked structure. Overall, the side-chain-retention stapling method bestowed Ano-3s with increased hydrophilicity and tumor cell selectivity.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/medium/jm0c02237_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Structure-based design of Ano-3s from Ano-3. (B) Synthetic scheme of Fmoc-Leu*-OH and Fmoc-Lys*-OH. (C) Sequence, charge, Î±-helicity, and antitumor activities of Ano-3s. (D) Analytical HPLC chromatogram (Î» = 214 nm) of Ano-3 and Ano-3s. (E) RBC hemolytic activity of Ano-3 and Ano-3s (<i>n</i> = 3). (F) CD spectra of anoplin, LTX-315, Ano-3, and Ano-3s. (G) Ano-3s effects on 4T1 cells observed by a confocal microscope (16 Î¼M). (H) 4T1 cells after treatment with Ano-3s and stained with the LIVE/DEAD cell viability/cytotoxicity kit. Statistical significance: ***<i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02237&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In terms of oncolytic potency, FITC-Ano-3s also disrupted and permeated cancer cell membranes (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>G). Additionally, the PI influx was detected immediately after Ano-3s was added to calcein-AM-loaded 4T1 cells, suggesting that Ano-3s permeabilized cell membranes in a time-dependent manner (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>H). The proteolytic sensitivity of the lead StAnos toward Î±-chymotrypsin-mediated degradation [pH 7.4, phosphate-buffered saline (PBS) buffer, room temperature] was monitored by HPLC (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02237/suppl_file/jm0c02237_si_002.pdf" class="ext-link">Figure S6A</a>). As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c02237/suppl_file/jm0c02237_si_002.pdf" class="ext-link">Figure S6B</a>, linear anoplin and LTX-315 displayed a weak protease stability with a half-life (<i>t</i><sub>1/2</sub>) of 12 min and 34 min, respectively. In contrast, Ano-3 was stable with no degradation observed after 12 h, and over 60% of Ano-3s remained intact after 2 h protease exposure likely because of a probable kinked helix of Ano-3s that altered the peptide exposure to enzyme cleavage sites. These properties indicated that the structurally reinforced, cancer cell membrane-selective and protease-resistant StAnos have significant advantages over the linear peptides.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> StAnos Induces Tumor Ablation <i>In Vivo</i></h3><div class="NLM_p">Upon confirming the pronounced selectivity and antitumor effect of the lead StAnos <i>in vitro</i>, these peptides were further evaluated for their therapeutic potential <i>in vivo</i> using the 4T1 cell-based mouse cancer model (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). Approximately, two days after inoculation (when the 4T1 tumor volumes reached â¼30 mm<sup>3</sup>), the tumor-bearing female BALB/c mice were divided into groups and administered a vehicle, LTX-315, anoplin, Ano-3, or Ano-3s <i>via</i> intratumorally injection once every day, for a total of three consecutive injections. The equivalent dose of peptide was 1 mg/50 Î¼L solution. During treatment, the body weight from all groups had a similar increase (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D), indicating no overt signs of toxicity. Unexpectedly, initial tumor growth was only slightly inhibited after treatment with LTX-315, Ano-3, and Ano-3s. The tumors relapsed shortly thereafter, while LTX-315 and StAnos failed to stall tumor progression. Analysis of the dissected tumor weight identified a statistically significant difference between the control and Ano-3 groups (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B,C). Hematoxylinâeosin (HE) staining of the excised tumor tissue showed notable levels of necrosis in the LTX-315, Ano-3 and Ano-3s groups on day 7 (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A,C), but there was no extensive necrosis of the tumor tissue on day 18 (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A,D). Collectively, LTX-315, Ano-3, and Ano-3s did not affect the 4T1 tumor growth <i>in vivo</i> significantly.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/medium/jm0c02237_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Schematic illustration of the timeline for the therapeutic experiments. (B) Images of excised 4T1 tumors. (C) Weight of 4T1 tumors. (D) Body weight of mice bearing 4T1 tumors throughout the study. (E) Images of excised B16F10 tumors. (F) Weight of B16F10 tumors. (G) Body weight of mice bearing B16F10 tumors throughout the study, <i>n</i> = 5. Statistical significance: *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02237&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/medium/jm0c02237_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A,C,D) H&E staining and quantitative analysis of the excised 4T1 tumor tissues. (B,E,F) H&E staining and quantitative analysis of the excised B16F10 tumor tissues. Statistical significance: *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02237&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In a separate study, the same administration schedule was used to treat subcutaneous B16F10 tumor-bearing C57 mice when the tumor volume reached 20â30 mm<sup>3</sup> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A), As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>E,F, the anoplin monotherapy had no significant impact on tumor growth due to the subtherapeutic treatment. In contrast, all other treated groups exhibited reduced tumor growth. The HE-stained tumor tissue samples revealed that LTX-315 and StAnos treatment induced cellular necrosis and tumor cell killing, indicated by a significantly lower percentage of live cells in comparison to the control and anoplin treatment by day 10 or 14 (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B,E,F). In addition, none of the group caused any significant change in body weight during treatment (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>G). These results indicated that StAnos could be a promising antitumor agent in the B16F10 model.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> StAnos Boosts Innate Immunity by Oncolytic Efficacy and Resulting ICD</h3><div class="NLM_p">The intriguing observation was that the StAnos displayed higher antiproliferative activity on 4T1 cells than that on B16F10 cells <i>in vitro</i>, while the situation was reversed in the animal models. These peptides did not produce an antiproliferative effect in 4T1 tumor-bearing mice equivalent to that observed at the cellular level. Our results are consistent with previous work on LTX-315, although the authors did not provide an explanation for this difference.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> Because intratumoral treatment with LTX-315 can provide local tumor control, followed by ICD in B16 melanoma cells,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> StAnos was evaluated in 4T1 and B16F10 cells for the ability to induce ICD. The expression of calreticulin (CRT) and high-mobility group box 1 (HMGB-1) was used as markers for ICD. Similar to those observed in the LTX-315 study, Ano-3 triggered surface translocation of CRT (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A) and the release of HMGB-1 (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B) in both cell lines, thereby facilitating the maturation of antigen presenting cells and intratumoral recruitment of cytotoxic lymphocytes (CTLs).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> These results in combination with the ATP release data (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>E) suggested that StAnos induces ICD which can mediate a subsequent immune response.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/medium/jm0c02237_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Confocal microscopy images showing surface translocation of (A) CRT and (B) HMGB1 in 4T1 and B16F10 cells incubated with or without Ano-3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02237&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Melanomas are considered to be immunologically âhotâ tumors and are characterized by a high level of CTL infiltration within the tumor matrix,<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34,35)</a> rendering them capable of inducing a synergistic immunological therapeutic response following the oncolytic effect, resulting in tumor ablation. Meanwhile, TNBC belongs to the infiltration-excluded âcoldâ class of tumors that are relatively void of CTLs within the tumor mass.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> To test this hypothesis, immunohistochemical staining was performed to determine immune cell infiltration. Among the samples examined, both CD4+ and CD8+ T lymphocytes were extremely scarce among all groups of 4T1 tumors (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02237/suppl_file/jm0c02237_si_002.pdf" class="ext-link">Figure S7</a>) and B16F10-untreated control (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). Compared with TNBC tumors (4T1), melanoma tumors (B16F10) exhibited enhanced CD4+ and CD8+ T cell infiltration as an immunologically âhotâ tumor. In B16F10-inoculated mice, both LTX-315 and StAnos induced a significant infiltration of CD8+ T cells into tumors (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). Increased CD8+ T cell infiltration has also been observed in LTX-315-treated melanoma patients.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/medium/jm0c02237_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Immunohistochemical staining images of CD4+ T cells and CD8+ T cells in the B16F10 tumor sections. (B,C) Quantitative analysis of CD4+ T cells and CD8+ T cells on B16F10 tumor tissue sections. Statistical significance: *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02237&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The effects of StAnos on tumor growth and CD8+ T cell infiltration suggested that the oncolytic peptide may also promote antitumor immunity. To test this hypothesis in melanoma models, mice carrying B16F10 tumors treated with StAnos also received anti-CD8 antibodies to deplete the CD8+ T cells (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). As expected, CD8+ T cell depletion in Ano-3s treated mice did not prevent initial B16F10 tumor progression within the first 20 days after StAno administration (first response phase). However, CD8+ T cell depletion triggered faster tumor reoccurrence (second response phase). After 40 days of B16F10 inoculation, only StAno monotherapy groups still had fifty percent of tumor-free mice (3 in 6 mice); these findings support the notion that Ano-3s treatment-induced CD8+ T cell infiltration in B16F10 tumors had antitumor functions and was involved in long-term suppression of malignant progression.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/medium/jm0c02237_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (A) Schematic illustration of the timeline for the therapeutic experiments. (B) Survival analysis of B16F10 tumor-bearing mice treated with Ano-3s (<i>n</i> = 6). (C) Table of the number of tumor-free mice over the total number of mice under different treatment conditions for 3 representative days after tumor challenge. (D) Individual tumor growth kinetics of different groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02237&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">These findings shed lights on the cause for tumor model-dependent therapeutic outcome incurred by the same treatment. Furthermore, cancer treatments that employ StAnos or other oncolytic peptides should afford additional clinical benefit due to the combination of a powerful oncolytic effect and antitumor immune response.<a onclick="showRef(event, 'ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref40">(38â40)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53616" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53616" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">There is an urgent need for highly effective and relatively nontoxic chemotherapeutics that can eradicate multidrug-resistance (MDR) tumors.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Because specific drug target-associated gene mutations<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and drug efflux pump expression (<i>e.g. P</i>-glycoprotein and MDR proteins)<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> can decrease tumor sensitivity to traditional chemotherapy, the tumor membrane-lytic NCPs offer a highly desirable chemotherapeutic solution.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Meanwhile, in the cell membrane of many cancers, phosphatidylserine and <i>O</i>-glycosylated mucins are usually overexpressed, thereby causing these membranes to carry higher net negative charge than those of normal eukaryotic cells.<a onclick="showRef(event, 'ref7 ref45'); return false;" href="javascript:void(0);" class="ref ref7 ref45">(7,45)</a> Therefore, the cationic oncolytic peptides or NCPs usually display the membrane potential-mediated selectivity. However, clinical development of oncolytic NCPs has been hampered by intrinsic peptide instability and subtherapeutic efficacy.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Based on the 10-amino acid wasp venom peptide, anoplin, an all-hydrocarbon stapling strategy was applied to yield potent, stable, and protease-resistant peptides with a relatively high degree of tumor cell selectivity.</div><div class="NLM_p">Prior efforts to develop stapled peptides involved a potential limitation with the sacrifice of side chain-bearing amino acids at the stapled positions, leading to reduction in solubility and selectivity.<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47,48)</a> By applying a side-chain-retention stapling strategy, we identified Ano-3s as an enhanced leading StAno with improved hydrophilicity, decreased hemolytic activity, stability to proteolytic degradation, and excellent oncolytic activity. Moreover, the therapeutic potential of selected StAnos was determined in two cancer models. Heterogeneity between these two tumor models led to different treatment outcomes, depending on peptide-induced immune responses that rely on CD8+ T cell infiltration <i>in vivo</i>. This is the first systematic report of the peptide stapling strategy applied in the improvement of oncolytic natural peptides and in-depth evaluation of their antitumor activities.</div><div class="NLM_p last">Owing to intrinsic drawbacks of current oncolytic peptides, including short circulation half-life <i>in vivo</i>, poor bioavailability, and unfavorable systemic toxicity profiles, intratumoral injection is the reasonable choice for clinical administration. However, this limits the further clinical indications. In this case, our pioneering efforts using stapled chemical strategy may serve as the potential ideas to accelerate oncolytic peptides development as novel systematic chemotherapeutics with improved therapeutic applications. Furthermore, truncated modification<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> and targeted drug delivery systems<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> should also be further evaluated and studied as the potential strategies to overcome previously mentioned limitation in the future.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75168" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75168" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> General Information</h3><div class="NLM_p last">All reagents and solvents were purchased from Adamas-beta, J&K Scientific, GL Biotech, Energy Chemical or Sinopharm Chemical Reagent Co. Ltd. Rink Amide MBHA resin (0.30 mmol/g loading) was purchased from Tianjin Nankai Hecheng Science & Technology Co. Ltd. Dulbeccoâs modified Eagleâs medium (DMEM), Roswell Park Memorial Institute (RPMI)-1640, fetal bovine serum (FBS), PBS solution, penicillin, and streptomycin were gained from Thermo Fisher Scientific Inc. (Waltham, MA). Double distilled water was purified using a Millipore Simplicity system (Millipore, Bedford, MA). All other commercially obtained reagents and solvents were used directly without further purification. TLC was performed on plates precoated with silica gel 60 F254 (250 layer thickness). Column chromatographic purification of products was finished on silica gel (300â400 mesh). Visualization was accomplished with UV light and phosphomolybdic acid (PMA) solution.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Analytical Methods</h3><div class="NLM_p last"><sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were obtained on a Bruker Avance 600 MHz NMR Spectrometer (Germany). The chemical shifts of protons are given on the Î´ scale, ppm, with tetramethylsilane as the internal standard. All NMR experiments were conducted at room temperature unless otherwise stated. The <sup>1</sup>H NMR spectra are reported as follows: Î´/ppm (multiplicity, coupling constant <i>J</i>/Hz, and number of protons). Multiplicity is abbreviated as follows: s = singlet, d = doublet, t = triplet, m = multiplet, and dd = doublet of doublet. Coupling constants (<i>J</i>) are quoted in hertz and recorded to the nearest 0.1 Hz. The <sup>13</sup>C NMR spectra are reported in Î´/ppm. HR-Q-TOF-MS was measured on an Agilent 6538 UHD Accurate Mass Q-TOF LC/MS mass spectrometer (America). Analytical HPLC was run on an Agilent 1260 Infinity LC instrument using an analytical column (ZORBAX Eclipse XDB 80 Ã C<sub>18</sub>, 4.6 Ã 150 mm, 3.5 Î¼m particle size, flow rate 1.0 mL/min, r.t.). Analytical injections were monitored at 214 and 254 nm. All separations used a mobile phase of 0.1% trifluoroacetic acid (TFA) (v/v) in water (solvent A) and 0.1% TFA (v/v) in MeCN (solvent B), with a linear gradient of 5â65% solvent B in 30 min at room temperature. Semipreparative HPLC was run on a Waters Auto Purification System (America) instrument using a semipreparative column (XBridge Prep C<sub>18</sub>, 19 Ã 250 mm, 10 Î¼m particle size, flow rate 20 mL/min). Solution A was 0.1% TFA in water, and solution B was 0.1% TFA in MeCN. Gradient A was a linear gradient of 10â10% B over 2 min and then a linear gradient of 10â90% B over 25 min. Gradient B was a linear gradient of 1â1% B over 3 min and then a linear gradient of 1â35% B over 25 min. The linear and stapled peptides were dissolved in the phosphate buffer solutions (10 mM, pH = 7.4) to a final concentration of 50 Î¼M, respectively. The CD spectra were obtained with a 1 mm quartz cuvette on BRIGHT TIME Chirasca (Applied photophysics, Britain) spectropolarimeter at 25 Â°C. The measurement parameters were set up as follows: wavelength, 185â260 nm; step resolution, 0.5 nm; speed, 20 nm min<sup>â1</sup>; and accumulation, 3. All spectra were converted to a uniform scale of molar ellipticity after background subtraction. The curves were smoothed using standard parameters. In addition, according to the ellipticity of the peptideâs spectrum at 222 nm and the number of amino acids in the peptide sequence, we calculated the helicity of each peptide using the literature equation.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Synthesis of StAnos</h3><div class="NLM_p last">All peptides were prepared using standard Fmoc-based SPPS on a Rink Amide MBHA resin. Briefly, 400 mg  resin was swelled with DCM (5 mL) for 20 min. Then, the resin was treated with 20% piperidine/dimethylformamide (DMF)/0.1 mol/L Oxyma pure twice (5 min Ã 2), followed by washing with DMF (5 times), DCM (5 times), and DMF (5 times) at 35 Â°C. For coupling of the natural amino acid, Fmoc-AA-OH (1 mmol), DIC (1 mmol), Oxyma pure (1 mmol), and NMP (6 mL) were mixed for 1 min and then added to the resin at 60 Â°C. After 15 min, the resin was washed with DMF (5 times), DCM (5 times), and DMF (5 times). The peptide couplings of S<sub>5</sub>, R<sub>8</sub>, Leu*, and Lys* were carried out over a single 2 h coupling cycle using 2 equiv of the Fmoc-protected amino acids at 60 Â°C. The deprotection, washing, coupling, and washing steps were repeated until all the amino acid residues were assembled. The peptide-bound resin was treated with 20% piperidine/DMF/0.1 mol/L Oxyma pure to remove the Fmoc group from the N-terminus. After the resin was washed, the resin was treated with 10 mM solution of Grubbsâ first-generation catalyst in DCE. After the first round of the 2 h metathesis, we repeated the same procedure for a second round of catalyst treatment with fresh catalyst solution, the peptide-resin was washed with DMF (5 times) and DCM (5 times). The peptide was cleaved from resin by treatment with cocktail TFA [TFA/triisopropylsilane (TIPS)/H<sub>2</sub>O = 95/2.5/2.5, v/v/v] for 2 h at room temperature. After completion of the cleavage reaction, TFA was evaporated by blowing with Ar. The crude peptides were obtained by precipitation with 40 mL of cold diethyl ether and centrifugation at 3500 rpm for 3 min (3 times). The supernatant diethyl ether was decanted from the centrifuge tube, and the crude peptide was allowed to air dry and purified by RP-HPLC to give the final product. All peptides possess a purity of at least 95%.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Fluorescent Labeling of StAnos</h3><div class="NLM_p last">Elongation of the peptide and metathesis reaction were conducted on the resin according to a general protocol. Then, the Fmoc group was removed, and the resin was treated with Fmoc-Ahx-OH (4 equiv), DIC (4 equiv), Oxyma pure (4 equiv), and NMP (6 mL) for 15 min at 60 Â°C. The Fmoc group was removed, and the resin was treated with fluorescein isothiocyanate (FITC, 2 equiv) and DIPEA (2 equiv) in DMF (6 mL) at room temperature overnight. Cleavage was conducted following a general protocol, and the crude peptide was purified by RP-HPLC to give the final products.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Synthesis of Novel Stapling Amino Acids</h3><div class="NLM_p">Fmoc-Leu*-OH and Fmoc-Lys*(6-Azide)-OH were prepared following the previous procedure.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> For Fmoc-Lys*(Boc)-OH, Zn (1.27 g, 19.46 mmol) was added into a solution of Fmoc-Lys*(6-Azide)-OH (500 mg, 1.08 mmol) in CH<sub>3</sub>COOH (10 mL) at 40 Â°C. The reaction mixture was stirred at 40 Â°C overnight, and the reaction mixture was concentrated <i>in vacuo</i>. The residue was suspended in a mixture of Et<sub>3</sub>N (437 mg, 4.32 mmol) and MeCN (60 mL); di-<i>tert</i>-butyl dicarbonate (354 mg, 1.62 mmol) was dissolved in MeCN (5 mL), and the solution was added with efficient stirring at room temperature overnight. The reaction mixture was concentrated to dryness. The residue was dissolved in 50 mL of EA and then washed with brine. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated <i>in vacuo</i>. The residue was purified by column chromatography eluting with 100/1 DCM/MeOH to give 450 mg (83%) of Fmoc-Lys*(Boc)-OH.</div><div class="NLM_p">HR-Q-TOF-MS <i>m/z</i>: calcd for C<sub>31</sub>H<sub>40</sub>N<sub>2</sub>O<sub>6</sub>Na<sup>+</sup>, 559.2779; found [M + Na]<sup>+</sup>, 559.2825.</div><div class="NLM_p"><sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): Î´ 7.75â7.71 (m, 2H), 7.59â7.53 (m, 2H), 7.41â7.26 (m, 4H), 6.12â5.98 (d, <i>J</i> = 84 Hz, 1H), 5.70â5.59 (m, 1H), 4.96â4.87 (m, 2H), 4.37â4.30 (m, 1H), 4.20â4.18 (t, <i>J</i> = 12 Hz, 1H), 3.21â2.88 (m, 2H), 2.32â2.21 (m, 2H), 1.98â1.95 (m, 2H), 1.76â1.60 (m, 2H), 1.45â1.31 (m, 11H), 1.27â1.18 (m, 4H).</div><div class="NLM_p last"><sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): Î´ 176.97, 161.06, 143.91, 141.24, 138.29, 127.58 (2C), 126.98 (2C), 125.00 (2C), 119.89 (2C), 119.08, 114.57, 66.11, 63.97, 47.23, 40.20, 35.29, 34.98, 33.41, 29.75, 28.22 (6C), 23.36, 21.01.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Cell Cultures</h3><div class="NLM_p last">The 4T1 cell line was purchased from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China); B16F10 cell line was originally provided by Chao Fang (Institute of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai, China). The 4T1 Cells and B16F10 cells were cultured in 1640 and DMEM medium, respectively, with 10% FBS, 10<sup>5</sup> U L<sup>â1</sup> penicillin, and 100 mg L<sup>â1</sup> streptomycin. The culture was maintained at 37 Â°C in a humidified atmosphere containing 5% CO<sub>2</sub>.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Cell Viability Assay</h3><div class="NLM_p last">Cancer cells were plated in triplicate wells into a 96-well plate at a density of 5000 cells/well. After 24 h culture, the medium in the wells was replaced with fresh medium containing peptides at different dose; cells without peptides were treated as control. After 24 h incubation, cells viabilities were determined using Cell Counting Kit-8 (Dojindo, CK-04) according to the manufacturerâs instructions. The cells were incubated with CCK-8 solution and cultured at 37 Â°C for another 1 h. Absorbance of the dissolved solutions was detected at 450 nm on a Cytation 5 (BioTek, America) microplate reader. The cell viability rate was calculated as follows: [(<i>A</i><sub>s</sub> â <i>A</i><sub>b</sub>)/(<i>A</i><sub>c</sub> â <i>A</i><sub>b</sub>)] Ã 100%, where <i>A</i><sub>s</sub> was the absorbance of the treatments of each group with different concentrations, <i>A</i><sub>c</sub> was the absorbance of the control treatments with medium, and <i>A</i><sub>b</sub> was the absorbance of the blank with only medium.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Hemolysis Assay</h3><div class="NLM_p last">The hemolytic activity of the peptides was evaluated by determining hemoglobin release from erythrocyte suspensions of fresh mice blood. The cells were centrifuged, washed three times with physiological saline (NS), dispensed into 96-well plates as 200 Î¼L of 4% (v/v) red blood cells in NS, and different peptide solutions were added to each well. Plates were incubated for 1 h at 37 Â°C and then centrifuged at 1000 rpm for 10 min. Samples (100 Î¼L) of the supernatant were transferred to 96-well plates, and hemoglobin release was monitored by measuring absorbance at 570 nm (BioTek Cytation 5, America). Zero hemolysis was determined in NS (<i>A</i><sub>NS</sub>), and 100% hemolysis was determined in 0.1% (v/v) Triton X-100 (<i>A</i><sub>Triton</sub>). Hemolysis percentage hemolysis was calculated as (<i>A</i><sub>peptide</sub> â <i>A</i><sub>NS</sub>)/(<i>A</i><sub>Triton</sub> â <i>A</i><sub>NS</sub>) Ã 100%.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> LDH Release Assay</h3><div class="NLM_p last">Lactate dehydrogenase release was performed by using cytotoxicity lactate dehydrogenase release assay Kit-WST (DOJINDO, CK-12). Briefly, 4T1 cells were plated in triplicate wells into a 96-well plate at a density of 5000 cells/well. After 24 h culture, the medium in the wells was replaced with fresh medium containing peptides at different dose; cells without peptides were treated as control. After 24 h incubation, lysis buffer was added as a positive control for 30 min. The working solution was then added to each well for 30 min at room temperature, followed by adding the stop solution. The absorbance at 490 nm was measured by a microplate reader (BioTek Cytation 5, America).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> ATP Release Assay</h3><div class="NLM_p last">The supernatant of peptide-treated 4T1 cells was analyzed using an enhanced ATP assay kit (Beyotime, S0027). Cells were seeded (20,000 cells/well) in a 96-well plate and treated with peptides (50 Î¼M) for varying time points (5, 15, 30, and 60 min). All experiments were performed in duplicate at a total of 3 times. Positive controls were untreated cells exposed to a serum-free medium containing lysis buffer. Negative controls were untreated cells exposed to a serum-free medium alone. Samples were analyzed using a luminometer (Tecan Spark, Switzerland) according to the manufacturerâs protocol.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Observation of the Peptide Effect Using a 3D Cell Explorer</h3><div class="NLM_p last">4T1 cells were seeded at 10,000 cells/well in a complete medium in a 20 mm dish and were allowed to adhere overnight. Cells were washed twice with a serum-free RPMI-1640, treated with peptides dissolved in RPMI, and investigated using Bright Field on a 3D cell explorer (Nanolive SA, Switzerland). The microscope was equipped with an incubation chamber with CO<sub>2</sub> and temperature control.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Observation of FITC-Peptide Translocation Using Confocal Microscopy</h3><div class="NLM_p last">4T1 cells (30,000 cells/well) in a 20 mm dish were treated with 16 Î¼M FITC-labeled peptides for 1 h, and the cells without peptide treatment served as controls. After washing three times with PBS, the cell membranes were labeled with DiD perchlorate (5 Î¼M), and the cell nuclei were stained with Hoechst 33342 (50 Î¼M). Peptide translocation into the cells was monitored using a Leica TCS SP8 confocal microscope (Leica Microsystems, Germany). The excitation wavelength was set at 488 nm, and the emission wavelengths were set at 505â530 nm for the FITC-labeled peptides. The excitation and emission wavelengths were set at 644 and 663 nm, respectively, for the DiD perchlorate-stained cell membranes. For cell nuclei, the excitation and emission wavelengths were set at 350 and 461 nm, respectively.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> LIVE/DEAD Cell Viability/Cytotoxicity</h3><div class="NLM_p last">4T1 cells were plated in triplicate wells into a 96-well plate at a density of 10,000 cells/well. After 24 h culture, the live cells were labeled with 2 Î¼M calcien-AM (<i>E</i><sub>x</sub>: 488 nm and <i>E</i><sub>m</sub>: 515 nm). Cells were washed twice with a serum-free RPMI-1640 and treated with 10 Î¼M peptide and 8 Î¼M PI (<i>E</i><sub>x</sub>: 535 nm and <i>E</i><sub>m</sub>: 617 nm) dissolved in RPMI-1640. The cells were photographed for varying time points by SparkCyto (Tecan, Switzerland). The microscope was equipped with an incubation chamber with CO<sub>2</sub> and temperature control.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Protease Stability</h3><div class="NLM_p last">The peptides were dissolved in PBS buffer solutions (50 mM, pH = 7.4) to a final concentration of 1 mM, respectively. Î±-Chymotrypsin was dissolved in PBS buffer (50 mM, containing 2 mM of CaCl<sub>2</sub>, pH = 7.4) to a final concentration of 0.5 ng/Î¼L. Then, the peptide solutions (100 Î¼L) were incubated with Î±-chymotrypsin solution (1 mL) at room temperature. 100 Î¼L of digestion mixture was taken at the different time and then quenched with 20 Î¼L of hydrochloric acid (1 M). The solution of the Î±-chymotrypsin peptide fragments was monitored by HPLC at different times to determine the fraction of protease degradation at 214 nm. Each experiment was performed in triplicate.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>In Vivo</i> Antitumor Therapy</h3><div class="NLM_p">Female BALB/c mice (4â5 weeks, 18â22 g) and Female C57 mice (4â5 weeks, 18â22 g) were purchased from Shanghai SIPPR BK Laboratory Animals Ltd. The animal experiment designed in this study was approved by the ethical committee of Shanghai University of Traditional Chinese Medicine. 1 Ã 10<sup>6</sup> 4T1 cells were suspended in 100 Î¼L of serum-free RPMI-1640 and subcutaneously inoculated into the right side of the abdomen in female BALB/c mice. The tumor volume was monitored periodically by a vernier caliper and calculated using the following formula: volume = (length Ã width<sup>2</sup>)/2, where length is the largest tumor diameter and width is the smallest tumor diameter. When the average volume of tumors reached about 30 mm<sup>3</sup>, the mice were randomly divided into five groups (<i>n</i> = 5) and treated with water, LTX-315, anoplin, Ano-3, and Ano-3s <i>via</i> intratumorally injection once a day for 3 consecutive days; the peptide was dissolved in water (1.0 mg peptide/50 Î¼L water), and the vehicle control was water only. At the end of the experiment, the animals were euthanized and tumors were collected for further study.</div><div class="NLM_p last">5 Ã 10<sup>5</sup> B16F10 cells were suspended in 100 Î¼L serum-free DMEM and subcutaneously inoculated into the right side of the abdomen in female C57 mice. The tumor volume was monitored periodically by a vernier caliper and calculated using the following formula: volume = (length Ã width<sup>2</sup>)/2, where length is the largest tumor diameter and width is the smallest tumor diameter. When the average volume of tumors reached about 20â30 mm<sup>3</sup>, the mice were randomly divided into five groups (<i>n</i> = 5) and treated with water, LTX-315, anoplin, Ano-3, and Ano-3s <i>via</i> intratumorally injection once a day for 3 consecutive days; the peptide was dissolved in water (1.0 mg peptide/50 Î¼L water), and the vehicle control was water only. At the end of the experiment, the animals were euthanized, and tumors were collected for further study.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Immunofluorescence Staining of Extracellular HMGB1</h3><div class="NLM_p last">4T1 cells and B16F10 cells were seeded in glass-bottom dish at a density of 5 Ã 10<sup>4</sup> cells/well and incubated overnight. The cells were treated with Ano-3 at a IC<sub>75</sub> concentration for 6 h. Cells incubated with medium without Ano-3 served as a control. Then, the cells were washed three times with cold PBS and fixed in 4% paraformaldehyde for 20 min and permeabilized with 1% Triton X-100 for 5 min. Nonspecific binding sites were blocked by preincubation with quick blocking solution for 1 h, followed by incubation with anti-HMGB1 antibody (Abcam ab227168) at 4 Â°C for 16 h, and then incubated with an Alexa Fluor 488-conjugated secondary antibody for 2 h after washing three times with PBS. Finally, the cells were stained with Hoechst 33342 and detected by GE DeltaVision OMX SR.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Immunofluorescence Staining of Calreticulin</h3><div class="NLM_p last">4T1 cells and B16F10 cells were seeded in a glass-bottom dish at a density of 5 Ã 10<sup>4</sup> cells/well and incubated overnight. The cells were treated with Ano-3 at a IC<sub>75</sub> concentration for 6 h. Cells incubated with medium without Ano-3 served as a control. Then, the cells were washed three times with cold PBS and fixed in 4% paraformaldehyde for 20 min. Nonspecific binding sites were blocked by preincubation with quick blocking solution for 1 h, followed by incubation with Alexa Fluor 488-CRT (Abcam ab196159) for 1 h, stained with DiR and Hoechst 33342 to label the cell membrane and nuclei, respectively. Surface detection of CRT was observed by GE DeltaVision OMX SR.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>In Vivo</i> CD8+ Cell Depletion</h3><div class="NLM_p last">To deplete CD8+ T cells, C57 mice received anti-CD8a monoclonal antibodies i.p. (clone YTS 169.4, BioXcell, BE0117). The antibody (200 Î¼g per mouse) was diluted in PBS. Injections were started one day before the first Ano-3s injection and were continued every 2 days for 3 times in total.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Statistical Analysis</h3><div class="NLM_p last">Data were analyzed using GraphPad Prism 8.0.1 statistical analysis software. The data are presented as the mean Â± standard deviation. Studentâs <i>t</i>-test or two-way ANOVA, followed by Tukeyâs test was applied for comparison between two groups or among multiple groups, respectively: *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.001.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30"><a href="/doi/suppl/10.1021/acs.jmedchem.0c02237" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02876" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02876" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c02237?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02237</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings with IC<sub>50</sub> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02237/suppl_file/jm0c02237_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">HPLC, HR-Q-TOF-MS, CD, and NMR characterization; antitumor activity of all compounds; LDH release of 4T1 cells following treatment with anoplin; 4T1 cells after treatment with anoplin and stained with the LIVE/DEAD cell viability/cytotoxicity kit; protease stability of peptides; and immunohistochemical staining images and quantitative analysis of CD4+ T cells and CD8+ T cells in the 4T1 tumor slices (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02237/suppl_file/jm0c02237_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02237/suppl_file/jm0c02237_si_001.csv">jm0c02237_si_001.csv (2.99 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02237/suppl_file/jm0c02237_si_002.pdf">jm0c02237_si_002.pdf (1.85 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c02237" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20322" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20322" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xin Luan</span> - <span class="hlFld-Affiliation affiliation">Institute
of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3674-256X" title="Orcid link">http://orcid.org/0000-0003-3674-256X</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d9b5acb8b7a1b0b799aab1acadbab4f7bcbdacf7bab7"><span class="__cf_email__" data-cfemail="0a667f6b647263644a79627f7e6967246f6e7f246964">[emailÂ protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weidong Zhang</span> - <span class="hlFld-Affiliation affiliation">Institute
of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China</span>;Â 
    <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Second Military Medical University, Shanghai 201203, China</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#fb9f81939a959c82bb93948f969a9297d5989496"><span class="__cf_email__" data-cfemail="acc8d6c4cdc2cbd5ecc4c3d8c1cdc5c082cfc3c1">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ye Wu</span> - <span class="hlFld-Affiliation affiliation">Institute
of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dong Lu</span> - <span class="hlFld-Affiliation affiliation">Institute
of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yixin Jiang</span> - <span class="hlFld-Affiliation affiliation">Institute
of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jinmei Jin</span> - <span class="hlFld-Affiliation affiliation">Institute
of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sanhong Liu</span> - <span class="hlFld-Affiliation affiliation">Institute
of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lili Chen</span> - <span class="hlFld-Affiliation affiliation">Institute
of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong Zhang</span> - <span class="hlFld-Affiliation affiliation">Institute
of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yudong Zhou</span> - <span class="hlFld-Affiliation affiliation">Institute
of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China</span>;Â 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Biochemistry, College of Liberal Arts, University of Mississippi, University, Mississippi 38677-1848, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hongzhuan Chen</span> - <span class="hlFld-Affiliation affiliation">Institute
of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dale G. Nagle</span> - <span class="hlFld-Affiliation affiliation">Institute
of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China</span>;Â 
    <span class="hlFld-Affiliation affiliation">Department
of Biomolecular Sciences and Research of Institute of Pharmaceutical
Sciences, School of Pharmacy, University
of Mississippi, University, Mississippi 38677-1848, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Y.W. and D.L. contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80465" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80465" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the National Natural Science Foundation of China (no. 81903654), Program for Professor of Special Appointment (Young Eastern Scholar) at Shanghai Institutions of Higher Learning (QD2018035), Shanghai âChenguang Programâ of Education Commission of Shanghai Municipality (no. 18CG46), Shanghai Sailing Program (no. 19YF1449400), Graduate Innovation Training research project of the Shanghai University of Traditional Chinese Medicine (no. Y2019064), National Key Subject of Drug Innovation (2019ZX09201005-007), National key R & D program for key research project of modernization of traditional Chinese medicine (2019YFC1711602), and the U.S. NIH grant CA199016.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73574" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73574" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 51 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bray, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferlay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soerjomataram, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torre, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span> <span> </span><span class="NLM_article-title">Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</span>. <i>Ca-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">394</span>â <span class="NLM_lpage">424</span>, <span class="refDoi">Â DOI: 10.3322/caac.21492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.3322%2Fcaac.21492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=30207593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A280%3ADC%252BB3c3otVGlsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2018&pages=394-424&author=F.+Brayauthor=J.+Ferlayauthor=I.+Soerjomataramauthor=R.+L.+Siegelauthor=L.+A.+Torreauthor=A.+Jemal&title=Global+cancer+statistics+2018%3A+GLOBOCAN+estimates+of+incidence+and+mortality+worldwide+for+36+cancers+in+185+countries&doi=10.3322%2Fcaac.21492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</span></div><div class="casAuthors">Bray Freddie; Ferlay Jacques; Soerjomataram Isabelle; Siegel Rebecca L; Torre Lindsey A; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">394-424</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions.  There will be an estimated 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018.  In both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths), closely followed by female breast cancer (11.6%), prostate cancer (7.1%), and colorectal cancer (6.1%) for incidence and colorectal cancer (9.2%), stomach cancer (8.2%), and liver cancer (8.2%) for mortality.  Lung cancer is the most frequent cancer and the leading cause of cancer death among males, followed by prostate and colorectal cancer (for incidence) and liver and stomach cancer (for mortality).  Among females, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death, followed by colorectal and lung cancer (for incidence), and vice versa (for mortality); cervical cancer ranks fourth for both incidence and mortality.  The most frequently diagnosed cancer and the leading cause of cancer death, however, substantially vary across countries and within each country depending on the degree of economic development and associated social and life style factors.  It is noteworthy that high-quality cancer registry data, the basis for planning and implementing evidence-based cancer control programs, are not available in most low- and middle-income countries.  The Global Initiative for Cancer Registry Development is an international partnership that supports better estimation, as well as the collection and use of local data, to prioritize and evaluate national cancer control efforts.  CA: A Cancer Journal for Clinicians 2018;0:1-31. Â© 2018 American Cancer Society.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQaW5wv8ocuhLxanA7vODO6fW6udTcc2eZ5eDbrgXL20rntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3otVGlsg%253D%253D&md5=48529f8f794092779d70a27eec5c9017</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21492%26sid%3Dliteratum%253Aachs%26aulast%3DBray%26aufirst%3DF.%26aulast%3DFerlay%26aufirst%3DJ.%26aulast%3DSoerjomataram%26aufirst%3DI.%26aulast%3DSiegel%26aufirst%3DR.%2BL.%26aulast%3DTorre%26aufirst%3DL.%2BA.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DGlobal%2520cancer%2520statistics%25202018%253A%2520GLOBOCAN%2520estimates%2520of%2520incidence%2520and%2520mortality%2520worldwide%2520for%252036%2520cancers%2520in%2520185%2520countries%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2018%26volume%3D68%26spage%3D394%26epage%3D424%26doi%3D10.3322%2Fcaac.21492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogueira, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariotto, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabroff, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alfano, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R. L.</span></span> <span> </span><span class="NLM_article-title">Cancer treatment and survivorship statistics, 2019</span>. <i>Ca-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">363</span>â <span class="NLM_lpage">385</span>, <span class="refDoi">Â DOI: 10.3322/caac.21565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.3322%2Fcaac.21565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=31184787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A280%3ADC%252BB3M3ltlemug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2019&pages=363-385&author=K.+D.+Millerauthor=L.+Nogueiraauthor=A.+B.+Mariottoauthor=J.+H.+Rowlandauthor=K.+R.+Yabroffauthor=C.+M.+Alfanoauthor=A.+Jemalauthor=J.+L.+Kramerauthor=R.+L.+Siegel&title=Cancer+treatment+and+survivorship+statistics%2C+2019&doi=10.3322%2Fcaac.21565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer treatment and survivorship statistics, 2019</span></div><div class="casAuthors">Miller Kimberly D; Jemal Ahmedin; Siegel Rebecca L; Nogueira Leticia; Yabroff K Robin; Jemal Ahmedin; Mariotto Angela B; Rowland Julia H; Alfano Catherine M; Kramer Joan L</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">363-385</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The number of cancer survivors continues to increase in the United States because of the growth and aging of the population as well as advances in early detection and treatment.  To assist the public health community in better serving these individuals, the American Cancer Society and the National Cancer Institute collaborate every 3 years to estimate cancer prevalence in the United States using incidence and survival data from the Surveillance, Epidemiology, and End Results cancer registries; vital statistics from the Centers for Disease Control and Prevention's National Center for Health Statistics; and population projections from the US Census Bureau.  Current treatment patterns based on information in the National Cancer Data Base are presented for the most prevalent cancer types.  Cancer-related and treatment-related short-term, long-term, and late health effects are also briefly described.  More than 16.9 million Americans (8.1 million males and 8.8 million females) with a history of cancer were alive on January 1, 2019; this number is projected to reach more than 22.1 million by January 1, 2030 based on the growth and aging of the population alone.  The 3 most prevalent cancers in 2019 are prostate (3,650,030), colon and rectum (776,120), and melanoma of the skin (684,470) among males, and breast (3,861,520), uterine corpus (807,860), and colon and rectum (768,650) among females.  More than one-half (56%) of survivors were diagnosed within the past 10 years, and almost two-thirds (64%) are aged 65 years or older.  People with a history of cancer have unique medical and psychosocial needs that require proactive assessment and management by follow-up care providers.  Although there are growing numbers of tools that can assist patients, caregivers, and clinicians in navigating the various phases of cancer survivorship, further evidence-based resources are needed to optimize care.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTqS-tR1uHDx5ggzHGM8X5CfW6udTcc2eZ5eDbrgXL20rntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3ltlemug%253D%253D&md5=3bcced5db38c65d9d98364c3884a21d9</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21565%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DNogueira%26aufirst%3DL.%26aulast%3DMariotto%26aufirst%3DA.%2BB.%26aulast%3DRowland%26aufirst%3DJ.%2BH.%26aulast%3DYabroff%26aufirst%3DK.%2BR.%26aulast%3DAlfano%26aufirst%3DC.%2BM.%26aulast%3DJemal%26aufirst%3DA.%26aulast%3DKramer%26aufirst%3DJ.%2BL.%26aulast%3DSiegel%26aufirst%3DR.%2BL.%26atitle%3DCancer%2520treatment%2520and%2520survivorship%2520statistics%252C%25202019%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2019%26volume%3D69%26spage%3D363%26epage%3D385%26doi%3D10.3322%2Fcaac.21565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arnst, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. D.</span></span> <span> </span><span class="NLM_article-title">Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1398</span>â <span class="NLM_lpage">1426</span>, <span class="refDoi">Â DOI: 10.1002/med.21568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1002%2Fmed.21568" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=30746734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A280%3ADC%252BB3cfhslejug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2019&pages=1398-1426&author=K.+E.+Arnstauthor=S.+Banerjeeauthor=H.+Chenauthor=S.+Dengauthor=D.+J.+Hwangauthor=W.+Liauthor=D.+D.+Miller&title=Current+advances+of+tubulin+inhibitors+as+dual+acting+small+molecules+for+cancer+therapy&doi=10.1002%2Fmed.21568"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy</span></div><div class="casAuthors">Arnst Kinsie E; Banerjee Souvik; Chen Hao; Deng Shanshan; Hwang Dong-Jin; Li Wei; Miller Duane D</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal research reviews</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1398-1426</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Microtubule (MT)-targeting agents are highly successful drugs as chemotherapeutic agents, and this is attributed to their ability to target MT dynamics and interfere with critical cellular functions, including, mitosis, cell signaling, intracellular trafficking, and angiogenesis.  Because MT dynamics vary in the different stages of the cell cycle, these drugs tend to be the most effective against mitotic cells.  While this class of drug has proven to be effective against many cancer types, significant hurdles still exist and include overcoming aspects such as dose limited toxicities and the development of resistance.  Newer generations of developed drugs attack these problems and alternative approaches such as the development of dual tubulin and kinase inhibitors are being investigated.  This approach offers the potential to show increased efficacy and lower toxicities.  This review covers different categories of MT-targeting agents, recent advances in dual inhibitors, and current challenges for this drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTqfJ98Efo_uekdrW1FkXG-fW6udTcc2eackfdmXfoSOrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cfhslejug%253D%253D&md5=dafb1dbc34589cd0e9a9ac0f384252f1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fmed.21568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21568%26sid%3Dliteratum%253Aachs%26aulast%3DArnst%26aufirst%3DK.%2BE.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDeng%26aufirst%3DS.%26aulast%3DHwang%26aufirst%3DD.%2BJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26atitle%3DCurrent%2520advances%2520of%2520tubulin%2520inhibitors%2520as%2520dual%2520acting%2520small%2520molecules%2520for%2520cancer%2520therapy%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2019%26volume%3D39%26spage%3D1398%26epage%3D1426%26doi%3D10.1002%2Fmed.21568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ning, X.</span></span> <span> </span><span class="NLM_article-title">The first integrins Î²3-mediated cellular and nuclear targeting therapeutics for prostate cancer</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>223</i></span>,  <span class="NLM_fpage">119471</span>, <span class="refDoi">Â DOI: 10.1016/j.biomaterials.2019.119471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1016%2Fj.biomaterials.2019.119471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=31525693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslOntrnI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=223&publication_year=2019&pages=119471&author=L.+Zhangauthor=X.+Shanauthor=X.+Mengauthor=T.+Guauthor=Q.+Luauthor=J.+Zhangauthor=J.+Chenauthor=Q.+Jiangauthor=X.+Ning&title=The+first+integrins+%CE%B23-mediated+cellular+and+nuclear+targeting+therapeutics+for+prostate+cancer&doi=10.1016%2Fj.biomaterials.2019.119471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The first integrins Î²3-mediated cellular and nuclear targeting therapeutics for prostate cancer</span></div><div class="casAuthors">Zhang, Lei; Shan, Xue; Meng, Xia; Gu, Tingting; Lu, Qiangbing; Zhang, Jikang; Chen, Jiao; Jiang, Qing; Ning, Xinghai</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">223</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">119471</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Prostate cancer is one of the most commonly diagnosed cancers in men, leading to a high mortality rate due to a lack of effective anticancer treatment.  Current anticancer chemotherapeutics are often administrated at suboptimal doses because of nonspecific toxicities to normal tissues, resulting in the eventual failure of therapy as well as the development of drug resistance and metastatic disease.  Therefore, ligand-targeted therapeutics have the great potential of improving the selective anticancer toxicity.  Integrins Î²3 (Î±vÎ²3 and Î±IIbÎ²3) are an important cell adhesion mol. family, overexpressed on both cell membrane and perinuclear region of prostate cancer cells, and play a key role in the progression and metastasis of prostate cancer, making them an attractive target for anticancer therapy.  However, their clin. impacts have been limited due to lack of specific ligands.  Here, for the first time, we have identified a peptide Arginine-Tryptophan-(D-Arginine)-Asparagine-Arginine as an integrins Î²3 specific ligand, named B3int, which shows superior selectivity to integrins Î²3 over other integrin subunits.  B3int has high affinity to integrins Î²3 with a Kd value of 0.2 nM, which is 7-fold higher than c-RGDyK (1.4 nM), a well-established integrin Î±vÎ²3 ligand.  In addn., B3int shows high specificity for integrins Î²3, and can selectively target integrin Î²3 overexpressed cancer cells in vitro and in vivo.  Most importantly, B3int-modified liposomes (B3int-LS-DOX) can selectively deliver DOX not only into prostate cancer cells, but into nucleus via targeting integrins Î²3, thereby significantly improving anticancer effects in 2D prostate cancer cells and 3D tumor spheroids.  Particularly, B3int-LS-DOX effectively inhibits tumor growth with an ED of as low as 1.5 mg/kg, which is 3.3-fold less than c-RGDyK-LS-DOX (5 mg/kg), indicating that integrins Î²3 specific therapy is a promising anticancer strategy which can greatly improve the anticancer therapeutic index.  In summary, we have identified B3int as the first integrins Î²3 specific ligand with high affinity and specificity, and holds a great potential of improving the diagnosis and treatment for integrins Î²3-overexpressed cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquJyDBEyCCaLVg90H21EOLACvtfcHk0liLAXYV1RP2MA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslOntrnI&md5=a5fe0aa5983369c0ee88d4eb0eff8e98</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2019.119471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2019.119471%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DShan%26aufirst%3DX.%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DGu%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DNing%26aufirst%3DX.%26atitle%3DThe%2520first%2520integrins%2520%25CE%25B23-mediated%2520cellular%2520and%2520nuclear%2520targeting%2520therapeutics%2520for%2520prostate%2520cancer%26jtitle%3DBiomaterials%26date%3D2019%26volume%3D223%26spage%3D119471%26doi%3D10.1016%2Fj.biomaterials.2019.119471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marqus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirogova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piva, T. J.</span></span> <span> </span><span class="NLM_article-title">Evaluation of the use of therapeutic peptides for cancer treatment</span>. <i>J. Biomed. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">21</span>, <span class="refDoi">Â DOI: 10.1186/s12929-017-0328-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1186%2Fs12929-017-0328-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=28320393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtVSgtb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=21&author=S.+Marqusauthor=E.+Pirogovaauthor=T.+J.+Piva&title=Evaluation+of+the+use+of+therapeutic+peptides+for+cancer+treatment&doi=10.1186%2Fs12929-017-0328-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the use of therapeutic peptides for cancer treatment</span></div><div class="casAuthors">Marqus, Susan; Pirogova, Elena; Piva, Terrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomedical Science (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21/1-21/15</span>CODEN:
                <span class="NLM_cas:coden">JBCIEA</span>;
        ISSN:<span class="NLM_cas:issn">1423-0127</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Cancer along with cardiovascular disease are the main causes of death in the industrialized countries around the World.  Conventional cancer treatments are losing their therapeutic uses due to drug resistance, lack of tumor selectivity and soly. and as such there is a need to develop new therapeutic agents.  Therapeutic peptides are a promising and a novel approach to treat many diseases including cancer.  They have several advantages over proteins or antibodies: as they are (a) easy to synthesize, (b) have a high target specificity and selectivity and (c) have low toxicity.  Therapeutic peptides do have some significant drawbacks related to their stability and short half-life.  In this review, strategies used to overcome peptide limitations and to enhance their therapeutic effect will be compared.  The use of short cell permeable peptides that interfere and inhibit protein-protein interactions will also be evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ0O_jXGEAzbVg90H21EOLACvtfcHk0lgFcEEN1IlIPQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtVSgtb8%253D&md5=7b32f8b3aac28dad3ad49e532bbd009f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1186%2Fs12929-017-0328-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12929-017-0328-x%26sid%3Dliteratum%253Aachs%26aulast%3DMarqus%26aufirst%3DS.%26aulast%3DPirogova%26aufirst%3DE.%26aulast%3DPiva%26aufirst%3DT.%2BJ.%26atitle%3DEvaluation%2520of%2520the%2520use%2520of%2520therapeutic%2520peptides%2520for%2520cancer%2520treatment%26jtitle%3DJ.%2520Biomed.%2520Sci.%26date%3D2017%26volume%3D24%26spage%3D21%26doi%3D10.1186%2Fs12929-017-0328-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, R.</span></span> <span> </span><span class="NLM_article-title">The chemistry and biological activities of peptides from amphibian skin secretions</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">1760</span>â <span class="NLM_lpage">1846</span>, <span class="refDoi">Â DOI: 10.1021/cr4006704</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr4006704" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVCiu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2015&pages=1760-1846&author=X.+Xuauthor=R.+Lai&title=The+chemistry+and+biological+activities+of+peptides+from+amphibian+skin+secretions&doi=10.1021%2Fcr4006704"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The Chemistry and Biological Activities of Peptides from Amphibian Skin Secretions</span></div><div class="casAuthors">Xu, Xueqing; Lai, Ren</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1760-1846</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Amphibians can live in a wide range of habitats and ecol. conditions because of their morphol., biochem., and physiol. complex skins, which perform versatile functions and contain pharmacol. compds. of interest because of their potential for drug development.  Amphibians might be the only natural source of >7 types of drug candidates with analgesic, antibiotic, antiviral, wound-healing, antidiabetic, and anticancerous properties and the potential of treating cardiovascular diseases.  In particular, amphibian skin peptides are promising for treating cancer, HIV, and drug-resistant Staphylococcus aureus, which are major problems facing the 21st century medical community.  More than 100,000 bioactive compds. are estd. to occur in amphibian skin secretions, but â¼33% of 6300 amphibian species are endangered.  In addn. to protecting them for their potential pharmaceutical value, much more effort should be paid to amphibian conservation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC139PFpLDk7Vg90H21EOLACvtfcHk0lgFcEEN1IlIPQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVCiu7c%253D&md5=f5d4be9cc623e4ccc50bd40d104d70c8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fcr4006704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr4006704%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DX.%26aulast%3DLai%26aufirst%3DR.%26atitle%3DThe%2520chemistry%2520and%2520biological%2520activities%2520of%2520peptides%2520from%2520amphibian%2520skin%2520secretions%26jtitle%3DChem.%2520Rev.%26date%3D2015%26volume%3D115%26spage%3D1760%26epage%3D1846%26doi%3D10.1021%2Fcr4006704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W. D.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic and antitumor peptides as novel chemotherapeutics</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">7</span>â <span class="NLM_lpage">17</span>, <span class="refDoi">Â DOI: 10.1039/d0np00019a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1039%2Fd0np00019a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=32776055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsFGgsL%252FP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2021&pages=7-17&author=X.+Luanauthor=Y.+Wuauthor=Y.+W.+Shenauthor=H.+Zhangauthor=Y.+D.+Zhouauthor=H.+Z.+Chenauthor=D.+G.+Nagleauthor=W.+D.+Zhang&title=Cytotoxic+and+antitumor+peptides+as+novel+chemotherapeutics&doi=10.1039%2Fd0np00019a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic and antitumor peptides as novel chemotherapeutics</span></div><div class="casAuthors">Luan, Xin; Wu, Ye; Shen, Yi-Wen; Zhang, Hong; Zhou, Yu-Dong; Chen, Hong-Zhuan; Nagle, Dale G.; Zhang, Wei-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-17</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Treatment resistance and drug-induced refractory malignancies pose significant challenges for current chemotherapy drugs.  There have been increasing research efforts aimed at developing novel chemotherapeutics, esp. from natural products and related derivs.  Natural cytotoxic peptides, an emerging source of chemotherapeutics, have exhibited the advantage of overcoming drug resistance and displayed broad-spectrum antitumor activities in the clinic.  This highlight examines the increasingly popular cytotoxic peptides from isolated natural products.  In-depth review of several peptides provides examples for how this novel strategy can lead to the improved anti-tumor effects.  The mechanisms and current application of representative natural cytotoxic peptides (NCPs) have also been discussed, with a particular focus on future directions for interdisciplinary research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCrFHP39P6arVg90H21EOLACvtfcHk0lgoZeUp-61zkQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsFGgsL%252FP&md5=e3baf126f272a0c2e5734f0cfe95458e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1039%2Fd0np00019a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fd0np00019a%26sid%3Dliteratum%253Aachs%26aulast%3DLuan%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DY.%2BW.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DY.%2BD.%26aulast%3DChen%26aufirst%3DH.%2BZ.%26aulast%3DNagle%26aufirst%3DD.%2BG.%26aulast%3DZhang%26aufirst%3DW.%2BD.%26atitle%3DCytotoxic%2520and%2520antitumor%2520peptides%2520as%2520novel%2520chemotherapeutics%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2021%26volume%3D38%26spage%3D7%26epage%3D17%26doi%3D10.1039%2Fd0np00019a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarena, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span> <span> </span><span class="NLM_article-title">Host defense antimicrobial peptides as antibiotics: design and application strategies</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">87</span>â <span class="NLM_lpage">96</span>, <span class="refDoi">Â DOI: 10.1016/j.cbpa.2017.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1016%2Fj.cbpa.2017.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=28399505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvVGjs7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=87-96&author=B.+Mishraauthor=S.+Reilingauthor=D.+Zarenaauthor=G.+Wang&title=Host+defense+antimicrobial+peptides+as+antibiotics%3A+design+and+application+strategies&doi=10.1016%2Fj.cbpa.2017.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Host defense antimicrobial peptides as antibiotics: design and application strategies</span></div><div class="casAuthors">Mishra, Biswajit; Reiling, Scott; Zarena, D.; Wang, Guangshun</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87-96</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This review deals with the design and application strategies of new antibiotics based on naturally occurring antimicrobial peptides (AMPs).  The initial candidate can be designed based on three-dimensional structure or selected from a library of peptides from natural or lab. sources followed by optimization via structure-activity relationship studies.  There are also advanced application strategies such as induction of AMP expression from host cells by various factors (e.g., metals, amino acids, vitamin D and sunlight), the use of engineered probiotic bacteria to deliver peptides, the design of prodrug and peptide conjugates to improve specific targeting.  In addn., combined uses of newly developed AMPs with existing antimicrobial agents may provide a practical avenue for effective management of antibiotic-resistant bacteria (superbugs), including biofilms.  Finally, we highlight AMPs already in use or under clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTk0CCg6Ayc7Vg90H21EOLACvtfcHk0lgoZeUp-61zkQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvVGjs7k%253D&md5=7be2a39ed31cabebfa2d1a30038a2615</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2017.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2017.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DMishra%26aufirst%3DB.%26aulast%3DReiling%26aufirst%3DS.%26aulast%3DZarena%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DG.%26atitle%3DHost%2520defense%2520antimicrobial%2520peptides%2520as%2520antibiotics%253A%2520design%2520and%2520application%2520strategies%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2017%26volume%3D38%26spage%3D87%26epage%3D96%26doi%3D10.1016%2Fj.cbpa.2017.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parvy, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dostalova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurjan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LemaÃ®tre, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordero, J. B.</span></span> <span> </span><span class="NLM_article-title">The antimicrobial peptide defensin cooperates with tumour necrosis factor to drive tumour cell death in Drosophila</span>. <i>elife</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e45061</span> <span class="refDoi">Â DOI: 10.7554/elife.45061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.7554%2Felife.45061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=31358113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BB3cXht1CrtrrO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&author=J.-P.+Parvyauthor=Y.+Yuauthor=A.+Dostalovaauthor=S.+Kondoauthor=A.+Kurjanauthor=P.+Buletauthor=B.+Lema%C3%AEtreauthor=M.+Vidalauthor=J.+B.+Cordero&title=The+antimicrobial+peptide+defensin+cooperates+with+tumour+necrosis+factor+to+drive+tumour+cell+death+in+Drosophila&doi=10.7554%2Felife.45061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The antimicrobial peptide defensin cooperates with tumour necrosis factor to drive tumour cell death in Drosophila</span></div><div class="casAuthors">Parvy, Jean-Philippe; Yu, Yachuan; Dostalova, Anna; Kondo, Shu; Kurjan, Alina; Bulet, Philippe; Lemaitre, Bruno; Vidal, Marcos; Cordero, Julia B.</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e45061</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">Antimicrobial peptides (AMPs) are small cationic mols. best known as mediators of the innate defense against microbial infection.  While in vitro and ex vivo evidence suggest AMPs' capacity to kill cancer cells, in vivo demonstration of an anti-tumor role of endogenous AMPs is lacking.  Using a Drosophila model of tumorigenesis, we demonstrate a role for the AMP Defensin in the control of tumor progression.  Our results reveal that Tumor Necrosis Factor mediates exposure of phosphatidylserine (PS), which makes tumor cells selectively sensitive to the action of Defensin remotely secreted from tracheal and fat tissues.  Defensin binds tumor cells in PS-enriched areas, provoking cell death and tumor regression.  Altogether, our results provide the first in vivo demonstration for a role of an endogenous AMP as an anti-cancer agent, as well as a mechanism that explains tumor cell sensitivity to the action of AMPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNU7UowFJg_rVg90H21EOLACvtfcHk0li8MQoZOQHx3g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXht1CrtrrO&md5=92f1a12d74c5a39fe1d122a6c7ff4abc</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.7554%2Felife.45061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252Felife.45061%26sid%3Dliteratum%253Aachs%26aulast%3DParvy%26aufirst%3DJ.-P.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DDostalova%26aufirst%3DA.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DKurjan%26aufirst%3DA.%26aulast%3DBulet%26aufirst%3DP.%26aulast%3DLema%25C3%25AEtre%26aufirst%3DB.%26aulast%3DVidal%26aufirst%3DM.%26aulast%3DCordero%26aufirst%3DJ.%2BB.%26atitle%3DThe%2520antimicrobial%2520peptide%2520defensin%2520cooperates%2520with%2520tumour%2520necrosis%2520factor%2520to%2520drive%2520tumour%2520cell%2520death%2520in%2520Drosophila%26jtitle%3Delife%26date%3D2019%26volume%3D8%26doi%3D10.7554%2Felife.45061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuroda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okumura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isogai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isogai, E.</span></span> <span> </span><span class="NLM_article-title">The human cathelicidin antimicrobial peptide LL-37 and mimics are potential anticancer drugs</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">144</span>, <span class="refDoi">Â DOI: 10.3389/fonc.2015.00144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.3389%2Ffonc.2015.00144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=26175965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A280%3ADC%252BC28%252Fjs1alug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=144&author=K.+Kurodaauthor=K.+Okumuraauthor=H.+Isogaiauthor=E.+Isogai&title=The+human+cathelicidin+antimicrobial+peptide+LL-37+and+mimics+are+potential+anticancer+drugs&doi=10.3389%2Ffonc.2015.00144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The Human Cathelicidin Antimicrobial Peptide LL-37 and Mimics are Potential Anticancer Drugs</span></div><div class="casAuthors">Kuroda Kengo; Isogai Emiko; Okumura Kazuhiko; Isogai Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">144</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">Antimicrobial peptides (AMPs) play a critical role in innate host defense against microbial pathogens in many organisms.  The human cathelicidin, LL-37, has a net positive charge and is amphiphilic, and can eliminate pathogenic microbes directly via electrostatic attraction toward negatively charged bacterial membranes.  A number of studies have shown that LL-37 participates in various host immune systems, such as inflammatory responses and tissue repair, in addition to its antibacterial properties.  Moreover, recent evidence suggests that it is also involved in the regulation of cancer.  Indeed, previous studies have suggested that human LL-37 is involved in carcinogenesis via multiple reporters, such as FPR2 (FPRL1), epidermal growth factor receptor, and ERBb2, although LL-37 and its fragments and analogs also show anticancer effects in various cancer cell lines.  This discrepancy can be attributed to peptide-based factors, host membrane-based factors, and signal regulation.  Here, we describe the association between AMPs and cancer with a focus on anticancer peptide functions and selectivity in an effort to understand potential therapeutic implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTQvjmAchpbZyO2kE7krGOBfW6udTcc2eb_izG3E6ZTzbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252Fjs1alug%253D%253D&md5=14e9e1bc9303762f33100d54110b1e33</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2015.00144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2015.00144%26sid%3Dliteratum%253Aachs%26aulast%3DKuroda%26aufirst%3DK.%26aulast%3DOkumura%26aufirst%3DK.%26aulast%3DIsogai%26aufirst%3DH.%26aulast%3DIsogai%26aufirst%3DE.%26atitle%3DThe%2520human%2520cathelicidin%2520antimicrobial%2520peptide%2520LL-37%2520and%2520mimics%2520are%2520potential%2520anticancer%2520drugs%26jtitle%3DFront.%2520Oncol.%26date%3D2015%26volume%3D5%26spage%3D144%26doi%3D10.3389%2Ffonc.2015.00144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">SveinbjÃ¸rnsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camilio, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haug, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rekdal, Ã.</span></span> <span> </span><span class="NLM_article-title">LTX-315: a first-in-class oncolytic peptide that reprograms the tumor microenvironment</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1339</span>â <span class="NLM_lpage">1344</span>, <span class="refDoi">Â DOI: 10.4155/fmc-2017-0088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.4155%2Ffmc-2017-0088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=28490192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht12mu7%252FN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=1339-1344&author=B.+Sveinbj%C3%B8rnssonauthor=K.+A.+Camilioauthor=B.+E.+Haugauthor=%C3%98.+Rekdal&title=LTX-315%3A+a+first-in-class+oncolytic+peptide+that+reprograms+the+tumor+microenvironment&doi=10.4155%2Ffmc-2017-0088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">LTX-315: a first-in-class oncolytic peptide that reprograms the tumor microenvironment</span></div><div class="casAuthors">Sveinbjornsson, Baldur; Camilio, Ketil Andre; Haug, Bengt Erik; Rekdal, Oystein</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1339-1344</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">The oncolytic peptide LTX-315, which has been de novo designed based on structure-activity relationship studies of host defense peptides, has the ability to kill human cancer cells and induce specific anticancer immune response when injected locally into tumors established in immunocompetent mice.  The oncolytic effect of LTX-315 involves perturbation of plasma membrane and the mitochondria with subsequent release of danger-assocd. mol. pattern mols., which highlights the ability of LTX-315 to induce complete regression and protective immune responses.  Treatment with LTX-315 reprograms the tumor microenvironment by decreasing the local abundance of immunosuppressive cells and by increasing the frequency of effector T cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYPrwmBhHTdLVg90H21EOLACvtfcHk0lhZgfcggHQYhQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht12mu7%252FN&md5=4864dfab7f66afe967905c4128f3e954</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2017-0088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2017-0088%26sid%3Dliteratum%253Aachs%26aulast%3DSveinbj%25C3%25B8rnsson%26aufirst%3DB.%26aulast%3DCamilio%26aufirst%3DK.%2BA.%26aulast%3DHaug%26aufirst%3DB.%2BE.%26aulast%3DRekdal%26aufirst%3D%25C3%2598.%26atitle%3DLTX-315%253A%2520a%2520first-in-class%2520oncolytic%2520peptide%2520that%2520reprograms%2520the%2520tumor%2520microenvironment%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2017%26volume%3D9%26spage%3D1339%26epage%3D1344%26doi%3D10.4155%2Ffmc-2017-0088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rady, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rady, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhtar, H.</span></span> <span> </span><span class="NLM_article-title">Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy</span>. <i>Canc. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>402</i></span>,  <span class="NLM_fpage">16</span>â <span class="NLM_lpage">31</span>, <span class="refDoi">Â DOI: 10.1016/j.canlet.2017.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1016%2Fj.canlet.2017.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=28536009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotlyjurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=2017&pages=16-31&author=I.+Radyauthor=I.+A.+Siddiquiauthor=M.+Radyauthor=H.+Mukhtar&title=Melittin%2C+a+major+peptide+component+of+bee+venom%2C+and+its+conjugates+in+cancer+therapy&doi=10.1016%2Fj.canlet.2017.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy</span></div><div class="casAuthors">Rady, Islam; Siddiqui, Imtiaz A.; Rady, Mohamad; Mukhtar, Hasan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">402</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16-31</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Melittin (MEL), a major peptide component of bee venom, is an attractive candidate for cancer therapy.  This agent has shown a variety of anti-cancer effects in preclin. cell culture and animal model systems.  Despite a convincing efficacy data against variety of cancers, its applicability to humans has met with challenges due to several issues including its non-specific cytotoxicity, degrdn. and hemolytic activity.  Several optimization approaches including utilization of nanoparticle based delivery of MEL have been utilized to circumvent the issues.  Here, we summarize the current understanding of the anticancer effects of bee venom and MEL on different kinds of cancers.  Further, we also present the available information for the possible mechanism of action of bee venom and/or MEL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiL7L11f0CsbVg90H21EOLACvtfcHk0lhZgfcggHQYhQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotlyjurw%253D&md5=32e134d0322a2cec4736b06cfaa1c6f3</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2017.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2017.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DRady%26aufirst%3DI.%26aulast%3DSiddiqui%26aufirst%3DI.%2BA.%26aulast%3DRady%26aufirst%3DM.%26aulast%3DMukhtar%26aufirst%3DH.%26atitle%3DMelittin%252C%2520a%2520major%2520peptide%2520component%2520of%2520bee%2520venom%252C%2520and%2520its%2520conjugates%2520in%2520cancer%2520therapy%26jtitle%3DCanc.%2520Lett.%26date%3D2017%26volume%3D402%26spage%3D16%26epage%3D31%26doi%3D10.1016%2Fj.canlet.2017.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haug, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camilio, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliassen, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stensen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svendsen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortensen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirjolet, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bichat, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rekdal, Ã.</span></span> <span> </span><span class="NLM_article-title">Discovery of a 9-mer cationic peptide (LTX-315) as a potential first in class oncolytic peptide</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2918</span>â <span class="NLM_lpage">2927</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b02025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b02025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC28Xkt1CmsLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2918-2927&author=B.+E.+Haugauthor=K.+A.+Camilioauthor=L.+T.+Eliassenauthor=W.+Stensenauthor=J.+S.+Svendsenauthor=K.+Bergauthor=B.+Mortensenauthor=G.+Serinauthor=J.-F.+Mirjoletauthor=F.+Bichatauthor=%C3%98.+Rekdal&title=Discovery+of+a+9-mer+cationic+peptide+%28LTX-315%29+as+a+potential+first+in+class+oncolytic+peptide&doi=10.1021%2Facs.jmedchem.5b02025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide</span></div><div class="casAuthors">Haug, Bengt Erik; Camilio, Ketil Andre; Eliassen, Liv Tone; Stensen, Wenche; Svendsen, John Sigurd; Berg, Kristel; Mortensen, Bjarte; Serin, Guillaume; Mirjolet, Jean-Francois; Bichat, Francis; Rekdal, Oeystein</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2918-2927</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oncolytic immunotherapies represent a new promising strategy in the treatment of cancer.  In our efforts to develop oncolytic peptides, we identified a series of chem. modified 9-mer cationic peptides that were highly effective against both drug-resistant and drug-sensitive cancer cells and with lower toxicity toward normal cells.  Among these peptides, LTX-315 displayed superior anticancer activity and was selected as a lead candidate.  This peptide showed relative high plasma protein binding abilities and a human plasma half-life of 160 min, resulting in formation of nontoxic metabolites.  In addn., the lead candidate demonstrated relatively low ability to inhibit CYP450 enzymes.  Collectively these data indicated that this peptide has potential to be developed as a new anticancer agent for intratumoral administration and is currently being evaluated in a phase I/IIa study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosnc_kVs8B7LVg90H21EOLACvtfcHk0lhZgfcggHQYhQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xkt1CmsLY%253D&md5=0df37524b3691a17e3137920fc02316c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b02025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b02025%26sid%3Dliteratum%253Aachs%26aulast%3DHaug%26aufirst%3DB.%2BE.%26aulast%3DCamilio%26aufirst%3DK.%2BA.%26aulast%3DEliassen%26aufirst%3DL.%2BT.%26aulast%3DStensen%26aufirst%3DW.%26aulast%3DSvendsen%26aufirst%3DJ.%2BS.%26aulast%3DBerg%26aufirst%3DK.%26aulast%3DMortensen%26aufirst%3DB.%26aulast%3DSerin%26aufirst%3DG.%26aulast%3DMirjolet%26aufirst%3DJ.-F.%26aulast%3DBichat%26aufirst%3DF.%26aulast%3DRekdal%26aufirst%3D%25C3%2598.%26atitle%3DDiscovery%2520of%2520a%25209-mer%2520cationic%2520peptide%2520%2528LTX-315%2529%2520as%2520a%2520potential%2520first%2520in%2520class%2520oncolytic%2520peptide%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2918%26epage%3D2927%26doi%3D10.1021%2Facs.jmedchem.5b02025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ifrah, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doisy, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryge, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, P. R.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship study of anoplin</span>. <i>J. Pept. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">113</span>â <span class="NLM_lpage">121</span>, <span class="refDoi">Â DOI: 10.1002/psc.598</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1002%2Fpsc.598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=15635634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvFKmt7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=113-121&author=D.+Ifrahauthor=X.+Doisyauthor=T.+S.+Rygeauthor=P.+R.+Hansen&title=Structure-activity+relationship+study+of+anoplin&doi=10.1002%2Fpsc.598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship study of anoplin</span></div><div class="casAuthors">Ifrah, Dan; Doisy, Xavier; Ryge, Trine S.; Hansen, Paul R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Science</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-121</span>CODEN:
                <span class="NLM_cas:coden">JPSIEI</span>;
        ISSN:<span class="NLM_cas:issn">1075-2617</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Anoplin is a decapeptide amide, GLLKRIKTLL-NH2 derived from the venom sac of the solitary spider wasp, Anoplius samariensis.  It is active against Gram-pos. and Gram-neg. bacteria and is not hemolytic towards human erythrocytes.  The present paper reports a structure-activity study of anoplin based on 37 analogs including an Ala-scan, C- and N-truncations, and single and multiple residue substitutions with various amino acids.  The analogs were tested for antibacterial activity against both S. aureus ATCC 25923 and E. coli ATCC 25922, and several potent antibacterial analogs were identified.  The cytotoxicity of the analogs against human erythrocytes was assessed in a hemolytic activity assay.  The antibacterial activity and selectivity of the analogs against S. aureus and E. coli varied considerably, depending on the hydrophobicity and position of the various substituted amino acids.  In certain cases the selectivity for Gram-pos. and Gram-neg. bacteria was either reversed or altogether eliminated.  In addn., it was generally found that antibacterial activity coincided with hemolytic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryykoLGgL-J7Vg90H21EOLACvtfcHk0ljUZlkfeGUr9Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvFKmt7w%253D&md5=1393be628124813dc7891df81b81ba43</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fpsc.598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpsc.598%26sid%3Dliteratum%253Aachs%26aulast%3DIfrah%26aufirst%3DD.%26aulast%3DDoisy%26aufirst%3DX.%26aulast%3DRyge%26aufirst%3DT.%2BS.%26aulast%3DHansen%26aufirst%3DP.%2BR.%26atitle%3DStructure-activity%2520relationship%2520study%2520of%2520anoplin%26jtitle%3DJ.%2520Pept.%2520Sci.%26date%3D2005%26volume%3D11%26spage%3D113%26epage%3D121%26doi%3D10.1002%2Fpsc.598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luan, X.</span></span> <span> </span><span class="NLM_article-title">Advances in the study of structural modification and biological activities of anoplin</span>. <i>Front. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">519</span>, <span class="refDoi">Â DOI: 10.3389/fchem.2020.00519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.3389%2Ffchem.2020.00519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=32733845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitFWitrvF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2020&pages=519&author=Y.+Wuauthor=R.+Huangauthor=J.+M.+Jinauthor=L.+J.+Zhangauthor=H.+Zhangauthor=H.+Z.+Chenauthor=L.+L.+Chenauthor=X.+Luan&title=Advances+in+the+study+of+structural+modification+and+biological+activities+of+anoplin&doi=10.3389%2Ffchem.2020.00519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the study of structural modification and biological activities of anoplin</span></div><div class="casAuthors">Wu, Ye; Huang, Rui; Jin, Jin-Mei; Zhang, Li-Jun; Zhang, Hong; Chen, Hong-Zhuan; Chen, Li-Li; Luan, Xin</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Chemistry (Lausanne, Switzerland)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">519</span>CODEN:
                <span class="NLM_cas:coden">FCLSAA</span>;
        ISSN:<span class="NLM_cas:issn">2296-2646</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  Anoplin is an amphipathic, Î±-helical bioactive peptide from wasp venom.  In recent years, pharmaceutical and org. chemists discovered that anoplin and its derivs. showed multiple pharmacol. activities in antibacterial, antitumor, antifungal, and antimalarial activities.  Owing to the simple and unique structure and diverse biol. activities, anoplin has attracted considerable research interests.  This review highlights the advances in structural modification, biol. activities, and the outlook of anoplin in order to provide a basis for new drug design and delivery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCDIxfNFo-QrVg90H21EOLACvtfcHk0ljUZlkfeGUr9Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitFWitrvF&md5=d0a43e9ac1fd1617d206570cab9eed0c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.3389%2Ffchem.2020.00519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffchem.2020.00519%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DR.%26aulast%3DJin%26aufirst%3DJ.%2BM.%26aulast%3DZhang%26aufirst%3DL.%2BJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DH.%2BZ.%26aulast%3DChen%26aufirst%3DL.%2BL.%26aulast%3DLuan%26aufirst%3DX.%26atitle%3DAdvances%2520in%2520the%2520study%2520of%2520structural%2520modification%2520and%2520biological%2520activities%2520of%2520anoplin%26jtitle%3DFront.%2520Chem.%26date%3D2020%26volume%3D8%26spage%3D519%26doi%3D10.3389%2Ffchem.2020.00519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Da
Silva, A. M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva-GonÃ§alves, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcisio-Miranda, M.</span></span> <span> </span><span class="NLM_article-title">Pro-necrotic activity of cationic mastoparan peptides in human glioblastoma multiforme cells via membranolytic action</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5490</span>â <span class="NLM_lpage">5504</span>, <span class="refDoi">Â DOI: 10.1007/s12035-017-0782-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1007%2Fs12035-017-0782-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=28965321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A280%3ADC%252BC1M%252FktVeqtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2018&pages=5490-5504&author=A.+M.+B.+Da%0ASilvaauthor=L.+C.+Silva-Gon%C3%A7alvesauthor=F.+A.+Oliveiraauthor=M.+Arcisio-Miranda&title=Pro-necrotic+activity+of+cationic+mastoparan+peptides+in+human+glioblastoma+multiforme+cells+via+membranolytic+action&doi=10.1007%2Fs12035-017-0782-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pro-necrotic Activity of Cationic Mastoparan Peptides in Human Glioblastoma Multiforme Cells Via Membranolytic Action</span></div><div class="casAuthors">da Silva Annielle Mendes Brito; Silva-Goncalves Laiz Costa; Arcisio-Miranda Manoel; Oliveira Fernando Augusto</div><div class="citationInfo"><span class="NLM_cas:title">Molecular neurobiology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">5490-5504</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Glioblastoma multiforme is the most common and lethal malignant brain tumor.  Because of its complexity and heterogeneity, this tumor has become resistant to conventional therapies and the available treatment produces multiple side effects.  Here, using multiple experimental approaches, we demonstrate that three mastoparan peptides-Polybia-MP1, Mastoparan X, and HR1-from solitary wasp venom exhibit potent anticancer activity toward human glioblastoma multiforme cells.  Importantly, the antiglioblastoma action of mastoparan peptides occurs by membranolytic activity, leading to necrosis.  Our data also suggest a direct relation between mastoparan membranolytic potency and the presence of negatively charged phospholipids like phosphatidylserine.  Collectively, these data may warrant additional studies for mastoparan peptides as new agents for the treatment of glioblastoma multiforme brain tumor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSOnt_sG1bsqS-bLEOO4dYpfW6udTcc2eZO7zQh6sVuC7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M%252FktVeqtg%253D%253D&md5=e0cfbc1e0c066c67fac4a752d36e3934</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs12035-017-0782-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-017-0782-1%26sid%3Dliteratum%253Aachs%26aulast%3DDa%2BSilva%26aufirst%3DA.%2BM.%2BB.%26aulast%3DSilva-Gon%25C3%25A7alves%26aufirst%3DL.%2BC.%26aulast%3DOliveira%26aufirst%3DF.%2BA.%26aulast%3DArcisio-Miranda%26aufirst%3DM.%26atitle%3DPro-necrotic%2520activity%2520of%2520cationic%2520mastoparan%2520peptides%2520in%2520human%2520glioblastoma%2520multiforme%2520cells%2520via%2520membranolytic%2520action%26jtitle%3DMol.%2520Neurobiol.%26date%3D2018%26volume%3D55%26spage%3D5490%26epage%3D5504%26doi%3D10.1007%2Fs12035-017-0782-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span> <span> </span><span class="NLM_article-title">Effects of linker amino acids on the potency and selectivity of dimeric antimicrobial peptides</span>. <i>Chin. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1163</span>â <span class="NLM_lpage">1166</span>, <span class="refDoi">Â DOI: 10.1016/j.cclet.2018.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1016%2Fj.cclet.2018.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotlClt74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=1163-1166&author=M.+Kaiauthor=W.+Zhangauthor=H.+Xieauthor=L.+Liuauthor=S.+Huangauthor=X.+Liauthor=Z.+Zhangauthor=Y.+Liuauthor=B.+Zhangauthor=J.+Songauthor=R.+Wang&title=Effects+of+linker+amino+acids+on+the+potency+and+selectivity+of+dimeric+antimicrobial+peptides&doi=10.1016%2Fj.cclet.2018.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of linker amino acids on the potency and selectivity of dimeric antimicrobial peptides</span></div><div class="casAuthors">Kai, Ming; Zhang, Wei; Xie, Huan; Liu, Liwei; Huang, Sujie; Li, Xiao; Zhang, Zhengzheng; Liu, Yuyang; Zhang, Bangzhi; Song, Jingjing; Wang, Rui</div><div class="citationInfo"><span class="NLM_cas:title">Chinese Chemical Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1163-1166</span>CODEN:
                <span class="NLM_cas:coden">CCLEE7</span>;
        ISSN:<span class="NLM_cas:issn">1001-8417</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dimerization is an effective strategy for designing antimicrobial peptides that combine the advantages of different native peptides.  In this study, the authors explored the effects of different linker amino acids, including leucine, proline and aminocaproic acid, on the anticancer, antimicrobial and hemolytic activities of the heteromeric antimicrobial peptides AM-1, AM-2, and AM-3.  Proline and aminocaproic acid are ideal linkers for increasing the potency and selectivity of heteromeric antimicrobial peptides.  The results of MD simulations provided a rationalization for this observation.  Both AM-2, which had a proline linker, and AM-3, which had an aminocaproic acid linker, adopted a compact conformation in water and a bent conformation in membranes.  This change in the flexible structures of AM-2 and AM-3 could have resulted in decreased binding of these peptides to zwitterionic lipid bilayers and increased damage to mixed lipid bilayers contg. acidic phospholipids.  In short, these findings obtained via assessing the effects of linker amino acids will contribute to the design of ideal heteromeric antimicrobial peptides with high selectivity and potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPoHPlD1ZAerVg90H21EOLACvtfcHk0li9rj0h8XozjQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotlClt74%253D&md5=78a668c6b87e5c411a5028e77855d8c6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.cclet.2018.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cclet.2018.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKai%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DEffects%2520of%2520linker%2520amino%2520acids%2520on%2520the%2520potency%2520and%2520selectivity%2520of%2520dimeric%2520antimicrobial%2520peptides%26jtitle%3DChin.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D29%26spage%3D1163%26epage%3D1166%26doi%3D10.1016%2Fj.cclet.2018.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, M.-f.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.-y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.-f.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, H.-l.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and antiproliferative activities of stapled melittin peptides</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">17514</span>â <span class="NLM_lpage">17518</span>, <span class="refDoi">Â DOI: 10.1039/c6ra26427a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1039%2Fc6ra26427a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC2sXksVyjt7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=17514-17518&author=Y.+Wuauthor=M.-f.+Hanauthor=C.+Liuauthor=T.-y.+Liuauthor=Y.-f.+Fengauthor=Y.+Zouauthor=B.+Liauthor=H.-l.+Liao&title=Design%2C+synthesis%2C+and+antiproliferative+activities+of+stapled+melittin+peptides&doi=10.1039%2Fc6ra26427a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and antiproliferative activities of stapled melittin peptides</span></div><div class="casAuthors">Wu, Ye; Han, Meng-fei; Liu, Chao; Liu, Tai-yu; Feng, Yu-fei; Zou, Yan; Li, Bai; Liao, Hong-li</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">17514-17518</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Melittin is a 26-residue, amphipathic, cell-penetrating, Î±-helical anti-hepatoma peptide isolated from bee venom.  However, the application of melittin as a drug is limited owing to its original conformational flexibility and low stability.  In this study, we designed, synthesized, and tested a series of hydrocarbon-stapled analogs of melittin, of which, some analogs showed remarkable enhancement not only in anti-hepatoma activity, but also in Î±-helicity and protease resistance when compared to the parent melittin.  These results disclosed the important impact of all-hydrocarbon crosslinking on the biol. activity, stability, and hemolytic activity of melittin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBrPFO9bCuFLVg90H21EOLACvtfcHk0li9rj0h8XozjQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXksVyjt7c%253D&md5=4e312f1adb811ef13d772443481a6142</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1039%2Fc6ra26427a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc6ra26427a%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DM.-f.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DT.-y.%26aulast%3DFeng%26aufirst%3DY.-f.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DLiao%26aufirst%3DH.-l.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520antiproliferative%2520activities%2520of%2520stapled%2520melittin%2520peptides%26jtitle%3DRSC%2520Adv.%26date%3D2017%26volume%3D7%26spage%3D17514%26epage%3D17518%26doi%3D10.1039%2Fc6ra26427a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walensky, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, G. H.</span></span> <span> </span><span class="NLM_article-title">Hydrocarbon-stapled peptides: principles, practice, and progress</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">6275</span>â <span class="NLM_lpage">6288</span>, <span class="refDoi">Â DOI: 10.1021/jm4011675</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4011675" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC2cXislensbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6275-6288&author=L.+D.+Walenskyauthor=G.+H.+Bird&title=Hydrocarbon-stapled+peptides%3A+principles%2C+practice%2C+and+progress&doi=10.1021%2Fjm4011675"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrocarbon-Stapled Peptides: Principles, Practice, and Progress</span></div><div class="casAuthors">Walensky, Loren D.; Bird, Gregory H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6275-6288</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Protein structure underlies essential biol. processes and provides a blueprint for mol. mimicry that drives drug discovery.  Although small mols. represent the lion's share of agents that target proteins for therapeutic benefit, there remains no substitute for the natural properties of proteins and their peptide subunits in the majority of biol. contexts.  The peptide Î±-helix represents a common structural motif that mediates communication between signaling proteins.  Because peptides can lose their shape when taken out of context, developing chem. interventions to stabilize their bioactive structure remains an active area of research.  The all-hydrocarbon staple has emerged as one such soln., conferring Î±-helical structure, protease resistance, cellular penetrance, and biol. activity upon successful incorporation of a series of design and application principles.  Here, we describe our more than decade-long experience in developing stapled peptides as biomedical research tools and prototype therapeutics, highlighting lessons learned, pitfalls to avoid, and keys to success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC-4FlhgczWbVg90H21EOLACvtfcHk0ljv-6yNwSeleA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXislensbs%253D&md5=a2d11fd1668df5707099b94d2932d352</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm4011675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4011675%26sid%3Dliteratum%253Aachs%26aulast%3DWalensky%26aufirst%3DL.%2BD.%26aulast%3DBird%26aufirst%3DG.%2BH.%26atitle%3DHydrocarbon-stapled%2520peptides%253A%2520principles%252C%2520practice%252C%2520and%2520progress%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6275%26epage%3D6288%26doi%3D10.1021%2Fjm4011675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lau, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Andrade, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">Peptide stapling techniques based on different macrocyclisation chemistries</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">91</span>â <span class="NLM_lpage">102</span>, <span class="refDoi">Â DOI: 10.1039/c4cs00246f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1039%2Fc4cs00246f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=25199043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2mtb%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2015&pages=91-102&author=Y.+H.+Lauauthor=P.+de+Andradeauthor=Y.+Wuauthor=D.+R.+Spring&title=Peptide+stapling+techniques+based+on+different+macrocyclisation+chemistries&doi=10.1039%2Fc4cs00246f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide stapling techniques based on different macrocyclization chemistries</span></div><div class="casAuthors">Lau, Yu Heng; de Andrade, Peterson; Wu, Yuteng; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-102</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Peptide stapling is a strategy for constraining short peptides typically in an alpha-helical conformation.  Stapling is carried out by covalently linking the side-chains of two amino acids, thereby forming a peptide macrocycle.  There is an expanding repertoire of stapling techniques based on different macrocyclization chemistries.  In this tutorial review, the authors categorize and analyze key examples of peptide stapling in terms of their synthesis and applicability to biol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkqQ6yGsikIbVg90H21EOLACvtfcHk0ljv-6yNwSeleA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2mtb%252FL&md5=0efb31241f9809b61a81474131a54de3</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1039%2Fc4cs00246f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc4cs00246f%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DY.%2BH.%26aulast%3Dde%2BAndrade%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DPeptide%2520stapling%2520techniques%2520based%2520on%2520different%2520macrocyclisation%2520chemistries%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2015%26volume%3D44%26spage%3D91%26epage%3D102%26doi%3D10.1039%2Fc4cs00246f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cabrea, M. P. D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcisio-Miranda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, S. T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konno, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggiero, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Procopio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neto, J. R.</span></span> <span> </span><span class="NLM_article-title">Study of the mechanism of action of anoplin, a helical antimicrobial decapeptide with ion channel-like activity, and the role of the amidated C-terminus</span>. <i>J. Pept. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">661</span>â <span class="NLM_lpage">669</span>, <span class="refDoi">Â DOI: 10.1002/psc.960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1002%2Fpsc.960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=17994639" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=661-669&author=M.+P.+D.+S.+Cabreaauthor=M.+Arcisio-Mirandaauthor=S.+T.+B.+Costaauthor=K.+Konnoauthor=J.+R.+Ruggieroauthor=J.+Procopioauthor=J.+R.+Neto&title=Study+of+the+mechanism+of+action+of+anoplin%2C+a+helical+antimicrobial+decapeptide+with+ion+channel-like+activity%2C+and+the+role+of+the+amidated+C-terminus&doi=10.1002%2Fpsc.960"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fpsc.960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpsc.960%26sid%3Dliteratum%253Aachs%26aulast%3DCabrea%26aufirst%3DM.%2BP.%2BD.%2BS.%26aulast%3DArcisio-Miranda%26aufirst%3DM.%26aulast%3DCosta%26aufirst%3DS.%2BT.%2BB.%26aulast%3DKonno%26aufirst%3DK.%26aulast%3DRuggiero%26aufirst%3DJ.%2BR.%26aulast%3DProcopio%26aufirst%3DJ.%26aulast%3DNeto%26aufirst%3DJ.%2BR.%26atitle%3DStudy%2520of%2520the%2520mechanism%2520of%2520action%2520of%2520anoplin%252C%2520a%2520helical%2520antimicrobial%2520decapeptide%2520with%2520ion%2520channel-like%2520activity%252C%2520and%2520the%2520role%2520of%2520the%2520amidated%2520C-terminus%26jtitle%3DJ.%2520Pept.%2520Sci.%26date%3D2008%26volume%3D14%26spage%3D661%26epage%3D669%26doi%3D10.1002%2Fpsc.960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leung, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Won, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ianoul, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholl, A.</span></span> <span> </span><span class="NLM_article-title">Imaging interactions of cationic antimicrobial peptides with model lipid monolayers using X-ray spectromicroscopy</span>. <i>Eur. Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">805</span>â <span class="NLM_lpage">810</span>, <span class="refDoi">Â DOI: 10.1007/s00249-011-0690-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1007%2Fs00249-011-0690-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=21380600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlslChsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=805-810&author=B.+O.+Leungauthor=A.+P.+Hitchcockauthor=A.+Wonauthor=A.+Ianoulauthor=A.+Scholl&title=Imaging+interactions+of+cationic+antimicrobial+peptides+with+model+lipid+monolayers+using+X-ray+spectromicroscopy&doi=10.1007%2Fs00249-011-0690-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging interactions of cationic antimicrobial peptides with model lipid monolayers using X-ray spectromicroscopy</span></div><div class="casAuthors">Leung, Bonnie O.; Hitchcock, Adam P.; Won, Amy; Ianoul, Anatoli; Scholl, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">European Biophysics Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">805-810</span>CODEN:
                <span class="NLM_cas:coden">EBJOE8</span>;
        ISSN:<span class="NLM_cas:issn">0175-7571</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The interaction of antimicrobial peptide anoplin with 1,2-dipalmitoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] lipid monolayers was imaged with at. force microscopy, scanning transmission X-ray microscopy, and X-ray photoemission electron microscopy.  X-ray absorption spectromicroscopy of the surface revealed the domains of the phase-segregated surface to be composed of 98(Â±5)% lipid while the matrix consisted of a â¼50:50 lipid-peptide mixt.  We show X-ray spectromicroscopy to be a valuable quant. tool for label-free imaging of lipid monolayers with antimicrobial peptides at a lateral spatial resoln. below 80 nm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxaJQb9OmLs7Vg90H21EOLACvtfcHk0lg-yj2yzNCITg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlslChsL0%253D&md5=4ac25425e6c59d826fbd86f5fb0caec1</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs00249-011-0690-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00249-011-0690-7%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DB.%2BO.%26aulast%3DHitchcock%26aufirst%3DA.%2BP.%26aulast%3DWon%26aufirst%3DA.%26aulast%3DIanoul%26aufirst%3DA.%26aulast%3DScholl%26aufirst%3DA.%26atitle%3DImaging%2520interactions%2520of%2520cationic%2520antimicrobial%2520peptides%2520with%2520model%2520lipid%2520monolayers%2520using%2520X-ray%2520spectromicroscopy%26jtitle%3DEur.%2520Biophys.%2520J.%26date%3D2011%26volume%3D40%26spage%3D805%26epage%3D810%26doi%3D10.1007%2Fs00249-011-0690-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bird, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opoku-Nsiah, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lammert, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuberg, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walensky, L. D.</span></span> <span> </span><span class="NLM_article-title">Biophysical determinants for cellular uptake of hydrocarbon-stapled peptide helices</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">845</span>â <span class="NLM_lpage">852</span>, <span class="refDoi">Â DOI: 10.1038/nchembio.2153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1038%2Fnchembio.2153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=27547919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlyqsbbP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=845-852&author=G.+H.+Birdauthor=E.+Mazzolaauthor=K.+Opoku-Nsiahauthor=M.+A.+Lammertauthor=M.+Godesauthor=D.+S.+Neubergauthor=L.+D.+Walensky&title=Biophysical+determinants+for+cellular+uptake+of+hydrocarbon-stapled+peptide+helices&doi=10.1038%2Fnchembio.2153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Biophysical determinants for cellular uptake of hydrocarbon-stapled peptide helices</span></div><div class="casAuthors">Bird, Gregory H.; Mazzola, Emanuele; Opoku-Nsiah, Kwadwo; Lammert, Margaret A.; Godes, Marina; Neuberg, Donna S.; Walensky, Loren D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">845-852</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hydrocarbon-stapled peptides are a class of bioactive alpha-helical ligands developed to dissect and target protein interactions.  While there is consensus that stapled peptides can be effective chem. tools for investigating protein regulation, their broader utility for therapeutic modulation of intracellular interactions remains an active area of study.  In particular, the design principles for generating cell-permeable stapled peptides are empiric, yet consistent intracellular access is essential to in vivo application.  Here, we used an unbiased statistical approach to det. which biophys. parameters dictate the uptake of stapled-peptide libraries.  We found that staple placement at the amphipathic boundary combined with optimal hydrophobic and helical content are the key drivers of cellular uptake, whereas excess hydrophobicity and pos. charge at isolated amino acid positions can trigger membrane lysis at elevated peptide dosing.  Our results provide a design roadmap for maximizing the potential to generate cell-permeable stapled peptides with on-mechanism cellular activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowcU10JcijIbVg90H21EOLACvtfcHk0lg-yj2yzNCITg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlyqsbbP&md5=f31d10106beebfe08f69ec9a1b215ec1</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2153%26sid%3Dliteratum%253Aachs%26aulast%3DBird%26aufirst%3DG.%2BH.%26aulast%3DMazzola%26aufirst%3DE.%26aulast%3DOpoku-Nsiah%26aufirst%3DK.%26aulast%3DLammert%26aufirst%3DM.%2BA.%26aulast%3DGodes%26aufirst%3DM.%26aulast%3DNeuberg%26aufirst%3DD.%2BS.%26aulast%3DWalensky%26aufirst%3DL.%2BD.%26atitle%3DBiophysical%2520determinants%2520for%2520cellular%2520uptake%2520of%2520hydrocarbon-stapled%2520peptide%2520helices%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D845%26epage%3D852%26doi%3D10.1038%2Fnchembio.2153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muddineti, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torchilin, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswas, S.</span></span> <span> </span><span class="NLM_article-title">d-Î±-Tocopheryl succinate/phosphatidyl ethanolamine conjugated amphiphilic polymer-based nanomicellar system for the efficient delivery of curcumin and to overcome multiple drug resistance in cancer</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">16778</span>â <span class="NLM_lpage">16792</span>, <span class="refDoi">Â DOI: 10.1021/acsami.7b01087</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.7b01087" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC2sXns1aru74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=16778-16792&author=O.+S.+Muddinetiauthor=P.+Kumariauthor=B.+Ghoshauthor=V.+P.+Torchilinauthor=S.+Biswas&title=d-%CE%B1-Tocopheryl+succinate%2Fphosphatidyl+ethanolamine+conjugated+amphiphilic+polymer-based+nanomicellar+system+for+the+efficient+delivery+of+curcumin+and+to+overcome+multiple+drug+resistance+in+cancer&doi=10.1021%2Facsami.7b01087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">D-Î±-Tocopheryl Succinate/Phosphatidyl Ethanolamine Conjugated Amphiphilic Polymer-Based Nanomicellar System for the Efficient Delivery of Curcumin and To Overcome Multiple Drug Resistance in Cancer</span></div><div class="casAuthors">Muddineti, Omkara Swami; Kumari, Preeti; Ghosh, Balaram; Torchilin, Vladimir P.; Biswas, Swati</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">16778-16792</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nanomedicines have emerged as a promising treatment strategy for cancer.  Multiple drug resistance due to overexpression of various drug efflux transporters and upregulation of apoptotic inhibitory pathways in cancer cells are major barriers that limit the success of chemotherapy.  Here, we have developed a D-Î±-tocopherol (Î±-TOS)/lipid based copolymeric nanomicellar system (VPM) by conjugating phosphatidyl ethanolamine (PE) and Î±-TOS with poly(ethylene glycol) via an amino acid linkage.  The synthesis of polymer by multireaction steps was detd. by characterizing the polymers by FTIR, GPC, 1H and 13C NMR spectroscopy.  VPM exhibited mean hydrodynamic diam. of 141.0 Â± 0.94 nm with low crit. micelles concns. (CMC) of 15 Î¼M compared to plain PEG-PE micelles (PPM) with size of 23.9 Â± 0.34 nm and CMC 20 Î¼M.  The bigger hydrophobic compartment in VPM resulted in improved loading of a potent chemotherapeutic drug, Curcumin (Cur) and increased encapsulation efficiency (EE) (% drug loading 98.3 Â± 1.92, and 85.3 Â± 3.29; EE 14.8 Â± 0.16 and 12.8 Â± 0.09 for VPM and PPM, resp.).  C-VPM exhibited higher cytotoxicity compared to C-PPM in tested cancer cell lines.  C-VPM demonstrated â¼3.2 and â¼2.7fold higher ability to reverse multiple drug resistance compared to PPM and Verapamil (concn. used 30 Î¼M), resp.  In the in vivo study by using B16F10 implanted C57Bl6/J mice, C-VPM reduced the tumor vol. and wt. more efficiently than C-PPM by inducing apoptosis as analyzed by TUNEL assay on tumor cryo-sections.  The newly developed polymeric micelles, VPM with improved drug loadability and ability to reverse the drug resistance could successfully be utilized as a nanocarrier system for hydrophobic chemotherapeutic agents for the treatment of drug resistant solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRtVomZBezsbVg90H21EOLACvtfcHk0lg-yj2yzNCITg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXns1aru74%253D&md5=af530bd7ed74b4afcf9f0596089664f5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facsami.7b01087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.7b01087%26sid%3Dliteratum%253Aachs%26aulast%3DMuddineti%26aufirst%3DO.%2BS.%26aulast%3DKumari%26aufirst%3DP.%26aulast%3DGhosh%26aufirst%3DB.%26aulast%3DTorchilin%26aufirst%3DV.%2BP.%26aulast%3DBiswas%26aufirst%3DS.%26atitle%3Dd-%25CE%25B1-Tocopheryl%2520succinate%252Fphosphatidyl%2520ethanolamine%2520conjugated%2520amphiphilic%2520polymer-based%2520nanomicellar%2520system%2520for%2520the%2520efficient%2520delivery%2520of%2520curcumin%2520and%2520to%2520overcome%2520multiple%2520drug%2520resistance%2520in%2520cancer%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2017%26volume%3D9%26spage%3D16778%26epage%3D16792%26doi%3D10.1021%2Facsami.7b01087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">pH-Sensitive nano-complexes overcome drug resistance and inhibit metastasis of breast cancer by silencing Akt expression</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">4204</span>â <span class="NLM_lpage">4216</span>, <span class="refDoi">Â DOI: 10.7150/thno.21516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.7150%2Fthno.21516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=29158820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFaitLbP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=4204-4216&author=J.+Yinauthor=T.+Langauthor=D.+Cunauthor=Z.+Zhengauthor=Y.+Huangauthor=Q.+Yinauthor=H.+Yuauthor=Y.+Li&title=pH-Sensitive+nano-complexes+overcome+drug+resistance+and+inhibit+metastasis+of+breast+cancer+by+silencing+Akt+expression&doi=10.7150%2Fthno.21516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">pH-sensitive nano-complexes overcome drug resistance and inhibit metastasis of breast cancer by silencing Akt expression</span></div><div class="casAuthors">Yin, Jieying; Lang, Tianqun; Cun, Dongmei; Zheng, Zhong; Huang, Yan; Yin, Qi; Yu, Haijun; Li, Yaping</div><div class="citationInfo"><span class="NLM_cas:title">Theranostics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4204-4216</span>CODEN:
                <span class="NLM_cas:coden">THERDS</span>;
        ISSN:<span class="NLM_cas:issn">1838-7640</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">The therapy of breast cancer is encumbered by drug resistance and metastasis, which can be due to a defective PI3K/AKT/mTOR signaling pathway.  This study was aimed at improving the anti-cancer effect of the chemotherapeutic agent paclitaxel (PTX) on the drug resistant and metastatic breast cancer by co-delivering PTX and a siRNA, siAkt, directed at silencing the Akt expression.  The pH-sensitive amphiphilic polymer, poly [(1,4-butanediol)-diacrylate-Î²-N, N-diisopropylethylenediamine]-polyethyleneimine (BDP) was synthesized.  The PTX-loaded BDP micelle/siAkt nano-complex (PMA) was prepd. and characterized.  The cellular uptake, cytotoxicity, RNA interference efficiency, biodistribution, pharmacokinetics, pharmacodynamics, and biocompatibility of PMA in the murine metastatic breast cancer 4T1 cells and the 4T1 tumor-bearing mice were evaluated.  Results: PMA was stable at the neutral as well as tumor extracellular pH and released the drugs in the intra-endo/lysosome acidic environment.  In 4T1 cells, the RNA interference against the Akt gene down-regulated the expression of Akt and P-glycoprotein and up-regulated the expression of Caspase-3.  The down-regulated P-gp inhibits the efflux of PTX thereby increasing its intracellular concn., improving the cytotoxicity, and inhibiting the migration and invasion of 4T1 cells.  In the 4T1 tumor-bearing mice, co-delivery of PTX and siAkt by PMA achieved a tumor inhibiting rate of 94.1% and suppressed 96.8% lung metastases.  PMA did not cause pathol. lesions in normal organs.  PMA, by virtue of overcoming drug resistance and simultaneously restraining lung metastasis, might be an efficient drug delivery system for the therapy of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwy14RdCM2prVg90H21EOLACvtfcHk0lgCHmi_oK6yrw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFaitLbP&md5=41175d135b4606b8e1dc0b38d12e77d1</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.7150%2Fthno.21516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.21516%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DLang%26aufirst%3DT.%26aulast%3DCun%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DYin%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DpH-Sensitive%2520nano-complexes%2520overcome%2520drug%2520resistance%2520and%2520inhibit%2520metastasis%2520of%2520breast%2520cancer%2520by%2520silencing%2520Akt%2520expression%26jtitle%3DTheranostics%26date%3D2017%26volume%3D7%26spage%3D4204%26epage%3D4216%26doi%3D10.7150%2Fthno.21516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">UggerhÃ¸j, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munk, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredborg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sondergaard, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frimodt-Moller, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wimmer, R.</span></span> <span> </span><span class="NLM_article-title">Rational design of alpha-helical antimicrobial peptides: doâs and donâts</span>. <i>Chembiochem</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">242</span>â <span class="NLM_lpage">253</span>, <span class="refDoi">Â DOI: 10.1002/cbic.201402581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1002%2Fcbic.201402581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=25530580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFamsLvJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=242-253&author=L.+E.+Uggerh%C3%B8jauthor=T.+J.+Poulsenauthor=J.+K.+Munkauthor=M.+Fredborgauthor=T.+E.+Sondergaardauthor=N.+Frimodt-Mollerauthor=P.+R.+Hansenauthor=R.+Wimmer&title=Rational+design+of+alpha-helical+antimicrobial+peptides%3A+do%E2%80%99s+and+don%E2%80%99ts&doi=10.1002%2Fcbic.201402581"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Alpha-Helical Antimicrobial Peptides: Do's and Don'ts</span></div><div class="casAuthors">Uggerhoj, Lars Erik; Poulsen, Tanja Juul; Munk, Jens Kristian; Fredborg, Marlene; Sondergaard, Teis Esben; Frimodt-Moller, Niels; Hansen, Paul Robert; Wimmer, Reinhard</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">242-253</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Antimicrobial peptides (AMPs) are promising candidates for battling multiresistant bacteria.  Despite extensive research, structure-activity relationships of AMPs are not fully understood, and there is a lack of structural data relating to AMPs in lipids.  Here we present the NMR structure of anoplin (GLLKRIKTLL-NH2) in a micellar environment.  A vast library of substitutions was designed and tested for antimicrobial and hemolytic activity, as well as for changes in structure and lipid interactions.  This showed that improvement of antimicrobial activity without concomitant introduction of strong hemolytic activity can be achieved through subtle increases in the hydrophobicity of the hydrophobic face or through subtle increases in the polarity of the hydrophilic face of the helix, or-most efficiently-a combination of both.  A set of guidelines based on the results is given, for assistance in how to modify cationic Î±-helical AMPs in order to control activity and selectivity.  The guidelines are finally tested on a different peptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHlWjS56lQL7Vg90H21EOLACvtfcHk0lgCHmi_oK6yrw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFamsLvJ&md5=f55279a04afacd29ab9af091154e0fe3</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201402581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201402581%26sid%3Dliteratum%253Aachs%26aulast%3DUggerh%25C3%25B8j%26aufirst%3DL.%2BE.%26aulast%3DPoulsen%26aufirst%3DT.%2BJ.%26aulast%3DMunk%26aufirst%3DJ.%2BK.%26aulast%3DFredborg%26aufirst%3DM.%26aulast%3DSondergaard%26aufirst%3DT.%2BE.%26aulast%3DFrimodt-Moller%26aufirst%3DN.%26aulast%3DHansen%26aufirst%3DP.%2BR.%26aulast%3DWimmer%26aufirst%3DR.%26atitle%3DRational%2520design%2520of%2520alpha-helical%2520antimicrobial%2520peptides%253A%2520do%25E2%2580%2599s%2520and%2520don%25E2%2580%2599ts%26jtitle%3DChembiochem%26date%3D2015%26volume%3D16%26spage%3D242%26epage%3D253%26doi%3D10.1002%2Fcbic.201402581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MigoÅ, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubauer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamysz, W.</span></span> <span> </span><span class="NLM_article-title">Hydrocarbon stapled antimicrobial peptides</span>. <i>Protein J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">2</span>â <span class="NLM_lpage">12</span>, <span class="refDoi">Â DOI: 10.1007/s10930-018-9755-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1007%2Fs10930-018-9755-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=29330644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVKlsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2018&pages=2-12&author=D.+Migo%C5%84author=D.+Neubauerauthor=W.+Kamysz&title=Hydrocarbon+stapled+antimicrobial+peptides&doi=10.1007%2Fs10930-018-9755-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrocarbon Stapled Antimicrobial Peptides</span></div><div class="casAuthors">Migon, Dorian; Neubauer, Damian; Kamysz, Wojciech</div><div class="citationInfo"><span class="NLM_cas:title">Protein Journal</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-12</span>CODEN:
                <span class="NLM_cas:coden">PJROAH</span>;
        ISSN:<span class="NLM_cas:issn">1572-3887</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A Review.  Antimicrobial peptides are promising candidates for anti-infective pharmaceuticals.  Unfortunately, because of their low proteolytic and chem. stability, their usage is generally narrowed down to topical formulations.  Until now, numerous approaches to increase peptide stability have been proposed.  One of them, peptide hydrocarbon stapling, a modification based on stabilizing peptide secondary structure with a side-chain covalent hydrocarbon bridge, have been successfully applied to many peptides.  Moreover, constraining secondary structure of peptides have also been proven to increase their biol. activity.  This review article describes studies on hydrocarbon stapled antimicrobial peptides with respect to improved drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonkdLuAftqzLVg90H21EOLACvtfcHk0linHVh5aR-1gA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVKlsb8%253D&md5=d36884c57dfe17a152ec43d1b6a5b7f6</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2Fs10930-018-9755-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10930-018-9755-0%26sid%3Dliteratum%253Aachs%26aulast%3DMigo%25C5%2584%26aufirst%3DD.%26aulast%3DNeubauer%26aufirst%3DD.%26aulast%3DKamysz%26aufirst%3DW.%26atitle%3DHydrocarbon%2520stapled%2520antimicrobial%2520peptides%26jtitle%3DProtein%2520J.%26date%3D2018%26volume%3D37%26spage%3D2%26epage%3D12%26doi%3D10.1007%2Fs10930-018-9755-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stone, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deber, C. M.</span></span> <span> </span><span class="NLM_article-title">Influence of hydrocarbon-stapling on membrane interactions of synthetic antimicrobial peptides</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1189</span>â <span class="NLM_lpage">1196</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2017.10.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1016%2Fj.bmc.2017.10.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=29275987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVeht7fK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=1189-1196&author=T.+A.+Stoneauthor=G.+B.+Coleauthor=H.+Q.+Nguyenauthor=S.+Sharpeauthor=C.+M.+Deber&title=Influence+of+hydrocarbon-stapling+on+membrane+interactions+of+synthetic+antimicrobial+peptides&doi=10.1016%2Fj.bmc.2017.10.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of hydrocarbon-stapling on membrane interactions of synthetic antimicrobial peptides</span></div><div class="casAuthors">Stone, Tracy A.; Cole, Gregory B.; Nguyen, Huong Q.; Sharpe, Simon; Deber, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1189-1196</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cyclization has been recognized as a valuable technique for increasing the efficacy of small mol. and peptide therapeutics.  Here we report the application of a hydrocarbon staple to a rationally-designed cationic antimicrobial peptide (CAP) that acquires increased membrane targeting and interaction vs. its linear counterpart.  The previously-described CAP, 6K-F17 (KKKKKK-AAFAAWAAFAA-NH2) was used as the backbone for incorporation of an i to i + 4 helical hydrocarbon staple through olefin ring closing metathesis.  Stapled versions of 6K-F17 showed an increase in non-selective membrane interaction, where the staple itself enhances the degree of membrane interaction and rate of cell death while maintaining high potency against bacterial membranes.  However, the higher averaged hydrophobicity imparted by the staple also significantly increases toxicity to mammalian cells.  This deleterious effect is countered through stepwise redn. of the stapled 6K-F17's backbone hydrophobicity through polar amino acid substitutions.  CD assessment of secondary structure in various bacterial membrane mimetics reveals that a helical structure may improve - but is not an abs. requirement for - antimicrobial activity of 6K-F17.  Further, phosphorus-31 static solid state NMR spectra revealed that both non-toxic stapled and linear peptides bind bacterial membranes in a similar manner that does not involve a detergent-like mechanism of lipid removal.  The overall results suggest that the technique of hydrocarbon stapling can be readily applied to membrane-interactive CAPs to modulate how they interact and target biol. membranes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrF912vc6mnrVg90H21EOLACvtfcHk0linHVh5aR-1gA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVeht7fK&md5=af22818a24e2b7133c48e81f9e37a787</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.10.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.10.020%26sid%3Dliteratum%253Aachs%26aulast%3DStone%26aufirst%3DT.%2BA.%26aulast%3DCole%26aufirst%3DG.%2BB.%26aulast%3DNguyen%26aufirst%3DH.%2BQ.%26aulast%3DSharpe%26aufirst%3DS.%26aulast%3DDeber%26aufirst%3DC.%2BM.%26atitle%3DInfluence%2520of%2520hydrocarbon-stapling%2520on%2520membrane%2520interactions%2520of%2520synthetic%2520antimicrobial%2520peptides%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D1189%26epage%3D1196%26doi%3D10.1016%2Fj.bmc.2017.10.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mourtada, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herce, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moroco, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wales, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walensky, L. D.</span></span> <span> </span><span class="NLM_article-title">Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1186</span>â <span class="NLM_lpage">1197</span>, <span class="refDoi">Â DOI: 10.1038/s41587-019-0222-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1038%2Fs41587-019-0222-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=31427820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1WjurjP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2019&pages=1186-1197&author=R.+Mourtadaauthor=H.+D.+Herceauthor=D.+J.+Yinauthor=J.+A.+Morocoauthor=T.+E.+Walesauthor=J.+R.+Engenauthor=L.+D.+Walensky&title=Design+of+stapled+antimicrobial+peptides+that+are+stable%2C+nontoxic+and+kill+antibiotic-resistant+bacteria+in+mice&doi=10.1038%2Fs41587-019-0222-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice</span></div><div class="casAuthors">Mourtada, Rida; Herce, Henry D.; Yin, Daniel J.; Moroco, Jamie A.; Wales, Thomas E.; Engen, John R.; Walensky, Loren D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1186-1197</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The clin. translation of cationic Î±-helical antimicrobial peptides (AMPs) has been hindered by structural instability, proteolytic degrdn. and in vivo toxicity from nonspecific membrane lysis.  Although analyses of hydrophobic content and charge distribution have informed the design of synthetic AMPs with increased potency and reduced in vitro hemolysis, nonspecific membrane toxicity in vivo continues to impede AMP drug development.  Here, we analyzed a 58-member library of stapled AMPs (StAMPs) based on magainin II and applied the insights from structure-function-toxicity measurements to devise an algorithm for the design of stable, protease-resistant, potent and nontoxic StAMP prototypes.  We show that a lead double-stapled StAMP named Mag(i+4)1,15(A9K,B21A,N22K,S23K) can kill multidrug-resistant Gram-neg. pathogens, such as colistin-resistant Acinetobacter baumannii in a mouse peritonitis-sepsis model, without obsd. hemolysis or renal injury in murine toxicity studies.  Inputting the amino acid sequences alone, we further generated membrane-selective StAMPs of pleurocidin, CAP18 and esculentin, highlighting the generalizability of our design platform.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPEI2M6f3z2bVg90H21EOLACvtfcHk0liZKwEfS3IgIQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1WjurjP&md5=48d439283037426cd8275d550bbbcd80</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fs41587-019-0222-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41587-019-0222-z%26sid%3Dliteratum%253Aachs%26aulast%3DMourtada%26aufirst%3DR.%26aulast%3DHerce%26aufirst%3DH.%2BD.%26aulast%3DYin%26aufirst%3DD.%2BJ.%26aulast%3DMoroco%26aufirst%3DJ.%2BA.%26aulast%3DWales%26aufirst%3DT.%2BE.%26aulast%3DEngen%26aufirst%3DJ.%2BR.%26aulast%3DWalensky%26aufirst%3DL.%2BD.%26atitle%3DDesign%2520of%2520stapled%2520antimicrobial%2520peptides%2520that%2520are%2520stable%252C%2520nontoxic%2520and%2520kill%2520antibiotic-resistant%2520bacteria%2520in%2520mice%26jtitle%3DNat.%2520Biotechnol.%26date%3D2019%26volume%3D37%26spage%3D1186%26epage%3D1197%26doi%3D10.1038%2Fs41587-019-0222-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, H.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bierer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.-G.</span></span> <span> </span><span class="NLM_article-title">A novel peptide stapling strategy enables the retention of ring-closing amino acid side chains for the Wnt/Î²-catenin signalling pathway</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">7368</span>â <span class="NLM_lpage">7373</span>, <span class="refDoi">Â DOI: 10.1039/c7sc02420g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1039%2Fc7sc02420g" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=29163887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVGjurzE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=7368-7373&author=Y.+Wuauthor=Y.-H.+Liauthor=X.+Liauthor=Y.+Zouauthor=H.-L.+Liaoauthor=L.+Liuauthor=Y.-G.+Chenauthor=D.+Biererauthor=H.-G.+Hu&title=A+novel+peptide+stapling+strategy+enables+the+retention+of+ring-closing+amino+acid+side+chains+for+the+Wnt%2F%CE%B2-catenin+signalling+pathway&doi=10.1039%2Fc7sc02420g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A novel peptide stapling strategy enables the retention of ring-closing amino acid side chains for the Wnt/Î²-catenin signalling pathway</span></div><div class="casAuthors">Wu, Ye; Li, Ye-Hua; Li, Xiang; Zou, Yan; Liao, Hong-Li; Liu, Lei; Chen, Ye-Guang; Bierer, Donald; Hu, Hong-Gang</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">7368-7373</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The all-hydrocarbon peptide stapling strategy has recently been extensively explored in drug discovery.  There remains the potential for improvement regarding the retention of the amino acid side chains at the stapled positions.  Herein, we describe a new series of amino acids that not only contain the native side chains, but also carry the alkenyl arms that are needed for the ring-closing stapling chem.  We incorporate the new amino acids into a Î²-catenin-binding domain of Axin (469-482) and develop a new category of stapled peptides with the retention of the native side chains.  These stapled peptides exhibit high Î±-helicity, strong proteolytic stability and good cell permeability.  Biochem. expts. demonstrate that these stapled peptides can activate Î²-catenin more efficiently than canonical stapled peptides due to the presence of extra side chains.  We expect that the new side-chain-retention stapling method would expand the scope of the all-hydrocarbon stapled peptide strategy by retaining some important peripheral residues for protein-protein interactions or preserving key hydrophilic side chains to improve soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzifiqUvr-37Vg90H21EOLACvtfcHk0liZKwEfS3IgIQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVGjurzE&md5=1bc302b99fa3cd11177a7a9ed1d01e09</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1039%2Fc7sc02420g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc7sc02420g%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.-H.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DLiao%26aufirst%3DH.-L.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DY.-G.%26aulast%3DBierer%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DH.-G.%26atitle%3DA%2520novel%2520peptide%2520stapling%2520strategy%2520enables%2520the%2520retention%2520of%2520ring-closing%2520amino%2520acid%2520side%2520chains%2520for%2520the%2520Wnt%252F%25CE%25B2-catenin%2520signalling%2520pathway%26jtitle%3DChem.%2520Sci.%26date%3D2017%26volume%3D8%26spage%3D7368%26epage%3D7373%26doi%3D10.1039%2Fc7sc02420g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camilio, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berge, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravuri, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rekdal, Ã.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">SveinbjÃ¸rnsson, B.</span></span> <span> </span><span class="NLM_article-title">Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315</span>. <i>Cancer Immunol. Immunother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">601</span>â <span class="NLM_lpage">613</span>, <span class="refDoi">Â DOI: 10.1007/s00262-014-1540-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1007%2Fs00262-014-1540-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=24676901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFyjtLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2014&pages=601-613&author=K.+A.+Camilioauthor=G.+Bergeauthor=C.+S.+Ravuriauthor=%C3%98.+Rekdalauthor=B.+Sveinbj%C3%B8rnsson&title=Complete+regression+and+systemic+protective+immune+responses+obtained+in+B16+melanomas+after+treatment+with+LTX-315&doi=10.1007%2Fs00262-014-1540-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315</span></div><div class="casAuthors">Camilio, Ketil Andre; Berge, Gerd; Ravuri, Chandra Sekhar; Rekdal, Oeystein; Sveinbjoernsson, Baldur</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Immunotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">601-613</span>CODEN:
                <span class="NLM_cas:coden">CIIMDN</span>;
        ISSN:<span class="NLM_cas:issn">0340-7004</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Malignant melanoma is the most aggressive and deadliest form of skin cancer due to its highly metastatic potential, which calls for new and improved therapies.  Cationic antimicrobial peptides (CAPs) are naturally occurring mols. found in most species, in which they play a significant role in the first line of defense against pathogens, and several CAPs have shown promising potential as novel anticancer agents.  Structure-activity relationship studies on the CAP bovine lactoferricin allowed us to de novo design short chem. modified lytic anticancer peptides.  In the present study, we investigated the in vivo antitumor effects of LTX-315 against intradermally established B16 melanomas in syngeneic mice.  Intratumoral administration of LTX-315 resulted in tumor necrosis and the infiltration of immune cells into the tumor parenchyma followed by complete regression of the tumor in the majority of the animals.  LTX-315 induced the release of danger-assocd. mol. pattern mols. such as the high mobility group box-1 protein in vitro and the subsequent upregulation of proinflammatory cytokines such as interleukin (IL) 1Î², IL6 and IL18 in vivo.  Animals cured by LTX-315 treatment were protected against a re-challenge with live B16 tumor cells both intradermally and i.v.  Together, our data indicate that intratumoral treatment with LTX-315 can provide local tumor control followed by protective immune responses and has potential as a new immunotherapeutic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkrMTmNQJBzbVg90H21EOLACvtfcHk0liZKwEfS3IgIQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFyjtLw%253D&md5=a998cae3a19f9dd5e5e7783ae1cff6a9</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs00262-014-1540-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00262-014-1540-0%26sid%3Dliteratum%253Aachs%26aulast%3DCamilio%26aufirst%3DK.%2BA.%26aulast%3DBerge%26aufirst%3DG.%26aulast%3DRavuri%26aufirst%3DC.%2BS.%26aulast%3DRekdal%26aufirst%3D%25C3%2598.%26aulast%3DSveinbj%25C3%25B8rnsson%26aufirst%3DB.%26atitle%3DComplete%2520regression%2520and%2520systemic%2520protective%2520immune%2520responses%2520obtained%2520in%2520B16%2520melanomas%2520after%2520treatment%2520with%2520LTX-315%26jtitle%3DCancer%2520Immunol.%2520Immunother.%26date%3D2014%26volume%3D63%26spage%3D601%26epage%3D613%26doi%3D10.1007%2Fs00262-014-1540-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camilio, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauseth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waagene, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kvalheim, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rekdal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sveinbjornsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maelandsmo, G. M.</span></span> <span> </span><span class="NLM_article-title">Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model</span>. <i>Breast Canc. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">9</span>, <span class="refDoi">Â DOI: 10.1186/s13058-018-1092-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1186%2Fs13058-018-1092-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=30670061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A280%3ADC%252BB3cjktV2mtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2019&pages=9&author=K.+A.+Camilioauthor=M.+Y.+Wangauthor=B.+Mausethauthor=S.+Waageneauthor=G.+Kvalheimauthor=O.+Rekdalauthor=B.+Sveinbjornssonauthor=G.+M.+Maelandsmo&title=Combining+the+oncolytic+peptide+LTX-315+with+doxorubicin+demonstrates+therapeutic+potential+in+a+triple-negative+breast+cancer+model&doi=10.1186%2Fs13058-018-1092-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model</span></div><div class="casAuthors">Camilio Ketil A; Wang Meng-Yu; Waagene Stein; Maelandsmo Gunhild M; Camilio Ketil A; Mauseth Brynjar; Rekdal Oystein; Sveinbjornsson Baldur; Camilio Ketil A; Mauseth Brynjar; Mauseth Brynjar; Kvalheim Gunnar; Rekdal Oystein; Sveinbjornsson Baldur; Maelandsmo Gunhild M</div><div class="citationInfo"><span class="NLM_cas:title">Breast cancer research : BCR</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Immunochemotherapy, the combined use of immunotherapy and chemotherapy, has demonstrated great promise in several cancers.  LTX-315 is an oncolytic peptide with potent immunomodulatory properties designed for the local treatment of solid tumors.  By inducing rapid immunogenic cell death through the release of danger-associated molecular pattern molecules (DAMPs), LTX-315 is capable of reshaping the tumor microenvironment, turning "cold" tumors "hot" through a significant increase in tumor-infiltrating lymphocytes.  METHODS:  We investigated the potential of LTX-315 to be used in combination with standard-of-care chemotherapy (doxorubicin, brand name CAELYXÂ®) against triple-negative breast cancer in an orthotopic 4 T1 mammary fat pad model.  Tumor growth curves were compared using one-way ANOVA analysis of variance and Tukey's multiple comparisons test, and animal survival curves were compared using the log-rank (Mantel-Cox) test.  We considered p values â¤0.05 to indicate statistical significance.  RESULTS:  We found that LTX-315 displayed a strong additive antitumoral effect when used in combination with CAELYXÂ®, and induced immune-mediated changes in the tumor microenvironment, followed by complete regression in the majority of animals treated.  Furthermore, imaging techniques and histological examination showed that the combination induced strong local necrosis, followed by an increase in the infiltration of CD4+ and CD8+ immune cells into the tumor parenchymal tissue.  CONCLUSIONS:  Our data demonstrate that LTX-315 is a promising combination partner with CAELYXÂ® for the treatment of triple-negative breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSndeaf3qStzFf1XRtfYM0dfW6udTcc2eY3CNDgH00_D7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cjktV2mtw%253D%253D&md5=50f4fe9609cb4ef05f9a951a8427470e</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1186%2Fs13058-018-1092-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13058-018-1092-x%26sid%3Dliteratum%253Aachs%26aulast%3DCamilio%26aufirst%3DK.%2BA.%26aulast%3DWang%26aufirst%3DM.%2BY.%26aulast%3DMauseth%26aufirst%3DB.%26aulast%3DWaagene%26aufirst%3DS.%26aulast%3DKvalheim%26aufirst%3DG.%26aulast%3DRekdal%26aufirst%3DO.%26aulast%3DSveinbjornsson%26aufirst%3DB.%26aulast%3DMaelandsmo%26aufirst%3DG.%2BM.%26atitle%3DCombining%2520the%2520oncolytic%2520peptide%2520LTX-315%2520with%2520doxorubicin%2520demonstrates%2520therapeutic%2520potential%2520in%2520a%2520triple-negative%2520breast%2520cancer%2520model%26jtitle%3DBreast%2520Canc.%2520Res.%26date%3D2019%26volume%3D21%26spage%3D9%26doi%3D10.1186%2Fs13058-018-1092-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepp, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zitvogel, L.</span></span> <span> </span><span class="NLM_article-title">Immunogenic cell death in cancer therapy</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">51</span>â <span class="NLM_lpage">72</span>, <span class="refDoi">Â DOI: 10.1146/annurev-immunol-032712-100008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1146%2Fannurev-immunol-032712-100008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=23157435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsFClsL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=51-72&author=G.+Kroemerauthor=L.+Galluzziauthor=O.+Keppauthor=L.+Zitvogel&title=Immunogenic+cell+death+in+cancer+therapy&doi=10.1146%2Fannurev-immunol-032712-100008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Immunogenic cell death in cancer therapy</span></div><div class="casAuthors">Kroemer, Guido; Galluzzi, Lorenzo; Kepp, Oliver; Zitvogel, Laurence</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">51-72</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Depending on the initiating stimulus, cancer cell death can be immunogenic or nonimmunogenic.  Immunogenic cell death (ICD) involves changes in the compn. of the cell surface as well as the release of sol. mediators, occurring in a defined temporal sequence.  Such signals operate on a series of receptors expressed by dendritic cells to stimulate the presentation of tumor antigens to T cells.  We postulate that ICD constitutes a prominent pathway for the activation of the immune system against cancer, which in turn dets. the long-term success of anticancer therapies.  Hence, suboptimal regimens (failing to induce ICD), selective alterations in cancer cells (preventing the emission of immunogenic signals during ICD), or defects in immune effectors (abolishing the perception of ICD by the immune system) can all contribute to therapeutic failure.  We surmise that ICD and its subversion by pathogens also play major roles in antiviral immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruNjdkTvG-O7Vg90H21EOLACvtfcHk0lgXCljSvovhIg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsFClsL8%253D&md5=bc000639067604e4d67bcdcaf766c00c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1146%2Fannurev-immunol-032712-100008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-immunol-032712-100008%26sid%3Dliteratum%253Aachs%26aulast%3DKroemer%26aufirst%3DG.%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DKepp%26aufirst%3DO.%26aulast%3DZitvogel%26aufirst%3DL.%26atitle%3DImmunogenic%2520cell%2520death%2520in%2520cancer%2520therapy%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2013%26volume%3D31%26spage%3D51%26epage%3D72%26doi%3D10.1146%2Fannurev-immunol-032712-100008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wargo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reuben, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, P.</span></span> <span> </span><span class="NLM_article-title">Monitoring immune responses in the tumor microenvironment</span>. <i>Curr. Opin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">23</span>â <span class="NLM_lpage">31</span>, <span class="refDoi">Â DOI: 10.1016/j.coi.2016.05.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1016%2Fj.coi.2016.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=27240055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC28XosFWgur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2016&pages=23-31&author=J.+A.+Wargoauthor=S.+M.+Reddyauthor=A.+Reubenauthor=P.+Sharma&title=Monitoring+immune+responses+in+the+tumor+microenvironment&doi=10.1016%2Fj.coi.2016.05.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Monitoring immune responses in the tumor microenvironment</span></div><div class="casAuthors">Wargo, Jennifer A.; Reddy, Sangeetha M.; Reuben, Alexandre; Sharma, Padmanee</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">23-31</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Immune monitoring in the tumor microenvironment allows for important insights into immune mechanisms of response and resistance to various cancer treatments; however clin. challenges exist using current strategies.  Significant questions remain regarding monitoring of archival vs. fresh tissue, assessment of static vs. dynamic markers, evaluation of limited tissue samples, and the translation of insights gained from immunol. 'hot' tumors such as melanoma to other 'cold' tumor microenvironments prevalent in other cancer types.  Current and emerging immune monitoring strategies will be examd. herein, and genomic-based assays complementing these techniques will also be discussed.  Finally, host genomic and external environmental factors influencing anti-tumor immune responses will be considered, including the role of the gut microbiome.  Though optimal immune monitoring techniques are in evolution, great promise exists in recent advances that will help guide patient selection as far as type, sequence, and combination of therapeutic regimens to enhance anti-tumor immunity and clin. responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpENBW-z9IiFrVg90H21EOLACvtfcHk0lgXCljSvovhIg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosFWgur4%253D&md5=01ee546380bc39fe46e8d1f87853158c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.coi.2016.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coi.2016.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DWargo%26aufirst%3DJ.%2BA.%26aulast%3DReddy%26aufirst%3DS.%2BM.%26aulast%3DReuben%26aufirst%3DA.%26aulast%3DSharma%26aufirst%3DP.%26atitle%3DMonitoring%2520immune%2520responses%2520in%2520the%2520tumor%2520microenvironment%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D2016%26volume%3D41%26spage%3D23%26epage%3D31%26doi%3D10.1016%2Fj.coi.2016.05.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vareki, M. S.</span></span> <span> </span><span class="NLM_article-title">High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors</span>. <i>J. Immunother. Canc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">157</span>, <span class="refDoi">Â DOI: 10.1186/s40425-018-0479-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1186%2Fs40425-018-0479-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=30587233" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=157&author=M.+S.+Vareki&title=High+and+low+mutational+burden+tumors+versus+immunologically+hot+and+cold+tumors+and+response+to+immune+checkpoint+inhibitors&doi=10.1186%2Fs40425-018-0479-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1186%2Fs40425-018-0479-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40425-018-0479-7%26sid%3Dliteratum%253Aachs%26aulast%3DVareki%26aufirst%3DM.%2BS.%26atitle%3DHigh%2520and%2520low%2520mutational%2520burden%2520tumors%2520versus%2520immunologically%2520hot%2520and%2520cold%2520tumors%2520and%2520response%2520to%2520immune%2520checkpoint%2520inhibitors%26jtitle%3DJ.%2520Immunother.%2520Canc.%26date%3D2018%26volume%3D6%26spage%3D157%26doi%3D10.1186%2Fs40425-018-0479-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routh, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pullikuth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoadley, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Print, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knowlton, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demaria, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedognetti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatza, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perou, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triozzi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, L. D.</span></span> <span> </span><span class="NLM_article-title">Tumor mutational burden is a determinant of immune-mediated survival in breast cancer</span>. <i>Oncoimmunology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e1490854</span> <span class="refDoi">Â DOI: 10.1080/2162402x.2018.1490854</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1080%2F2162402x.2018.1490854" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=30386679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVCqurjE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2018&author=A.+Thomasauthor=E.+D.+Routhauthor=A.+Pullikuthauthor=G.+Jinauthor=J.+Suauthor=J.+W.+Chouauthor=K.+A.+Hoadleyauthor=C.+Printauthor=N.+Knowltonauthor=M.+A.+Blackauthor=S.+Demariaauthor=E.+Wangauthor=D.+Bedognettiauthor=W.+D.+Jonesauthor=G.+A.+Mehtaauthor=M.+L.+Gatzaauthor=C.+M.+Perouauthor=D.+B.+Pageauthor=P.+Triozziauthor=L.+D.+Miller&title=Tumor+mutational+burden+is+a+determinant+of+immune-mediated+survival+in+breast+cancer&doi=10.1080%2F2162402x.2018.1490854"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor mutational burden is a determinant of immune-mediated survival in breast cancer</span></div><div class="casAuthors">Thomas, Alexandra; Routh, Eric D.; Pullikuth, Ashok; Jin, Guangxu; Su, Jing; Chou, Jeff W.; Hoadley, Katherine A.; Print, Cristin; Knowlton, Nick; Black, Michael A.; Demaria, Sandra; Wang, Ena; Bedognetti, Davide; Jones, Wendell D.; Mehta, Gaurav A.; Gatza, Michael L.; Perou, Charles M.; Page, David B.; Triozzi, Pierre; Miller, Lance D.</div><div class="citationInfo"><span class="NLM_cas:title">OncoImmunology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e1490854/1-e1490854/12</span>CODEN:
                <span class="NLM_cas:coden">ONCOGX</span>;
        ISSN:<span class="NLM_cas:issn">2162-402X</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Mounting evidence supports a role for the immune system in breast cancer outcomes.  The ability to distinguish highly immunogenic tumors susceptible to anti-tumor immunity from weakly immunogenic or inherently immune-resistant tumors would guide development of therapeutic strategies in breast cancer.  Genomic, transcriptomic and clin. data from The Cancer Genome Atlas (TCGA) and Mol. Taxonomy of Breast Cancer International Consortium (METABRIC) breast cancer cohorts were used to examine statistical assocns. between tumor mutational burden (TMB) and the survival of patients whose tumors were assigned to previously-described prognostic immune subclasses reflecting favorable, weak or poor immune-infiltrate dispositions (FID, WID or PID, resp.).  Tumor immune subclasses were assocd. with survival in patients with high TMB (TMB-Hi, P < 0.001) but not in those with low TMB (TMB-Lo, P = 0.44).  This statistical relationship was confirmed in the METABRIC cohort (TMB-Hi, P = 0.047; TMB-Lo, P = 0.39), and also found to hold true in the more-indolent Luminal A tumor subtype (TMB-Hi, P = 0.011; TMB-Lo, P = 0.91).  In TMB-Hi tumors, the FID subclass was assocd. with prolonged survival independent of tumor stage, mol. subtype, age and treatment.  Copy no. anal. revealed the reproducible, preferential amplification of chromosome 1q immune-regulatory genes in the PID immune subclass.  These findings demonstrate a previously unappreciated role for TMB as a determinant of immune-mediated survival of breast cancer patients and identify candidate immune-regulatory mechanisms assocd. with immunol. cold tumors.  Immune subtyping of breast cancers may offer opportunities for therapeutic stratification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo20EcT1j7GMbVg90H21EOLACvtfcHk0li_et01e_4VKA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVCqurjE&md5=b2d3c90c131475ebfa2eb5ec0928027b</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1080%2F2162402x.2018.1490854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F2162402x.2018.1490854%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DA.%26aulast%3DRouth%26aufirst%3DE.%2BD.%26aulast%3DPullikuth%26aufirst%3DA.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DSu%26aufirst%3DJ.%26aulast%3DChou%26aufirst%3DJ.%2BW.%26aulast%3DHoadley%26aufirst%3DK.%2BA.%26aulast%3DPrint%26aufirst%3DC.%26aulast%3DKnowlton%26aufirst%3DN.%26aulast%3DBlack%26aufirst%3DM.%2BA.%26aulast%3DDemaria%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DBedognetti%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DW.%2BD.%26aulast%3DMehta%26aufirst%3DG.%2BA.%26aulast%3DGatza%26aufirst%3DM.%2BL.%26aulast%3DPerou%26aufirst%3DC.%2BM.%26aulast%3DPage%26aufirst%3DD.%2BB.%26aulast%3DTriozzi%26aufirst%3DP.%26aulast%3DMiller%26aufirst%3DL.%2BD.%26atitle%3DTumor%2520mutational%2520burden%2520is%2520a%2520determinant%2520of%2520immune-mediated%2520survival%2520in%2520breast%2520cancer%26jtitle%3DOncoimmunology%26date%3D2018%26volume%3D7%26doi%3D10.1080%2F2162402x.2018.1490854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, H.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garris, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfirschke, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickelt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arlauckas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siwicki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohler, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissleder, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundvold-Gjerstad, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">SveinbjÃ¸rnsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rekdal, Ã.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pittet, M. J.</span></span> <span> </span><span class="NLM_article-title">LTX-315 sequentially promotes lymphocyte-independent and lymphocyte-dependent antitumor effects</span>. <i>Cell Stress</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">348</span>â <span class="NLM_lpage">360</span>, <span class="refDoi">Â DOI: 10.15698/cst2019.11.204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.15698%2Fcst2019.11.204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=31799501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVCjsr3M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2019&pages=348-360&author=H.-W.+Liaoauthor=C.+Garrisauthor=C.+Pfirschkeauthor=S.+Rickeltauthor=S.+Arlauckasauthor=M.+Siwickiauthor=R.+H.+Kohlerauthor=R.+Weisslederauthor=V.+Sundvold-Gjerstadauthor=B.+Sveinbj%C3%B8rnssonauthor=%C3%98.+Rekdalauthor=M.+J.+Pittet&title=LTX-315+sequentially+promotes+lymphocyte-independent+and+lymphocyte-dependent+antitumor+effects&doi=10.15698%2Fcst2019.11.204"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">LTX-315 sequentially promotes lymphocyte-independent and lymphocyte-dependent antitumor effects</span></div><div class="casAuthors">Liao, Hsin-Wei; Garris, Christopher; Pfirschke, Christina; Rickelt, Steffen; Arlauckas, Sean; Siwicki, Marie; Kohler, Rainer H.; Weissleder, Ralph; Sundvold-Gjerstad, Vibeke; Sveinbjoernsson, Baldur; Rekdal, Oeystein; Pittet, Mikael J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Stress</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">348-360</span>CODEN:
                <span class="NLM_cas:coden">CSETBO</span>;
        ISSN:<span class="NLM_cas:issn">2523-0204</span>.
    
            (<span class="NLM_cas:orgname">Shared Science Publishers OG</span>)
        </div><div class="casAbstract">LTX-315 is an oncolytic peptide that has antitumor efficacy in mice grafted with various tumor cell lines and is currently being tested in phase II clin. trials.  Here we aimed to further evaluate LTX-315 in conditional genetic mouse models of cancer that typically resist current treatment options and to better understand the drug's mode of action in vivo.  We report LTX-315 mediates profound antitumor effects against Braf- and Pten-driven melanoma and delays the progression of Kras- and P53-driven soft tissue sarcoma in mice.  Addnl., we show in melanoma that LTX-315 triggers two sequential phases of antitumor response.  The first phase of response, which begins within minutes of drug delivery into tumors, is defined by disrupted tumor vasculature and decreased tumor burden and occurs independently of lymphocytes.  The second phase of response, which continues over weeks, is defined by long-term alteration of the tumor microenvironment; the changes induced by LTX-315 are most notably characterized by CD8+ T cell infiltration.  We further show that these CD8+ T cells are involved in suppressing melanoma outgrowth in mice and report similar CD8+ T cell infiltration following LTX-315 treatment in melanoma and sarcoma patients.  Taken together, these findings reveal LTX-315's multiple antitumor effects, including disrupting the tumor vasculature and promoting the conversion of poorly immunogenic tumors into ones that display antitumor T cell immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVsfysai3b3LVg90H21EOLACvtfcHk0li_et01e_4VKA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVCjsr3M&md5=a10cec9c564ee71fe8bcbd74405cd255</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.15698%2Fcst2019.11.204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15698%252Fcst2019.11.204%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DH.-W.%26aulast%3DGarris%26aufirst%3DC.%26aulast%3DPfirschke%26aufirst%3DC.%26aulast%3DRickelt%26aufirst%3DS.%26aulast%3DArlauckas%26aufirst%3DS.%26aulast%3DSiwicki%26aufirst%3DM.%26aulast%3DKohler%26aufirst%3DR.%2BH.%26aulast%3DWeissleder%26aufirst%3DR.%26aulast%3DSundvold-Gjerstad%26aufirst%3DV.%26aulast%3DSveinbj%25C3%25B8rnsson%26aufirst%3DB.%26aulast%3DRekdal%26aufirst%3D%25C3%2598.%26aulast%3DPittet%26aufirst%3DM.%2BJ.%26atitle%3DLTX-315%2520sequentially%2520promotes%2520lymphocyte-independent%2520and%2520lymphocyte-dependent%2520antitumor%2520effects%26jtitle%3DCell%2520Stress%26date%3D2019%26volume%3D3%26spage%3D348%26epage%3D360%26doi%3D10.15698%2Fcst2019.11.204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Correction to redox-activated porphyrin-based liposome remote-loaded with indoleamine 2,3-dioxygenase (IDO) inhibitor for synergistic photoimmunotherapy through induction of immunogenic cell death and blockage of IDO pathway</span>. <i>Nano Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1476</span>, <span class="refDoi">Â DOI: 10.1021/acs.nanolett.0c00113</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.nanolett.0c00113" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtVKls7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2020&pages=1476&author=D.+Liuauthor=B.+Chenauthor=Y.+Moauthor=Z.+Wangauthor=T.+Qiauthor=Q.+Zhangauthor=Y.+Wang&title=Correction+to+redox-activated+porphyrin-based+liposome+remote-loaded+with+indoleamine+2%2C3-dioxygenase+%28IDO%29+inhibitor+for+synergistic+photoimmunotherapy+through+induction+of+immunogenic+cell+death+and+blockage+of+IDO+pathway&doi=10.1021%2Facs.nanolett.0c00113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Correction to Redox-Activated Porphyrin-Based Liposome Remote-Loaded with Indoleamine 2,3-Dioxygenase (IDO) Inhibitor for Synergistic Photoimmunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway</span></div><div class="casAuthors">Liu, Dechun; Chen, Binlong; Mo, Yulin; Wang, Zenghui; Qi, Tong; Zhang, Qiang; Wang, Yiguang</div><div class="citationInfo"><span class="NLM_cas:title">Nano Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1476</span>CODEN:
                <span class="NLM_cas:coden">NALEFD</span>;
        ISSN:<span class="NLM_cas:issn">1530-6984</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQJ9VruPivJ7Vg90H21EOLACvtfcHk0lglbLZCigyo5g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtVKls7o%253D&md5=c2ac2ab8663eeb2d5d15330d8110ec31</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.nanolett.0c00113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.nanolett.0c00113%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DMo%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DQi%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DCorrection%2520to%2520redox-activated%2520porphyrin-based%2520liposome%2520remote-loaded%2520with%2520indoleamine%25202%252C3-dioxygenase%2520%2528IDO%2529%2520inhibitor%2520for%2520synergistic%2520photoimmunotherapy%2520through%2520induction%2520of%2520immunogenic%2520cell%2520death%2520and%2520blockage%2520of%2520IDO%2520pathway%26jtitle%3DNano%2520Lett.%26date%3D2020%26volume%3D20%26spage%3D1476%26doi%3D10.1021%2Facs.nanolett.0c00113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span> <span> </span><span class="NLM_article-title">Tumors and their microenvironment dual-targeting chemotherapy with local immune adjuvant therapy for effective antitumor immunity against breast cancer</span>. <i>Adv. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1801868</span>, <span class="refDoi">Â DOI: 10.1002/advs.201801868</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1002%2Fadvs.201801868" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A280%3ADC%252BB3M%252Fgs12rsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2019&pages=1801868&author=C.+Dengauthor=Q.+Zhangauthor=M.+Jiaauthor=J.+Zhaoauthor=X.+Sunauthor=T.+Gongauthor=Z.+Zhang&title=Tumors+and+their+microenvironment+dual-targeting+chemotherapy+with+local+immune+adjuvant+therapy+for+effective+antitumor+immunity+against+breast+cancer&doi=10.1002%2Fadvs.201801868"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Tumors and Their Microenvironment Dual-Targeting Chemotherapy with Local Immune Adjuvant Therapy for Effective Antitumor Immunity against Breast Cancer</span></div><div class="casAuthors">Deng Caifeng; Jia Mengdi; Zhao Jin; Sun Xun; Gong Tao; Zhang Zhirong; Zhang Quan</div><div class="citationInfo"><span class="NLM_cas:title">Advanced science (Weinheim, Baden-Wurttemberg, Germany)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1801868</span>
        ISSN:<span class="NLM_cas:issn">2198-3844</span>.
    </div><div class="casAbstract">Chemotherapy turns tumor cells into "tumor vaccines" by immunogenic cell death (ICD).  However, it remains a challenge to exploit chemotherapy-induced "tumor vaccines" for solid cancer immunotherapy due to the inefficient effector T cells activation and tumor microenvironment immunosuppression.  Here, a matrix metalloprotease 2 responsive liposome (PEG-FA-Lip) composed of cleavable PEG chains covering the folate (FA)-modified liposome is developed to deliver ICD inducer doxorubicin.  In breast cancer-bearing mice, PEG-FA-Lip targets both 4T1 breast cancer cells and M2-tumor associated macrophages (M2-TAMs) via FA-receptor mediated endocytosis, resulting in abundant "tumor vaccines" and efficient elimination of M2-TAMs.  The combination of local cytosine-phosphate-guanine (CpG) therapy facilitates PEG-FA-Lip induced "tumor vaccines" to effectively arouse systematic effector T cells immune response through promoting dendritic cell maturation and immunostimulatory cytokines secretion.  The simultaneous elimination of M2-TAMs ensures the activated effector T cells exert antitumor immunity within tumor via decreasing immunosuppressive cytokines secretion and tumor infiltration of Treg cells.  After receiving the combined treatment, 30.1% of breast cancer-bearing mice (initial tumor volume > 100 mm(3)) achieves the goal of tumor eradication.  Remarkably, this combination therapy greatly inhibits lung metastasis and controls the growth of already metastasized breast cancers (initial tumor volume > 100 mm(3)).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9omYqtS42lsrRqEXsZufAfW6udTcc2eb2kLHfQm_ZGbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M%252Fgs12rsQ%253D%253D&md5=3e49e26828fd5463bfe7ed2becda69cf</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fadvs.201801868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadvs.201801868%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DJia%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DGong%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DZ.%26atitle%3DTumors%2520and%2520their%2520microenvironment%2520dual-targeting%2520chemotherapy%2520with%2520local%2520immune%2520adjuvant%2520therapy%2520for%2520effective%2520antitumor%2520immunity%2520against%2520breast%2520cancer%26jtitle%3DAdv.%2520Sci.%26date%3D2019%26volume%3D6%26spage%3D1801868%26doi%3D10.1002%2Fadvs.201801868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Nanomedicine-based immunotherapy for the treatment of cancer metastasis</span>. <i>Adv. Mater.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1904156</span>, <span class="refDoi">Â DOI: 10.1002/adma.201904156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1002%2Fadma.201904156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=31566275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVKkur3I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2019&pages=1904156&author=P.+Zhangauthor=Y.+Zhaiauthor=Y.+Caiauthor=Y.+Zhaoauthor=Y.+Li&title=Nanomedicine-based+immunotherapy+for+the+treatment+of+cancer+metastasis&doi=10.1002%2Fadma.201904156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Nanomedicine-Based Immunotherapy for the Treatment of Cancer Metastasis</span></div><div class="casAuthors">Zhang, Pengcheng; Zhai, Yihui; Cai, Ying; Zhao, Yuliang; Li, Yaping</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Materials (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">1904156</span>CODEN:
                <span class="NLM_cas:coden">ADVMEW</span>;
        ISSN:<span class="NLM_cas:issn">0935-9648</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Metastasis is the leading cause of cancer-assocd. death, with poor prognosis even after extensive treatment.  The dormancy of metastatic cancer cells during dissemination or after colony formation is one major reason for treatment failure, as most drugs target cells of active proliferation.  Immunotherapy has shown great potential in cancer therapy because the activity of effector cells is less affected by the metabolic status of cancer cells.  In addn., metastatic cells out of immunosuppressive tumor microenvironment (TME) are more susceptible to immune clearance, although these cells can achieve immune surveillance evasion via strategies such as platelet and macrophage recruitment.  Since nanomaterials themselves or their carried drugs have the capability to modulate the immune system, a great amt. of focus has been placed on nanomedicine strategies that leverage immune cells participating the metastatic cascade.  These nanomedicines successfully inhibit the tumor metastasis and prolong the survival of model animals.  Immune cells that are involved in the metastasis cascade are first summarized and then recent and inspiring strategies and nanomaterials in this growing field are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAdL8c5wwN2LVg90H21EOLACvtfcHk0lgOLv-gsKIcLA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVKkur3I&md5=f0e75d502455119a7504dc7094475cde</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fadma.201904156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadma.201904156%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DNanomedicine-based%2520immunotherapy%2520for%2520the%2520treatment%2520of%2520cancer%2520metastasis%26jtitle%3DAdv.%2520Mater.%26date%3D2019%26volume%3D31%26spage%3D1904156%26doi%3D10.1002%2Fadma.201904156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holohan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Schaeybroeck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longley, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, P. G.</span></span> <span> </span><span class="NLM_article-title">Cancer drug resistance: an evolving paradigm</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">714</span>â <span class="NLM_lpage">726</span>, <span class="refDoi">Â DOI: 10.1038/nrc3599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1038%2Fnrc3599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=24060863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVyqurnE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=714-726&author=C.+Holohanauthor=S.+Van+Schaeybroeckauthor=D.+B.+Longleyauthor=P.+G.+Johnston&title=Cancer+drug+resistance%3A+an+evolving+paradigm&doi=10.1038%2Fnrc3599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer drug resistance: an evolving paradigm</span></div><div class="casAuthors">Holohan, Caitriona; Van Schaeybroeck, Sandra; Longley, Daniel B.; Johnston, Patrick G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">714-726</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Resistance to chemotherapy and molecularly targeted therapies is a major problem facing current cancer research.  The mechanisms of resistance to 'classical' cytotoxic chemotherapeutics and to therapies that are designed to be selective for specific mol. targets share many features, such as alterations in the drug target, activation of prosurvival pathways and ineffective induction of cell death.  With the increasing arsenal of anticancer agents, improving preclin. models and the advent of powerful high-throughput screening techniques, there are now unprecedented opportunities to understand and overcome drug resistance through the clin. assessment of rational therapeutic drug combinations and the use of predictive biomarkers to enable patient stratification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrykBEUSgvv7Vg90H21EOLACvtfcHk0lgOLv-gsKIcLA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVyqurnE&md5=b497a823bbd968904ce1591b918d0679</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnrc3599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3599%26sid%3Dliteratum%253Aachs%26aulast%3DHolohan%26aufirst%3DC.%26aulast%3DVan%2BSchaeybroeck%26aufirst%3DS.%26aulast%3DLongley%26aufirst%3DD.%2BB.%26aulast%3DJohnston%26aufirst%3DP.%2BG.%26atitle%3DCancer%2520drug%2520resistance%253A%2520an%2520evolving%2520paradigm%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2013%26volume%3D13%26spage%3D714%26epage%3D726%26doi%3D10.1038%2Fnrc3599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Russo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crisafulli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sogari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arena, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamba, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amodio, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MagrÃ¬, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novara, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarotto, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagel, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piett, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amatu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartore-Bianchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siena, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trusolino, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corigliano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gherardi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagomarsino, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Nicolantonio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardelli, A.</span></span> <span> </span><span class="NLM_article-title">Adaptive mutability of colorectal cancers in response to targeted therapies</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>366</i></span>,  <span class="NLM_fpage">1473</span>â <span class="NLM_lpage">1480</span>, <span class="refDoi">Â DOI: 10.1126/science.aav4474</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1126%2Fscience.aav4474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=31699882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVGhtLvN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2019&pages=1473-1480&author=M.+Russoauthor=G.+Crisafulliauthor=A.+Sogariauthor=N.+M.+Reillyauthor=S.+Arenaauthor=S.+Lambaauthor=A.+Bartoliniauthor=V.+Amodioauthor=A.+Magr%C3%ACauthor=L.+Novaraauthor=I.+Sarottoauthor=Z.+D.+Nagelauthor=C.+G.+Piettauthor=A.+Amatuauthor=A.+Sartore-Bianchiauthor=S.+Sienaauthor=A.+Bertottiauthor=L.+Trusolinoauthor=M.+Coriglianoauthor=M.+Gherardiauthor=M.+C.+Lagomarsinoauthor=F.+Di+Nicolantonioauthor=A.+Bardelli&title=Adaptive+mutability+of+colorectal+cancers+in+response+to+targeted+therapies&doi=10.1126%2Fscience.aav4474"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Adaptive mutability of colorectal cancers in response to targeted therapies</span></div><div class="casAuthors">Russo, Mariangela; Crisafulli, Giovanni; Sogari, Alberto; Reilly, Nicole M.; Arena, Sabrina; Lamba, Simona; Bartolini, Alice; Amodio, Vito; Magri, Alessandro; Novara, Luca; Sarotto, Ivana; Nagel, Zachary D.; Piett, Cortt G.; Amatu, Alessio; Sartore-Bianchi, Andrea; Siena, Salvatore; Bertotti, Andrea; Trusolino, Livio; Corigliano, Mattia; Gherardi, Marco; Lagomarsino, Marco Cosentino; Di Nicolantonio, Federica; Bardelli, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">6472</span>),
    <span class="NLM_cas:pages">1473-1480</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">1095-9203</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The emergence of drug resistance limits the efficacy of targeted therapies in human tumors.  The prevalent view is that resistance is a fait accompli: when treatment is initiated, cancers already contain drug-resistant mutant cells.  Bacteria exposed to antibiotics transiently increase their mutation rates (adaptive mutability), thus improving the likelihood of survival.  We investigated whether human colorectal cancer (CRC) cells likewise exploit adaptive mutability to evade therapeutic pressure.  We found that epidermal growth factor receptor (EGFR)/BRAF inhibition down-regulates mismatch repair (MMR) and homologous recombination DNA-repair genes and concomitantly up-regulates error-prone polymerases in drug-tolerant (persister) cells. MMR proteins were also down-regulated in patient-derived xenografts and tumor specimens during therapy.  EGFR/BRAF inhibition induced DNA damage, increased mutability, and triggered microsatellite instability.  Thus, like unicellular organisms, tumor cells evade therapeutic pressures by enhancing mutability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH-BSjnOzI0LVg90H21EOLACvtfcHk0lgOLv-gsKIcLA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVGhtLvN&md5=8b5ac7f79d2b4e97a1134a827a946a3d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1126%2Fscience.aav4474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aav4474%26sid%3Dliteratum%253Aachs%26aulast%3DRusso%26aufirst%3DM.%26aulast%3DCrisafulli%26aufirst%3DG.%26aulast%3DSogari%26aufirst%3DA.%26aulast%3DReilly%26aufirst%3DN.%2BM.%26aulast%3DArena%26aufirst%3DS.%26aulast%3DLamba%26aufirst%3DS.%26aulast%3DBartolini%26aufirst%3DA.%26aulast%3DAmodio%26aufirst%3DV.%26aulast%3DMagr%25C3%25AC%26aufirst%3DA.%26aulast%3DNovara%26aufirst%3DL.%26aulast%3DSarotto%26aufirst%3DI.%26aulast%3DNagel%26aufirst%3DZ.%2BD.%26aulast%3DPiett%26aufirst%3DC.%2BG.%26aulast%3DAmatu%26aufirst%3DA.%26aulast%3DSartore-Bianchi%26aufirst%3DA.%26aulast%3DSiena%26aufirst%3DS.%26aulast%3DBertotti%26aufirst%3DA.%26aulast%3DTrusolino%26aufirst%3DL.%26aulast%3DCorigliano%26aufirst%3DM.%26aulast%3DGherardi%26aufirst%3DM.%26aulast%3DLagomarsino%26aufirst%3DM.%2BC.%26aulast%3DDi%2BNicolantonio%26aufirst%3DF.%26aulast%3DBardelli%26aufirst%3DA.%26atitle%3DAdaptive%2520mutability%2520of%2520colorectal%2520cancers%2520in%2520response%2520to%2520targeted%2520therapies%26jtitle%3DScience%26date%3D2019%26volume%3D366%26spage%3D1473%26epage%3D1480%26doi%3D10.1126%2Fscience.aav4474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Genovese, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assaraf, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colotti, G.</span></span> <span> </span><span class="NLM_article-title">Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins</span>. <i>Drug Resist. Updates</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">23</span>â <span class="NLM_lpage">46</span>, <span class="refDoi">Â DOI: 10.1016/j.drup.2017.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1016%2Fj.drup.2017.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=29145976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A280%3ADC%252BC1M3itVaqtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2017&pages=23-46&author=I.+Genoveseauthor=A.+Ilariauthor=Y.+G.+Assarafauthor=F.+Faziauthor=G.+Colotti&title=Not+only+P-glycoprotein%3A+Amplification+of+the+ABCB1-containing+chromosome+region+7q21+confers+multidrug+resistance+upon+cancer+cells+by+coordinated+overexpression+of+an+assortment+of+resistance-related+proteins&doi=10.1016%2Fj.drup.2017.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins</span></div><div class="casAuthors">Genovese Ilaria; Ilari Andrea; Assaraf Yehuda G; Fazi Francesco; Colotti Gianni</div><div class="citationInfo"><span class="NLM_cas:title">Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">23-46</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The development of drug resistance continues to be a dominant hindrance toward curative cancer treatment.  Overexpression of a wide-spectrum of ATP-dependent efflux pumps, and in particular of ABCB1 (P-glycoprotein or MDR1) is a well-known resistance mechanism for a plethora of cancer chemotherapeutics including for example taxenes, anthracyclines, Vinca alkaloids, and epipodopyllotoxins, demonstrated by a large array of published papers, both in tumor cell lines and in a variety of tumors, including various solid tumors and hematological malignancies.  Upon repeated or even single dose treatment of cultured tumor cells or tumors in vivo with anti-tumor agents such as paclitaxel and doxorubicin, increased ABCB1 copy number has been demonstrated, resulting from chromosomal amplification events at 7q11.2-21 locus, leading to marked P-glycoprotein overexpression, and multidrug resistance (MDR).  Clearly however, additional mechanisms such as single nucleotide polymorphisms (SNPs) and epigenetic modifications have shown a role in the overexpression of ABCB1 and of other MDR efflux pumps.  However, notwithstanding the design of 4 generations of ABCB1 inhibitors and the wealth of information on the biochemistry and substrate specificity of ABC transporters, translation of this vast knowledge from the bench to the bedside has proven to be unexpectedly difficult.  Many studies show that upon repeated treatment schedules of cell cultures or tumors with taxenes and anthracyclines as well as other chemotherapeutic drugs, amplification, and/or overexpression of a series of genes genomically surrounding the ABCB1 locus, is observed.  Consequently, altered levels of other proteins may contribute to the establishment of the MDR phenotype, and lead to poor clinical outcome.  Thus, the genes contained in this ABCB1 amplicon including ABCB4, SRI, DBF4, TMEM243, and RUNDC3B are overexpressed in many cancers, and especially in MDR tumors, while TP53TG1 and DMTF1 are bona fide tumor suppressors.  This review describes the role of these genes in cancer and especially in the acquisition of MDR, elucidates possible connections in transcriptional regulation (co-amplification/repression) of genes belonging to the same ABCB1 amplicon region, and delineates their novel emerging contributions to tumor biology and possible strategies to overcome cancer MDR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTlGWXKBPOQGvtos8R3JUhXfW6udTcc2eaFG83zmOq3o7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3itVaqtQ%253D%253D&md5=60a54c7bae87c6f4ccffdaa242138de3</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2017.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2017.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DGenovese%26aufirst%3DI.%26aulast%3DIlari%26aufirst%3DA.%26aulast%3DAssaraf%26aufirst%3DY.%2BG.%26aulast%3DFazi%26aufirst%3DF.%26aulast%3DColotti%26aufirst%3DG.%26atitle%3DNot%2520only%2520P-glycoprotein%253A%2520Amplification%2520of%2520the%2520ABCB1-containing%2520chromosome%2520region%25207q21%2520confers%2520multidrug%2520resistance%2520upon%2520cancer%2520cells%2520by%2520coordinated%2520overexpression%2520of%2520an%2520assortment%2520of%2520resistance-related%2520proteins%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2017%26volume%3D32%26spage%3D23%26epage%3D46%26doi%3D10.1016%2Fj.drup.2017.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aronson, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonson, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orchard, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LlinÃ¡s, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, S. H.</span></span> <span> </span><span class="NLM_article-title">Lipopeptisomes: Anticancer peptide-assembled particles for fusolytic oncotherapy</span>. <i>Acta Biomater.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">269</span>â <span class="NLM_lpage">277</span>, <span class="refDoi">Â DOI: 10.1016/j.actbio.2018.09.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1016%2Fj.actbio.2018.09.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=30240951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslyqsr3O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2018&pages=269-277&author=M.+R.+Aronsonauthor=A.+W.+Simonsonauthor=L.+M.+Orchardauthor=M.+Llin%C3%A1sauthor=S.+H.+Medina&title=Lipopeptisomes%3A+Anticancer+peptide-assembled+particles+for+fusolytic+oncotherapy&doi=10.1016%2Fj.actbio.2018.09.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Lipopeptisomes: Anticancer peptide-assembled particles for fusolytic oncotherapy</span></div><div class="casAuthors">Aronson, Matthew R.; Simonson, Andrew W.; Orchard, Lindsey M.; Llinas, Manuel; Medina, Scott H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Biomaterialia</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">269-277</span>CODEN:
                <span class="NLM_cas:coden">ABCICB</span>;
        ISSN:<span class="NLM_cas:issn">1742-7061</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Anticancer peptides (ACPs) are cationic amphiphiles that preferentially kill cancer cells through folding-dependent membrane disruption.  Although ACPs represent attractive therapeutic candidates, particularly against drug-resistant cancers, their successful translation into clin. practice has gone unrealized due to their poor bioavailability, serum instability and, most importantly, severe hemolytic toxicity.  Here, we exploit the membrane-specific interactions of ACPs to prep. a new class of peptide-lipid particle, we term a lipopeptisome (LP).  This design sequesters loaded ACPs within a lipid lamellar corona to avoid contact with red blood cells and healthy tissues, while affording potent lytic destruction of cancer cells following LP-membrane fusion.  Biophys. studies show ACPs rapidly fold at, and integrate into, liposomal membranes to form stable LPs with high loading efficiencies (>80%).  Rational design of the particles to possess lipid combinations mimicking that of the aberrant cancer cell outer leaflet allows LPs to rapidly fuse with tumor cell membranes and afford localized assembly of loaded ACPs within the bilayer.  This leads to preferential fusolytic killing of cancer cells with minimal collateral toxicity towards non-cancerous cells and erythrocytes, thereby imparting clin. relevant therapeutic indexes to otherwise toxic ACPs.  Thus, integration of ACPs into self-assembled LPs represents a new delivery strategy to improve the therapeutic utility of oncolytic agents, and suggests this technol. may be added to targeted combinatorial approaches in precision medicine.  Despite their significant clin. potential, the therapeutic utility of many ACPs has been limited by their collateral hemolysis during administration.  Leveraging the membrane-specific interactions of ACPs, here we prep. self-assembled peptide-lipid nanoparticles, or 'lipopeptisomes' (LPs), capable of preferentially fusing with and lysing cancer cell membranes.  Key to this fusolytic action is the construction of LPs from lipids simulating the cancer cell outer leaflet.  This design recruits the oncolytic peptide payload into the carrier lamella and allows for selective destruction of cancer cells without disrupting healthy cells.  Consequently, LPs impart clin. relevant therapeutic indexes to previously toxic ACPs, and thus open new opportunities to improve the clin. translation of oncolytics challenged by narrow therapeutic windows.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrms7QPSxD_ArVg90H21EOLACvtfcHk0lgSAcApZblhDg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslyqsr3O&md5=91d468632aa4cc288649daa595fc62db</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.actbio.2018.09.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.actbio.2018.09.025%26sid%3Dliteratum%253Aachs%26aulast%3DAronson%26aufirst%3DM.%2BR.%26aulast%3DSimonson%26aufirst%3DA.%2BW.%26aulast%3DOrchard%26aufirst%3DL.%2BM.%26aulast%3DLlin%25C3%25A1s%26aufirst%3DM.%26aulast%3DMedina%26aufirst%3DS.%2BH.%26atitle%3DLipopeptisomes%253A%2520Anticancer%2520peptide-assembled%2520particles%2520for%2520fusolytic%2520oncotherapy%26jtitle%3DActa%2520Biomater.%26date%3D2018%26volume%3D80%26spage%3D269%26epage%3D277%26doi%3D10.1016%2Fj.actbio.2018.09.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vitale, I.</span>; <span class="NLM_string-name">Yamazaki, T.</span>; <span class="NLM_string-name">Wennerberg, E.</span>; <span class="NLM_string-name">SveinbjÃ¸rnsson, B.</span>; <span class="NLM_string-name">Rekdal, Ã.</span>; <span class="NLM_string-name">Demaria, S.</span>; <span class="NLM_string-name">Galluzzi, L.</span></span> <span> </span><span class="NLM_article-title">Targeting cancer heterogeneity with immune responses driven by oncolytic peptides</span>.  <i>Trends Cancer</i>. <span class="NLM_year" style="font-weight: bold;">2021</span>, <span class="refDoi">Â DOI: 10.1016/j.trecan.2020.12.012</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1016%2Fj.trecan.2020.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=33446447" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2021&author=I.+Vitale&author=T.+Yamazaki&author=E.+Wennerberg&author=B.+Sveinbj%C3%B8rnsson&author=%C3%98.+Rekdal&author=S.+Demaria&author=L.+Galluzzi&title=Targeting+cancer+heterogeneity+with+immune+responses+driven+by+oncolytic+peptides&doi=10.1016%2Fj.trecan.2020.12.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.trecan.2020.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trecan.2020.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DVitale%26aufirst%3DI.%26atitle%3DTargeting%2520cancer%2520heterogeneity%2520with%2520immune%2520responses%2520driven%2520by%2520oncolytic%2520peptides%26jtitle%3DTrends%2520Cancer%26date%3D2021%26doi%3D10.1016%2Fj.trecan.2020.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashmi, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Activatable protein nanoparticles for targeted delivery of therapeutic peptides</span>. <i>Adv. Mater.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">1705383</span>, <span class="refDoi">Â DOI: 10.1002/adma.201705383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1002%2Fadma.201705383" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2018&pages=1705383&author=X.+Yuauthor=X.+Gouauthor=P.+Wuauthor=L.+Hanauthor=D.+Tianauthor=F.+Duauthor=Z.+Chenauthor=F.+Liuauthor=G.+Dengauthor=A.+T.+Chenauthor=C.+Maauthor=J.+Liuauthor=S.+M.+Hashmiauthor=X.+Guoauthor=X.+Wangauthor=H.+Zhaoauthor=X.+Liuauthor=X.+Zhuauthor=K.+Shethauthor=Q.+Chenauthor=L.+Fanauthor=J.+Zhou&title=Activatable+protein+nanoparticles+for+targeted+delivery+of+therapeutic+peptides&doi=10.1002%2Fadma.201705383"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fadma.201705383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadma.201705383%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DX.%26aulast%3DGou%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DHan%26aufirst%3DL.%26aulast%3DTian%26aufirst%3DD.%26aulast%3DDu%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DDeng%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DA.%2BT.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DHashmi%26aufirst%3DS.%2BM.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DSheth%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DActivatable%2520protein%2520nanoparticles%2520for%2520targeted%2520delivery%2520of%2520therapeutic%2520peptides%26jtitle%3DAdv.%2520Mater.%26date%3D2018%26volume%3D30%26spage%3D1705383%26doi%3D10.1002%2Fadma.201705383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiedmann, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galloway, W. R. J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chattopadhyay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, T. T.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Andrade, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janecek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arumugam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itzhaki, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">Toolbox of diverse linkers for navigating the cellular efficacy landscape of stapled peptides</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">526</span>â <span class="NLM_lpage">533</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.9b00063</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.9b00063" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFyqu7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=526-533&author=Y.+Wuauthor=A.+Kaurauthor=E.+Fowlerauthor=M.+M.+Wiedmannauthor=R.+Youngauthor=W.+R.+J.+D.+Gallowayauthor=L.+Olsenauthor=H.+F.+Soreauthor=A.+Chattopadhyayauthor=T.+T.-L.+Kwanauthor=W.+Xuauthor=S.+J.+Walshauthor=P.+de+Andradeauthor=M.+Janecekauthor=S.+Arumugamauthor=L.+S.+Itzhakiauthor=Y.+H.+Lauauthor=D.+R.+Spring&title=Toolbox+of+diverse+linkers+for+navigating+the+cellular+efficacy+landscape+of+stapled+peptides&doi=10.1021%2Facschembio.9b00063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Toolbox of Diverse Linkers for Navigating the Cellular Efficacy Landscape of Stapled Peptides</span></div><div class="casAuthors">Wu, Yuteng; Kaur, Amandeep; Fowler, Elaine; Wiedmann, Mareike M.; Young, Reginald; Galloway, Warren R. J. D.; Olsen, Lasse; Sore, Hannah F.; Chattopadhyay, Anasuya; Kwan, Terence T.-L.; Xu, Wenshu; Walsh, Stephen J.; de Andrade, Peterson; Janecek, Matej; Arumugam, Senthil; Itzhaki, Laura S.; Lau, Yu Heng; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">526-533</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Stapled peptides have great potential as modulators of protein-protein interactions (PPIs).  However, there is a vast landscape of chem. features that can be varied for any given peptide, and identifying a set of features that maximizes cellular uptake and subsequent target engagement remains a key challenge.  Herein, we present a systematic anal. of staple functionality on the peptide bioactivity landscape in cellular assays.  Through application of a "toolbox" of diversified dialkynyl linkers to the stapling of MDM2-binding peptides via a double-click approach, we conducted a study of cellular uptake and p53 activation as a function of the linker.  Minor changes in the linker motif and the specific pairing of linker with peptide sequence can lead to substantial differences in bioactivity, a finding which may have important design implications for peptide-based inhibitors of other PPIs.  Given the complexity of the structure-activity relationships involved, the toolbox approach represents a generalizable strategy for optimization when progressing from in vitro binding assays to cellular efficacy studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMk22wTNrvLLVg90H21EOLACvtfcHk0lgMbuA2KOYnTw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFyqu7w%253D&md5=f22fff1cabf65589d182961382b9339e</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Facschembio.9b00063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.9b00063%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DKaur%26aufirst%3DA.%26aulast%3DFowler%26aufirst%3DE.%26aulast%3DWiedmann%26aufirst%3DM.%2BM.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGalloway%26aufirst%3DW.%2BR.%2BJ.%2BD.%26aulast%3DOlsen%26aufirst%3DL.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DChattopadhyay%26aufirst%3DA.%26aulast%3DKwan%26aufirst%3DT.%2BT.-L.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DWalsh%26aufirst%3DS.%2BJ.%26aulast%3Dde%2BAndrade%26aufirst%3DP.%26aulast%3DJanecek%26aufirst%3DM.%26aulast%3DArumugam%26aufirst%3DS.%26aulast%3DItzhaki%26aufirst%3DL.%2BS.%26aulast%3DLau%26aufirst%3DY.%2BH.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DToolbox%2520of%2520diverse%2520linkers%2520for%2520navigating%2520the%2520cellular%2520efficacy%2520landscape%2520of%2520stapled%2520peptides%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2019%26volume%3D14%26spage%3D526%26epage%3D533%26doi%3D10.1021%2Facschembio.9b00063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Won, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pripotnev, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruscito, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ianoul, A.</span></span> <span> </span><span class="NLM_article-title">Effect of point mutations on the secondary structure and membrane interaction of antimicrobial peptide anoplin</span>. <i>J. Phys. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">2371</span>â <span class="NLM_lpage">2379</span>, <span class="refDoi">Â DOI: 10.1021/jp108343g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp108343g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVWmsLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2011&pages=2371-2379&author=A.+Wonauthor=S.+Pripotnevauthor=A.+Ruscitoauthor=A.+Ianoul&title=Effect+of+point+mutations+on+the+secondary+structure+and+membrane+interaction+of+antimicrobial+peptide+anoplin&doi=10.1021%2Fjp108343g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of point mutations on the secondary structure and membrane interaction of antimicrobial peptide anoplin</span></div><div class="casAuthors">Won, Amy; Pripotnev, Stahs; Ruscito, Annamaria; Ianoul, Anatoli</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2371-2379</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1520-5207</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Anoplin (GLLKRIKTLL-NH2) is the smallest linear Î±-helical antimicrobial peptide found naturally to date.  Antibacterial and hemolytic properties of anoplin depend strongly on physicochem. properties.  Two anoplin derivs., anoplin-8K (Ano8K, GLLKRIKKLL-NH2) and anoplin-1K5 V8K (Ano1K5 V8K, KLLKVIKKLL-NH2), were found to have increased bacterial and low hemolytic activity.  In the present work physicochem. properties of these three peptides were studied by UV resonance Raman (UVRR) spectroscopy, Langmuir-Blodgett monolayer technique, and carboxyfluorescein (CF) leakage assay.  UVRR data indicated that all three peptides adopt predominantly unordered conformation in aq. buffer soln.  In membrane-mimicking trifluoroethanol, the Î±-helical content increases for all three peptides with Ano1K5 V8K having the highest Î±-helix percentage, followed by Ano8K and anoplin.  Crit. micelle concns. were found to be similar for all three peptides, and the satn. pressure decreases in the sequence Ano1K5 V8K, anoplin, Ano8K.  Crit. pressure of insertion was found to be greater for anionic lipid monolayer DPPG than for zwitterionic lipid DPPC, indicating preferential adsorption of all three peptides to DPPG.  Finally, membrane lytic activities of all three peptides toward various model lipid vesicles were compared through CF leakage assay.  Overall the data indicate that antimicrobial activity of anoplin increases with charge, whereas membrane lytic activity correlates with peptide helicity and amphipathicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq86WnKqef97LVg90H21EOLACvtfcHk0limSnyDDjEnhw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVWmsLs%253D&md5=134f41a25422180e5cd8e632060958b3</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjp108343g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp108343g%26sid%3Dliteratum%253Aachs%26aulast%3DWon%26aufirst%3DA.%26aulast%3DPripotnev%26aufirst%3DS.%26aulast%3DRuscito%26aufirst%3DA.%26aulast%3DIanoul%26aufirst%3DA.%26atitle%3DEffect%2520of%2520point%2520mutations%2520on%2520the%2520secondary%2520structure%2520and%2520membrane%2520interaction%2520of%2520antimicrobial%2520peptide%2520anoplin%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2011%26volume%3D115%26spage%3D2371%26epage%3D2379%26doi%3D10.1021%2Fjp108343g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinn, Y. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">Peptidomimetic inhibitors of APC-Asef interaction block colorectal cancer migration</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">994</span>â <span class="NLM_lpage">1001</span>, <span class="refDoi">Â DOI: 10.1038/nchembio.2442</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1038%2Fnchembio.2442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=28759015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1WrtLfE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=994-1001&author=H.+Jiangauthor=R.+Dengauthor=X.+Yangauthor=J.+Shangauthor=S.+Luauthor=Y.+Zhaoauthor=K.+Songauthor=X.+Liuauthor=Q.+Zhangauthor=Y.+Chenauthor=Y.+E.+Chinnauthor=G.+Wuauthor=J.+Liauthor=G.+Chenauthor=J.+Yuauthor=J.+Zhang&title=Peptidomimetic+inhibitors+of+APC-Asef+interaction+block+colorectal+cancer+migration&doi=10.1038%2Fnchembio.2442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidomimetic inhibitors of APC-Asef interaction block colorectal cancer migration</span></div><div class="casAuthors">Jiang, Haiming; Deng, Rong; Yang, Xiuyan; Shang, Jialin; Lu, Shaoyong; Zhao, Yanlong; Song, Kun; Liu, Xinyi; Zhang, Qiufen; Chen, Yu; Chinn, Y. Eugene; Wu, Geng; Li, Jian; Chen, Guoqiang; Yu, Jianxiu; Zhang, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">994-1001</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The binding of adenomatous polyposis coli (APC) to its receptor Asef relieves the neg. intramol. regulation of Asef and leads to aberrant cell migration in human colorectal cancer.  Because of its crucial role in metastatic dissemination, the interaction between APC and Asef is an attractive target for anti-colorectal-cancer therapy.  We rationally designed a series of peptidomimetics that act as potent inhibitors of the APC interface.  Crystal structures and biochem. and cellular assays showed that the peptidomimetics in the APC pocket inhibited the migration of colorectal cells by disrupting APC-Asef interaction.  By using the peptidomimetic inhibitor as a chem. probe, we found that CDC42 was the downstream GTPase involved in APC-stimulated Asef activation in colorectal cancer cells.  Our work demonstrates the feasibility of exploiting APC-Asef interaction to regulate the migration of colorectal cancer cells, and provides what to our knowledge is the first class of protein-protein interaction inhibitors available for the development of cancer therapeutics targeting APC-Asef signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQtEFrIZd5_rVg90H21EOLACvtfcHk0limSnyDDjEnhw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1WrtLfE&md5=03e378e877cc84646882a68f982a1ec4</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2442%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DDeng%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DShang%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DChinn%26aufirst%3DY.%2BE.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DPeptidomimetic%2520inhibitors%2520of%2520APC-Asef%2520interaction%2520block%2520colorectal%2520cancer%2520migration%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2017%26volume%3D13%26spage%3D994%26epage%3D1001%26doi%3D10.1038%2Fnchembio.2442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Q. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z. H.</span></span> <span> </span><span class="NLM_article-title">Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1110</span>, <span class="refDoi">Â DOI: 10.1038/s41467-020-14906-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1038%2Fs41467-020-14906-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=32111828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtVGmsbjK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=1110&author=X.+Yuauthor=Y.+F.+Daiauthor=Y.+F.+Zhaoauthor=S.+H.+Qiauthor=L.+Liuauthor=L.+S.+Luauthor=Q.+M.+Luoauthor=Z.+H.+Zhang&title=Melittin-lipid+nanoparticles+target+to+lymph+nodes+and+elicit+a+systemic+anti-tumor+immune+response&doi=10.1038%2Fs41467-020-14906-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response</span></div><div class="casAuthors">Yu, Xiang; Dai, Yanfeng; Zhao, Yifan; Qi, Shuhong; Liu, Lei; Lu, Lisen; Luo, Qingming; Zhang, Zhihong</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1110</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Targeted delivery of a nanovaccine loaded with a tumor antigen and adjuvant to the lymph nodes (LNs) is an attractive approach for improving cancer immunotherapy outcomes.  However, the application of this technique is restricted by the paucity of suitable tumor-assocd. antigens (TAAs) and the sophisticated technol. required to identify tumor neoantigens.  Here, we demonstrate that a self-assembling melittin-lipid nanoparticle (Î±-melittin-NP) that is not loaded with extra tumor antigens promotes whole tumor antigen release in situ and results in the activation of antigen-presenting cells (APCs) in LNs.  Compared with free melittin, Î±-melittin-NPs markedly enhance LN accumulation and activation of APCs, leading to a 3.6-fold increase in antigen-specific CD8+ T cell responses.  Furthermore, in a bilateral flank B16F10 tumor model, primary and distant tumor growth are significantly inhibited by Î±-melittin-NPs, with an inhibition rate of 95% and 92%, resp.  Thus, Î±-melittin-NPs induce a systemic anti-tumor response serving as an effective LN-targeted whole-cell nanovaccine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2cSmtqon3nLVg90H21EOLACvtfcHk0lgkUFsrMkeWyQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtVGmsbjK&md5=9fd42905787485f0ec7551e8b7b744b1</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fs41467-020-14906-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-020-14906-9%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DX.%26aulast%3DDai%26aufirst%3DY.%2BF.%26aulast%3DZhao%26aufirst%3DY.%2BF.%26aulast%3DQi%26aufirst%3DS.%2BH.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DL.%2BS.%26aulast%3DLuo%26aufirst%3DQ.%2BM.%26aulast%3DZhang%26aufirst%3DZ.%2BH.%26atitle%3DMelittin-lipid%2520nanoparticles%2520target%2520to%2520lymph%2520nodes%2520and%2520elicit%2520a%2520systemic%2520anti-tumor%2520immune%2520response%26jtitle%3DNat.%2520Commun.%26date%3D2020%26volume%3D11%26spage%3D1110%26doi%3D10.1038%2Fs41467-020-14906-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shepherd, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbenante, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, D. P.</span></span> <span> </span><span class="NLM_article-title">Single turn peptide alpha helices with exceptional stability in water</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">2974</span>â <span class="NLM_lpage">2983</span>, <span class="refDoi">Â DOI: 10.1021/ja0456003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0456003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yhsrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=2974-2983&author=N.+E.+Shepherdauthor=H.+N.+Hoangauthor=G.+Abbenanteauthor=D.+P.+Fairlie&title=Single+turn+peptide+alpha+helices+with+exceptional+stability+in+water&doi=10.1021%2Fja0456003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Single Turn Peptide Alpha Helices with Exceptional Stability in Water</span></div><div class="casAuthors">Shepherd, Nicholas E.; Hoang, Huy N.; Abbenante, Giovanni; Fairlie, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2974-2983</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclic pentapeptides are not known to exist in Î±-helical conformations.  CD and NMR spectra show that specific 20-membered cyclic pentapeptides, Ac-(cyclo-1,5)-[KXXXD]-NH2 (X = Ala, Arg) and Ac-(cyclo-2,6)-R[KXXXD]-NH2 (X = Ala, Leu, Met, Gln, Phe, Gly, Ser) are highly Î±-helical structures in water and independent of concn., TFE, denaturants, and proteases.  These are the smallest Î±-helical peptides in water.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKJhSsJ2TgQLVg90H21EOLACvtfcHk0lgkUFsrMkeWyQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yhsrY%253D&md5=5fc515610f290300af1be167a1446798</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fja0456003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0456003%26sid%3Dliteratum%253Aachs%26aulast%3DShepherd%26aufirst%3DN.%2BE.%26aulast%3DHoang%26aufirst%3DH.%2BN.%26aulast%3DAbbenante%26aufirst%3DG.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DSingle%2520turn%2520peptide%2520alpha%2520helices%2520with%2520exceptional%2520stability%2520in%2520water%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D2974%26epage%3D2983%26doi%3D10.1021%2Fja0456003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/medium/jm0c02237_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02237&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/medium/jm0c02237_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic illustration of the StAnos design and the proposed mechanism of action for StAnos-based oncolytic immunotherapy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02237&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/medium/jm0c02237_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Sequence, charge, C<sub>18</sub>-HPLC retention time (<i>T</i><sub>R</sub>), Î±-helicity, and antitumor activities of <i>i</i>, <i>i</i> + 4-stapled Anoplin library. The reported IC<sub>50</sub> values are the mean Â± standard deviation of three or more independent experiments. (B) Synthetic route for the production of Ano (<i>i</i> + 4). (C) Surface and ribbon views of the hydrophobic (left) and hydrophilic (right) faces of the amphipathic anoplin Î±-helix (protein data bank ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2MJQ">2MJQ</a>). Helical wheel diagram of anoplin (middle) shows the polar and nonpolar faces of the helix. Yellow symbols represent highly hydrophobic residues. Gray symbols represent low hydrophobic residues. Green symbols represent polar, uncharged residues. Blue symbols represent basic residues. (D) Surface views of the Ano (<i>i</i> + 4) (hydrocarbon staple represented by a black oval symbol). Staple locations for each StAons are indicated on the helical wheel.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02237&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/medium/jm0c02237_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) HNMs and the corresponding lyticity indices of anoplin, Ano-1, -3, and -5. (B) RBC hemolytic activity of anoplin, Ano-1, -3, and -5 (<i>n</i> = 3). (C) LDH release of 4T1 following treatment with Ano-3 and LTX-315 (<i>n</i> = 3). (D) Extracellular ATP levels of 4T1 following Ano-3 and LTX-315 treatment (50 Î¼M) (<i>n</i> = 3). (E) Bright field microscopy images of Ano-3-treated 4T1. (F) Peptide effects on 4T1 cells, as observed by a confocal microscope (16 Î¼M). (G) 4T1 cells after treatment with Ano-3 and LTX-315 and stained with the LIVE/DEAD cell viability/cytotoxicity kit. The representative photographs of the cells were shown. Statistical significance: **<i>P</i> < 0.01 and ***<i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02237&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/medium/jm0c02237_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Structure-based design of Ano-3s from Ano-3. (B) Synthetic scheme of Fmoc-Leu*-OH and Fmoc-Lys*-OH. (C) Sequence, charge, Î±-helicity, and antitumor activities of Ano-3s. (D) Analytical HPLC chromatogram (Î» = 214 nm) of Ano-3 and Ano-3s. (E) RBC hemolytic activity of Ano-3 and Ano-3s (<i>n</i> = 3). (F) CD spectra of anoplin, LTX-315, Ano-3, and Ano-3s. (G) Ano-3s effects on 4T1 cells observed by a confocal microscope (16 Î¼M). (H) 4T1 cells after treatment with Ano-3s and stained with the LIVE/DEAD cell viability/cytotoxicity kit. Statistical significance: ***<i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02237&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/medium/jm0c02237_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Schematic illustration of the timeline for the therapeutic experiments. (B) Images of excised 4T1 tumors. (C) Weight of 4T1 tumors. (D) Body weight of mice bearing 4T1 tumors throughout the study. (E) Images of excised B16F10 tumors. (F) Weight of B16F10 tumors. (G) Body weight of mice bearing B16F10 tumors throughout the study, <i>n</i> = 5. Statistical significance: *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02237&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/medium/jm0c02237_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A,C,D) H&E staining and quantitative analysis of the excised 4T1 tumor tissues. (B,E,F) H&E staining and quantitative analysis of the excised B16F10 tumor tissues. Statistical significance: *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02237&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/medium/jm0c02237_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Confocal microscopy images showing surface translocation of (A) CRT and (B) HMGB1 in 4T1 and B16F10 cells incubated with or without Ano-3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02237&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/medium/jm0c02237_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Immunohistochemical staining images of CD4+ T cells and CD8+ T cells in the B16F10 tumor sections. (B,C) Quantitative analysis of CD4+ T cells and CD8+ T cells on B16F10 tumor tissue sections. Statistical significance: *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02237&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/medium/jm0c02237_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (A) Schematic illustration of the timeline for the therapeutic experiments. (B) Survival analysis of B16F10 tumor-bearing mice treated with Ano-3s (<i>n</i> = 6). (C) Table of the number of tumor-free mice over the total number of mice under different treatment conditions for 3 representative days after tumor challenge. (D) Individual tumor growth kinetics of different groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02237/20210506/images/large/jm0c02237_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02237&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i33">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27013" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27013" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 51 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bray, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferlay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soerjomataram, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torre, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span> <span> </span><span class="NLM_article-title">Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</span>. <i>Ca-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">394</span>â <span class="NLM_lpage">424</span>, <span class="refDoi">Â DOI: 10.3322/caac.21492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.3322%2Fcaac.21492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=30207593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A280%3ADC%252BB3c3otVGlsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2018&pages=394-424&author=F.+Brayauthor=J.+Ferlayauthor=I.+Soerjomataramauthor=R.+L.+Siegelauthor=L.+A.+Torreauthor=A.+Jemal&title=Global+cancer+statistics+2018%3A+GLOBOCAN+estimates+of+incidence+and+mortality+worldwide+for+36+cancers+in+185+countries&doi=10.3322%2Fcaac.21492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</span></div><div class="casAuthors">Bray Freddie; Ferlay Jacques; Soerjomataram Isabelle; Siegel Rebecca L; Torre Lindsey A; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">394-424</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions.  There will be an estimated 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018.  In both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths), closely followed by female breast cancer (11.6%), prostate cancer (7.1%), and colorectal cancer (6.1%) for incidence and colorectal cancer (9.2%), stomach cancer (8.2%), and liver cancer (8.2%) for mortality.  Lung cancer is the most frequent cancer and the leading cause of cancer death among males, followed by prostate and colorectal cancer (for incidence) and liver and stomach cancer (for mortality).  Among females, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death, followed by colorectal and lung cancer (for incidence), and vice versa (for mortality); cervical cancer ranks fourth for both incidence and mortality.  The most frequently diagnosed cancer and the leading cause of cancer death, however, substantially vary across countries and within each country depending on the degree of economic development and associated social and life style factors.  It is noteworthy that high-quality cancer registry data, the basis for planning and implementing evidence-based cancer control programs, are not available in most low- and middle-income countries.  The Global Initiative for Cancer Registry Development is an international partnership that supports better estimation, as well as the collection and use of local data, to prioritize and evaluate national cancer control efforts.  CA: A Cancer Journal for Clinicians 2018;0:1-31. Â© 2018 American Cancer Society.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQaW5wv8ocuhLxanA7vODO6fW6udTcc2ebheYwXMhXUmbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3otVGlsg%253D%253D&md5=48529f8f794092779d70a27eec5c9017</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21492%26sid%3Dliteratum%253Aachs%26aulast%3DBray%26aufirst%3DF.%26aulast%3DFerlay%26aufirst%3DJ.%26aulast%3DSoerjomataram%26aufirst%3DI.%26aulast%3DSiegel%26aufirst%3DR.%2BL.%26aulast%3DTorre%26aufirst%3DL.%2BA.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DGlobal%2520cancer%2520statistics%25202018%253A%2520GLOBOCAN%2520estimates%2520of%2520incidence%2520and%2520mortality%2520worldwide%2520for%252036%2520cancers%2520in%2520185%2520countries%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2018%26volume%3D68%26spage%3D394%26epage%3D424%26doi%3D10.3322%2Fcaac.21492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogueira, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariotto, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabroff, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alfano, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R. L.</span></span> <span> </span><span class="NLM_article-title">Cancer treatment and survivorship statistics, 2019</span>. <i>Ca-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">363</span>â <span class="NLM_lpage">385</span>, <span class="refDoi">Â DOI: 10.3322/caac.21565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.3322%2Fcaac.21565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=31184787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A280%3ADC%252BB3M3ltlemug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2019&pages=363-385&author=K.+D.+Millerauthor=L.+Nogueiraauthor=A.+B.+Mariottoauthor=J.+H.+Rowlandauthor=K.+R.+Yabroffauthor=C.+M.+Alfanoauthor=A.+Jemalauthor=J.+L.+Kramerauthor=R.+L.+Siegel&title=Cancer+treatment+and+survivorship+statistics%2C+2019&doi=10.3322%2Fcaac.21565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer treatment and survivorship statistics, 2019</span></div><div class="casAuthors">Miller Kimberly D; Jemal Ahmedin; Siegel Rebecca L; Nogueira Leticia; Yabroff K Robin; Jemal Ahmedin; Mariotto Angela B; Rowland Julia H; Alfano Catherine M; Kramer Joan L</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">363-385</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The number of cancer survivors continues to increase in the United States because of the growth and aging of the population as well as advances in early detection and treatment.  To assist the public health community in better serving these individuals, the American Cancer Society and the National Cancer Institute collaborate every 3 years to estimate cancer prevalence in the United States using incidence and survival data from the Surveillance, Epidemiology, and End Results cancer registries; vital statistics from the Centers for Disease Control and Prevention's National Center for Health Statistics; and population projections from the US Census Bureau.  Current treatment patterns based on information in the National Cancer Data Base are presented for the most prevalent cancer types.  Cancer-related and treatment-related short-term, long-term, and late health effects are also briefly described.  More than 16.9 million Americans (8.1 million males and 8.8 million females) with a history of cancer were alive on January 1, 2019; this number is projected to reach more than 22.1 million by January 1, 2030 based on the growth and aging of the population alone.  The 3 most prevalent cancers in 2019 are prostate (3,650,030), colon and rectum (776,120), and melanoma of the skin (684,470) among males, and breast (3,861,520), uterine corpus (807,860), and colon and rectum (768,650) among females.  More than one-half (56%) of survivors were diagnosed within the past 10 years, and almost two-thirds (64%) are aged 65 years or older.  People with a history of cancer have unique medical and psychosocial needs that require proactive assessment and management by follow-up care providers.  Although there are growing numbers of tools that can assist patients, caregivers, and clinicians in navigating the various phases of cancer survivorship, further evidence-based resources are needed to optimize care.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTqS-tR1uHDx5ggzHGM8X5CfW6udTcc2ebheYwXMhXUmbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3ltlemug%253D%253D&md5=3bcced5db38c65d9d98364c3884a21d9</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21565%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DNogueira%26aufirst%3DL.%26aulast%3DMariotto%26aufirst%3DA.%2BB.%26aulast%3DRowland%26aufirst%3DJ.%2BH.%26aulast%3DYabroff%26aufirst%3DK.%2BR.%26aulast%3DAlfano%26aufirst%3DC.%2BM.%26aulast%3DJemal%26aufirst%3DA.%26aulast%3DKramer%26aufirst%3DJ.%2BL.%26aulast%3DSiegel%26aufirst%3DR.%2BL.%26atitle%3DCancer%2520treatment%2520and%2520survivorship%2520statistics%252C%25202019%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2019%26volume%3D69%26spage%3D363%26epage%3D385%26doi%3D10.3322%2Fcaac.21565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arnst, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. D.</span></span> <span> </span><span class="NLM_article-title">Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1398</span>â <span class="NLM_lpage">1426</span>, <span class="refDoi">Â DOI: 10.1002/med.21568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1002%2Fmed.21568" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=30746734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A280%3ADC%252BB3cfhslejug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2019&pages=1398-1426&author=K.+E.+Arnstauthor=S.+Banerjeeauthor=H.+Chenauthor=S.+Dengauthor=D.+J.+Hwangauthor=W.+Liauthor=D.+D.+Miller&title=Current+advances+of+tubulin+inhibitors+as+dual+acting+small+molecules+for+cancer+therapy&doi=10.1002%2Fmed.21568"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy</span></div><div class="casAuthors">Arnst Kinsie E; Banerjee Souvik; Chen Hao; Deng Shanshan; Hwang Dong-Jin; Li Wei; Miller Duane D</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal research reviews</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1398-1426</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Microtubule (MT)-targeting agents are highly successful drugs as chemotherapeutic agents, and this is attributed to their ability to target MT dynamics and interfere with critical cellular functions, including, mitosis, cell signaling, intracellular trafficking, and angiogenesis.  Because MT dynamics vary in the different stages of the cell cycle, these drugs tend to be the most effective against mitotic cells.  While this class of drug has proven to be effective against many cancer types, significant hurdles still exist and include overcoming aspects such as dose limited toxicities and the development of resistance.  Newer generations of developed drugs attack these problems and alternative approaches such as the development of dual tubulin and kinase inhibitors are being investigated.  This approach offers the potential to show increased efficacy and lower toxicities.  This review covers different categories of MT-targeting agents, recent advances in dual inhibitors, and current challenges for this drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTqfJ98Efo_uekdrW1FkXG-fW6udTcc2eZ8Lydr3jKlCrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cfhslejug%253D%253D&md5=dafb1dbc34589cd0e9a9ac0f384252f1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fmed.21568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21568%26sid%3Dliteratum%253Aachs%26aulast%3DArnst%26aufirst%3DK.%2BE.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDeng%26aufirst%3DS.%26aulast%3DHwang%26aufirst%3DD.%2BJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26atitle%3DCurrent%2520advances%2520of%2520tubulin%2520inhibitors%2520as%2520dual%2520acting%2520small%2520molecules%2520for%2520cancer%2520therapy%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2019%26volume%3D39%26spage%3D1398%26epage%3D1426%26doi%3D10.1002%2Fmed.21568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ning, X.</span></span> <span> </span><span class="NLM_article-title">The first integrins Î²3-mediated cellular and nuclear targeting therapeutics for prostate cancer</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>223</i></span>,  <span class="NLM_fpage">119471</span>, <span class="refDoi">Â DOI: 10.1016/j.biomaterials.2019.119471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1016%2Fj.biomaterials.2019.119471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=31525693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslOntrnI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=223&publication_year=2019&pages=119471&author=L.+Zhangauthor=X.+Shanauthor=X.+Mengauthor=T.+Guauthor=Q.+Luauthor=J.+Zhangauthor=J.+Chenauthor=Q.+Jiangauthor=X.+Ning&title=The+first+integrins+%CE%B23-mediated+cellular+and+nuclear+targeting+therapeutics+for+prostate+cancer&doi=10.1016%2Fj.biomaterials.2019.119471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The first integrins Î²3-mediated cellular and nuclear targeting therapeutics for prostate cancer</span></div><div class="casAuthors">Zhang, Lei; Shan, Xue; Meng, Xia; Gu, Tingting; Lu, Qiangbing; Zhang, Jikang; Chen, Jiao; Jiang, Qing; Ning, Xinghai</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">223</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">119471</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Prostate cancer is one of the most commonly diagnosed cancers in men, leading to a high mortality rate due to a lack of effective anticancer treatment.  Current anticancer chemotherapeutics are often administrated at suboptimal doses because of nonspecific toxicities to normal tissues, resulting in the eventual failure of therapy as well as the development of drug resistance and metastatic disease.  Therefore, ligand-targeted therapeutics have the great potential of improving the selective anticancer toxicity.  Integrins Î²3 (Î±vÎ²3 and Î±IIbÎ²3) are an important cell adhesion mol. family, overexpressed on both cell membrane and perinuclear region of prostate cancer cells, and play a key role in the progression and metastasis of prostate cancer, making them an attractive target for anticancer therapy.  However, their clin. impacts have been limited due to lack of specific ligands.  Here, for the first time, we have identified a peptide Arginine-Tryptophan-(D-Arginine)-Asparagine-Arginine as an integrins Î²3 specific ligand, named B3int, which shows superior selectivity to integrins Î²3 over other integrin subunits.  B3int has high affinity to integrins Î²3 with a Kd value of 0.2 nM, which is 7-fold higher than c-RGDyK (1.4 nM), a well-established integrin Î±vÎ²3 ligand.  In addn., B3int shows high specificity for integrins Î²3, and can selectively target integrin Î²3 overexpressed cancer cells in vitro and in vivo.  Most importantly, B3int-modified liposomes (B3int-LS-DOX) can selectively deliver DOX not only into prostate cancer cells, but into nucleus via targeting integrins Î²3, thereby significantly improving anticancer effects in 2D prostate cancer cells and 3D tumor spheroids.  Particularly, B3int-LS-DOX effectively inhibits tumor growth with an ED of as low as 1.5 mg/kg, which is 3.3-fold less than c-RGDyK-LS-DOX (5 mg/kg), indicating that integrins Î²3 specific therapy is a promising anticancer strategy which can greatly improve the anticancer therapeutic index.  In summary, we have identified B3int as the first integrins Î²3 specific ligand with high affinity and specificity, and holds a great potential of improving the diagnosis and treatment for integrins Î²3-overexpressed cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquJyDBEyCCaLVg90H21EOLACvtfcHk0ljQCfro8xlgbg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslOntrnI&md5=a5fe0aa5983369c0ee88d4eb0eff8e98</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2019.119471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2019.119471%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DShan%26aufirst%3DX.%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DGu%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DNing%26aufirst%3DX.%26atitle%3DThe%2520first%2520integrins%2520%25CE%25B23-mediated%2520cellular%2520and%2520nuclear%2520targeting%2520therapeutics%2520for%2520prostate%2520cancer%26jtitle%3DBiomaterials%26date%3D2019%26volume%3D223%26spage%3D119471%26doi%3D10.1016%2Fj.biomaterials.2019.119471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marqus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirogova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piva, T. J.</span></span> <span> </span><span class="NLM_article-title">Evaluation of the use of therapeutic peptides for cancer treatment</span>. <i>J. Biomed. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">21</span>, <span class="refDoi">Â DOI: 10.1186/s12929-017-0328-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1186%2Fs12929-017-0328-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=28320393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtVSgtb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=21&author=S.+Marqusauthor=E.+Pirogovaauthor=T.+J.+Piva&title=Evaluation+of+the+use+of+therapeutic+peptides+for+cancer+treatment&doi=10.1186%2Fs12929-017-0328-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the use of therapeutic peptides for cancer treatment</span></div><div class="casAuthors">Marqus, Susan; Pirogova, Elena; Piva, Terrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomedical Science (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21/1-21/15</span>CODEN:
                <span class="NLM_cas:coden">JBCIEA</span>;
        ISSN:<span class="NLM_cas:issn">1423-0127</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Cancer along with cardiovascular disease are the main causes of death in the industrialized countries around the World.  Conventional cancer treatments are losing their therapeutic uses due to drug resistance, lack of tumor selectivity and soly. and as such there is a need to develop new therapeutic agents.  Therapeutic peptides are a promising and a novel approach to treat many diseases including cancer.  They have several advantages over proteins or antibodies: as they are (a) easy to synthesize, (b) have a high target specificity and selectivity and (c) have low toxicity.  Therapeutic peptides do have some significant drawbacks related to their stability and short half-life.  In this review, strategies used to overcome peptide limitations and to enhance their therapeutic effect will be compared.  The use of short cell permeable peptides that interfere and inhibit protein-protein interactions will also be evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ0O_jXGEAzbVg90H21EOLACvtfcHk0liuuvooIH_f0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtVSgtb8%253D&md5=7b32f8b3aac28dad3ad49e532bbd009f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1186%2Fs12929-017-0328-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12929-017-0328-x%26sid%3Dliteratum%253Aachs%26aulast%3DMarqus%26aufirst%3DS.%26aulast%3DPirogova%26aufirst%3DE.%26aulast%3DPiva%26aufirst%3DT.%2BJ.%26atitle%3DEvaluation%2520of%2520the%2520use%2520of%2520therapeutic%2520peptides%2520for%2520cancer%2520treatment%26jtitle%3DJ.%2520Biomed.%2520Sci.%26date%3D2017%26volume%3D24%26spage%3D21%26doi%3D10.1186%2Fs12929-017-0328-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, R.</span></span> <span> </span><span class="NLM_article-title">The chemistry and biological activities of peptides from amphibian skin secretions</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">1760</span>â <span class="NLM_lpage">1846</span>, <span class="refDoi">Â DOI: 10.1021/cr4006704</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr4006704" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVCiu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2015&pages=1760-1846&author=X.+Xuauthor=R.+Lai&title=The+chemistry+and+biological+activities+of+peptides+from+amphibian+skin+secretions&doi=10.1021%2Fcr4006704"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The Chemistry and Biological Activities of Peptides from Amphibian Skin Secretions</span></div><div class="casAuthors">Xu, Xueqing; Lai, Ren</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1760-1846</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Amphibians can live in a wide range of habitats and ecol. conditions because of their morphol., biochem., and physiol. complex skins, which perform versatile functions and contain pharmacol. compds. of interest because of their potential for drug development.  Amphibians might be the only natural source of >7 types of drug candidates with analgesic, antibiotic, antiviral, wound-healing, antidiabetic, and anticancerous properties and the potential of treating cardiovascular diseases.  In particular, amphibian skin peptides are promising for treating cancer, HIV, and drug-resistant Staphylococcus aureus, which are major problems facing the 21st century medical community.  More than 100,000 bioactive compds. are estd. to occur in amphibian skin secretions, but â¼33% of 6300 amphibian species are endangered.  In addn. to protecting them for their potential pharmaceutical value, much more effort should be paid to amphibian conservation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC139PFpLDk7Vg90H21EOLACvtfcHk0liuuvooIH_f0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVCiu7c%253D&md5=f5d4be9cc623e4ccc50bd40d104d70c8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fcr4006704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr4006704%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DX.%26aulast%3DLai%26aufirst%3DR.%26atitle%3DThe%2520chemistry%2520and%2520biological%2520activities%2520of%2520peptides%2520from%2520amphibian%2520skin%2520secretions%26jtitle%3DChem.%2520Rev.%26date%3D2015%26volume%3D115%26spage%3D1760%26epage%3D1846%26doi%3D10.1021%2Fcr4006704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W. D.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic and antitumor peptides as novel chemotherapeutics</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">7</span>â <span class="NLM_lpage">17</span>, <span class="refDoi">Â DOI: 10.1039/d0np00019a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1039%2Fd0np00019a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=32776055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsFGgsL%252FP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2021&pages=7-17&author=X.+Luanauthor=Y.+Wuauthor=Y.+W.+Shenauthor=H.+Zhangauthor=Y.+D.+Zhouauthor=H.+Z.+Chenauthor=D.+G.+Nagleauthor=W.+D.+Zhang&title=Cytotoxic+and+antitumor+peptides+as+novel+chemotherapeutics&doi=10.1039%2Fd0np00019a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic and antitumor peptides as novel chemotherapeutics</span></div><div class="casAuthors">Luan, Xin; Wu, Ye; Shen, Yi-Wen; Zhang, Hong; Zhou, Yu-Dong; Chen, Hong-Zhuan; Nagle, Dale G.; Zhang, Wei-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-17</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Treatment resistance and drug-induced refractory malignancies pose significant challenges for current chemotherapy drugs.  There have been increasing research efforts aimed at developing novel chemotherapeutics, esp. from natural products and related derivs.  Natural cytotoxic peptides, an emerging source of chemotherapeutics, have exhibited the advantage of overcoming drug resistance and displayed broad-spectrum antitumor activities in the clinic.  This highlight examines the increasingly popular cytotoxic peptides from isolated natural products.  In-depth review of several peptides provides examples for how this novel strategy can lead to the improved anti-tumor effects.  The mechanisms and current application of representative natural cytotoxic peptides (NCPs) have also been discussed, with a particular focus on future directions for interdisciplinary research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCrFHP39P6arVg90H21EOLACvtfcHk0liuuvooIH_f0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsFGgsL%252FP&md5=e3baf126f272a0c2e5734f0cfe95458e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1039%2Fd0np00019a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fd0np00019a%26sid%3Dliteratum%253Aachs%26aulast%3DLuan%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DY.%2BW.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DY.%2BD.%26aulast%3DChen%26aufirst%3DH.%2BZ.%26aulast%3DNagle%26aufirst%3DD.%2BG.%26aulast%3DZhang%26aufirst%3DW.%2BD.%26atitle%3DCytotoxic%2520and%2520antitumor%2520peptides%2520as%2520novel%2520chemotherapeutics%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2021%26volume%3D38%26spage%3D7%26epage%3D17%26doi%3D10.1039%2Fd0np00019a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarena, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span> <span> </span><span class="NLM_article-title">Host defense antimicrobial peptides as antibiotics: design and application strategies</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">87</span>â <span class="NLM_lpage">96</span>, <span class="refDoi">Â DOI: 10.1016/j.cbpa.2017.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1016%2Fj.cbpa.2017.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=28399505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvVGjs7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=87-96&author=B.+Mishraauthor=S.+Reilingauthor=D.+Zarenaauthor=G.+Wang&title=Host+defense+antimicrobial+peptides+as+antibiotics%3A+design+and+application+strategies&doi=10.1016%2Fj.cbpa.2017.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Host defense antimicrobial peptides as antibiotics: design and application strategies</span></div><div class="casAuthors">Mishra, Biswajit; Reiling, Scott; Zarena, D.; Wang, Guangshun</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87-96</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This review deals with the design and application strategies of new antibiotics based on naturally occurring antimicrobial peptides (AMPs).  The initial candidate can be designed based on three-dimensional structure or selected from a library of peptides from natural or lab. sources followed by optimization via structure-activity relationship studies.  There are also advanced application strategies such as induction of AMP expression from host cells by various factors (e.g., metals, amino acids, vitamin D and sunlight), the use of engineered probiotic bacteria to deliver peptides, the design of prodrug and peptide conjugates to improve specific targeting.  In addn., combined uses of newly developed AMPs with existing antimicrobial agents may provide a practical avenue for effective management of antibiotic-resistant bacteria (superbugs), including biofilms.  Finally, we highlight AMPs already in use or under clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTk0CCg6Ayc7Vg90H21EOLACvtfcHk0lhf4LaWwjYJoA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvVGjs7k%253D&md5=7be2a39ed31cabebfa2d1a30038a2615</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2017.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2017.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DMishra%26aufirst%3DB.%26aulast%3DReiling%26aufirst%3DS.%26aulast%3DZarena%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DG.%26atitle%3DHost%2520defense%2520antimicrobial%2520peptides%2520as%2520antibiotics%253A%2520design%2520and%2520application%2520strategies%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2017%26volume%3D38%26spage%3D87%26epage%3D96%26doi%3D10.1016%2Fj.cbpa.2017.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parvy, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dostalova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurjan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LemaÃ®tre, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordero, J. B.</span></span> <span> </span><span class="NLM_article-title">The antimicrobial peptide defensin cooperates with tumour necrosis factor to drive tumour cell death in Drosophila</span>. <i>elife</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e45061</span> <span class="refDoi">Â DOI: 10.7554/elife.45061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.7554%2Felife.45061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=31358113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BB3cXht1CrtrrO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&author=J.-P.+Parvyauthor=Y.+Yuauthor=A.+Dostalovaauthor=S.+Kondoauthor=A.+Kurjanauthor=P.+Buletauthor=B.+Lema%C3%AEtreauthor=M.+Vidalauthor=J.+B.+Cordero&title=The+antimicrobial+peptide+defensin+cooperates+with+tumour+necrosis+factor+to+drive+tumour+cell+death+in+Drosophila&doi=10.7554%2Felife.45061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The antimicrobial peptide defensin cooperates with tumour necrosis factor to drive tumour cell death in Drosophila</span></div><div class="casAuthors">Parvy, Jean-Philippe; Yu, Yachuan; Dostalova, Anna; Kondo, Shu; Kurjan, Alina; Bulet, Philippe; Lemaitre, Bruno; Vidal, Marcos; Cordero, Julia B.</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e45061</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">Antimicrobial peptides (AMPs) are small cationic mols. best known as mediators of the innate defense against microbial infection.  While in vitro and ex vivo evidence suggest AMPs' capacity to kill cancer cells, in vivo demonstration of an anti-tumor role of endogenous AMPs is lacking.  Using a Drosophila model of tumorigenesis, we demonstrate a role for the AMP Defensin in the control of tumor progression.  Our results reveal that Tumor Necrosis Factor mediates exposure of phosphatidylserine (PS), which makes tumor cells selectively sensitive to the action of Defensin remotely secreted from tracheal and fat tissues.  Defensin binds tumor cells in PS-enriched areas, provoking cell death and tumor regression.  Altogether, our results provide the first in vivo demonstration for a role of an endogenous AMP as an anti-cancer agent, as well as a mechanism that explains tumor cell sensitivity to the action of AMPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNU7UowFJg_rVg90H21EOLACvtfcHk0lhf4LaWwjYJoA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXht1CrtrrO&md5=92f1a12d74c5a39fe1d122a6c7ff4abc</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.7554%2Felife.45061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252Felife.45061%26sid%3Dliteratum%253Aachs%26aulast%3DParvy%26aufirst%3DJ.-P.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DDostalova%26aufirst%3DA.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DKurjan%26aufirst%3DA.%26aulast%3DBulet%26aufirst%3DP.%26aulast%3DLema%25C3%25AEtre%26aufirst%3DB.%26aulast%3DVidal%26aufirst%3DM.%26aulast%3DCordero%26aufirst%3DJ.%2BB.%26atitle%3DThe%2520antimicrobial%2520peptide%2520defensin%2520cooperates%2520with%2520tumour%2520necrosis%2520factor%2520to%2520drive%2520tumour%2520cell%2520death%2520in%2520Drosophila%26jtitle%3Delife%26date%3D2019%26volume%3D8%26doi%3D10.7554%2Felife.45061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuroda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okumura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isogai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isogai, E.</span></span> <span> </span><span class="NLM_article-title">The human cathelicidin antimicrobial peptide LL-37 and mimics are potential anticancer drugs</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">144</span>, <span class="refDoi">Â DOI: 10.3389/fonc.2015.00144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.3389%2Ffonc.2015.00144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=26175965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A280%3ADC%252BC28%252Fjs1alug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=144&author=K.+Kurodaauthor=K.+Okumuraauthor=H.+Isogaiauthor=E.+Isogai&title=The+human+cathelicidin+antimicrobial+peptide+LL-37+and+mimics+are+potential+anticancer+drugs&doi=10.3389%2Ffonc.2015.00144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The Human Cathelicidin Antimicrobial Peptide LL-37 and Mimics are Potential Anticancer Drugs</span></div><div class="casAuthors">Kuroda Kengo; Isogai Emiko; Okumura Kazuhiko; Isogai Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">144</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">Antimicrobial peptides (AMPs) play a critical role in innate host defense against microbial pathogens in many organisms.  The human cathelicidin, LL-37, has a net positive charge and is amphiphilic, and can eliminate pathogenic microbes directly via electrostatic attraction toward negatively charged bacterial membranes.  A number of studies have shown that LL-37 participates in various host immune systems, such as inflammatory responses and tissue repair, in addition to its antibacterial properties.  Moreover, recent evidence suggests that it is also involved in the regulation of cancer.  Indeed, previous studies have suggested that human LL-37 is involved in carcinogenesis via multiple reporters, such as FPR2 (FPRL1), epidermal growth factor receptor, and ERBb2, although LL-37 and its fragments and analogs also show anticancer effects in various cancer cell lines.  This discrepancy can be attributed to peptide-based factors, host membrane-based factors, and signal regulation.  Here, we describe the association between AMPs and cancer with a focus on anticancer peptide functions and selectivity in an effort to understand potential therapeutic implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTQvjmAchpbZyO2kE7krGOBfW6udTcc2eaEcDs5EkvcIrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252Fjs1alug%253D%253D&md5=14e9e1bc9303762f33100d54110b1e33</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2015.00144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2015.00144%26sid%3Dliteratum%253Aachs%26aulast%3DKuroda%26aufirst%3DK.%26aulast%3DOkumura%26aufirst%3DK.%26aulast%3DIsogai%26aufirst%3DH.%26aulast%3DIsogai%26aufirst%3DE.%26atitle%3DThe%2520human%2520cathelicidin%2520antimicrobial%2520peptide%2520LL-37%2520and%2520mimics%2520are%2520potential%2520anticancer%2520drugs%26jtitle%3DFront.%2520Oncol.%26date%3D2015%26volume%3D5%26spage%3D144%26doi%3D10.3389%2Ffonc.2015.00144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">SveinbjÃ¸rnsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camilio, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haug, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rekdal, Ã.</span></span> <span> </span><span class="NLM_article-title">LTX-315: a first-in-class oncolytic peptide that reprograms the tumor microenvironment</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1339</span>â <span class="NLM_lpage">1344</span>, <span class="refDoi">Â DOI: 10.4155/fmc-2017-0088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.4155%2Ffmc-2017-0088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=28490192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht12mu7%252FN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=1339-1344&author=B.+Sveinbj%C3%B8rnssonauthor=K.+A.+Camilioauthor=B.+E.+Haugauthor=%C3%98.+Rekdal&title=LTX-315%3A+a+first-in-class+oncolytic+peptide+that+reprograms+the+tumor+microenvironment&doi=10.4155%2Ffmc-2017-0088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">LTX-315: a first-in-class oncolytic peptide that reprograms the tumor microenvironment</span></div><div class="casAuthors">Sveinbjornsson, Baldur; Camilio, Ketil Andre; Haug, Bengt Erik; Rekdal, Oystein</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1339-1344</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">The oncolytic peptide LTX-315, which has been de novo designed based on structure-activity relationship studies of host defense peptides, has the ability to kill human cancer cells and induce specific anticancer immune response when injected locally into tumors established in immunocompetent mice.  The oncolytic effect of LTX-315 involves perturbation of plasma membrane and the mitochondria with subsequent release of danger-assocd. mol. pattern mols., which highlights the ability of LTX-315 to induce complete regression and protective immune responses.  Treatment with LTX-315 reprograms the tumor microenvironment by decreasing the local abundance of immunosuppressive cells and by increasing the frequency of effector T cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYPrwmBhHTdLVg90H21EOLACvtfcHk0lhf4LaWwjYJoA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht12mu7%252FN&md5=4864dfab7f66afe967905c4128f3e954</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2017-0088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2017-0088%26sid%3Dliteratum%253Aachs%26aulast%3DSveinbj%25C3%25B8rnsson%26aufirst%3DB.%26aulast%3DCamilio%26aufirst%3DK.%2BA.%26aulast%3DHaug%26aufirst%3DB.%2BE.%26aulast%3DRekdal%26aufirst%3D%25C3%2598.%26atitle%3DLTX-315%253A%2520a%2520first-in-class%2520oncolytic%2520peptide%2520that%2520reprograms%2520the%2520tumor%2520microenvironment%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2017%26volume%3D9%26spage%3D1339%26epage%3D1344%26doi%3D10.4155%2Ffmc-2017-0088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rady, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rady, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhtar, H.</span></span> <span> </span><span class="NLM_article-title">Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy</span>. <i>Canc. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>402</i></span>,  <span class="NLM_fpage">16</span>â <span class="NLM_lpage">31</span>, <span class="refDoi">Â DOI: 10.1016/j.canlet.2017.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1016%2Fj.canlet.2017.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=28536009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotlyjurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=2017&pages=16-31&author=I.+Radyauthor=I.+A.+Siddiquiauthor=M.+Radyauthor=H.+Mukhtar&title=Melittin%2C+a+major+peptide+component+of+bee+venom%2C+and+its+conjugates+in+cancer+therapy&doi=10.1016%2Fj.canlet.2017.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy</span></div><div class="casAuthors">Rady, Islam; Siddiqui, Imtiaz A.; Rady, Mohamad; Mukhtar, Hasan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">402</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16-31</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Melittin (MEL), a major peptide component of bee venom, is an attractive candidate for cancer therapy.  This agent has shown a variety of anti-cancer effects in preclin. cell culture and animal model systems.  Despite a convincing efficacy data against variety of cancers, its applicability to humans has met with challenges due to several issues including its non-specific cytotoxicity, degrdn. and hemolytic activity.  Several optimization approaches including utilization of nanoparticle based delivery of MEL have been utilized to circumvent the issues.  Here, we summarize the current understanding of the anticancer effects of bee venom and MEL on different kinds of cancers.  Further, we also present the available information for the possible mechanism of action of bee venom and/or MEL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiL7L11f0CsbVg90H21EOLACvtfcHk0lgQYd9UnsBWCw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotlyjurw%253D&md5=32e134d0322a2cec4736b06cfaa1c6f3</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2017.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2017.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DRady%26aufirst%3DI.%26aulast%3DSiddiqui%26aufirst%3DI.%2BA.%26aulast%3DRady%26aufirst%3DM.%26aulast%3DMukhtar%26aufirst%3DH.%26atitle%3DMelittin%252C%2520a%2520major%2520peptide%2520component%2520of%2520bee%2520venom%252C%2520and%2520its%2520conjugates%2520in%2520cancer%2520therapy%26jtitle%3DCanc.%2520Lett.%26date%3D2017%26volume%3D402%26spage%3D16%26epage%3D31%26doi%3D10.1016%2Fj.canlet.2017.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haug, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camilio, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliassen, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stensen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svendsen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortensen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirjolet, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bichat, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rekdal, Ã.</span></span> <span> </span><span class="NLM_article-title">Discovery of a 9-mer cationic peptide (LTX-315) as a potential first in class oncolytic peptide</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2918</span>â <span class="NLM_lpage">2927</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b02025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b02025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC28Xkt1CmsLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2918-2927&author=B.+E.+Haugauthor=K.+A.+Camilioauthor=L.+T.+Eliassenauthor=W.+Stensenauthor=J.+S.+Svendsenauthor=K.+Bergauthor=B.+Mortensenauthor=G.+Serinauthor=J.-F.+Mirjoletauthor=F.+Bichatauthor=%C3%98.+Rekdal&title=Discovery+of+a+9-mer+cationic+peptide+%28LTX-315%29+as+a+potential+first+in+class+oncolytic+peptide&doi=10.1021%2Facs.jmedchem.5b02025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide</span></div><div class="casAuthors">Haug, Bengt Erik; Camilio, Ketil Andre; Eliassen, Liv Tone; Stensen, Wenche; Svendsen, John Sigurd; Berg, Kristel; Mortensen, Bjarte; Serin, Guillaume; Mirjolet, Jean-Francois; Bichat, Francis; Rekdal, Oeystein</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2918-2927</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oncolytic immunotherapies represent a new promising strategy in the treatment of cancer.  In our efforts to develop oncolytic peptides, we identified a series of chem. modified 9-mer cationic peptides that were highly effective against both drug-resistant and drug-sensitive cancer cells and with lower toxicity toward normal cells.  Among these peptides, LTX-315 displayed superior anticancer activity and was selected as a lead candidate.  This peptide showed relative high plasma protein binding abilities and a human plasma half-life of 160 min, resulting in formation of nontoxic metabolites.  In addn., the lead candidate demonstrated relatively low ability to inhibit CYP450 enzymes.  Collectively these data indicated that this peptide has potential to be developed as a new anticancer agent for intratumoral administration and is currently being evaluated in a phase I/IIa study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosnc_kVs8B7LVg90H21EOLACvtfcHk0lgQYd9UnsBWCw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xkt1CmsLY%253D&md5=0df37524b3691a17e3137920fc02316c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b02025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b02025%26sid%3Dliteratum%253Aachs%26aulast%3DHaug%26aufirst%3DB.%2BE.%26aulast%3DCamilio%26aufirst%3DK.%2BA.%26aulast%3DEliassen%26aufirst%3DL.%2BT.%26aulast%3DStensen%26aufirst%3DW.%26aulast%3DSvendsen%26aufirst%3DJ.%2BS.%26aulast%3DBerg%26aufirst%3DK.%26aulast%3DMortensen%26aufirst%3DB.%26aulast%3DSerin%26aufirst%3DG.%26aulast%3DMirjolet%26aufirst%3DJ.-F.%26aulast%3DBichat%26aufirst%3DF.%26aulast%3DRekdal%26aufirst%3D%25C3%2598.%26atitle%3DDiscovery%2520of%2520a%25209-mer%2520cationic%2520peptide%2520%2528LTX-315%2529%2520as%2520a%2520potential%2520first%2520in%2520class%2520oncolytic%2520peptide%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2918%26epage%3D2927%26doi%3D10.1021%2Facs.jmedchem.5b02025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ifrah, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doisy, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryge, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, P. R.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship study of anoplin</span>. <i>J. Pept. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">113</span>â <span class="NLM_lpage">121</span>, <span class="refDoi">Â DOI: 10.1002/psc.598</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1002%2Fpsc.598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=15635634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvFKmt7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=113-121&author=D.+Ifrahauthor=X.+Doisyauthor=T.+S.+Rygeauthor=P.+R.+Hansen&title=Structure-activity+relationship+study+of+anoplin&doi=10.1002%2Fpsc.598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship study of anoplin</span></div><div class="casAuthors">Ifrah, Dan; Doisy, Xavier; Ryge, Trine S.; Hansen, Paul R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Science</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-121</span>CODEN:
                <span class="NLM_cas:coden">JPSIEI</span>;
        ISSN:<span class="NLM_cas:issn">1075-2617</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Anoplin is a decapeptide amide, GLLKRIKTLL-NH2 derived from the venom sac of the solitary spider wasp, Anoplius samariensis.  It is active against Gram-pos. and Gram-neg. bacteria and is not hemolytic towards human erythrocytes.  The present paper reports a structure-activity study of anoplin based on 37 analogs including an Ala-scan, C- and N-truncations, and single and multiple residue substitutions with various amino acids.  The analogs were tested for antibacterial activity against both S. aureus ATCC 25923 and E. coli ATCC 25922, and several potent antibacterial analogs were identified.  The cytotoxicity of the analogs against human erythrocytes was assessed in a hemolytic activity assay.  The antibacterial activity and selectivity of the analogs against S. aureus and E. coli varied considerably, depending on the hydrophobicity and position of the various substituted amino acids.  In certain cases the selectivity for Gram-pos. and Gram-neg. bacteria was either reversed or altogether eliminated.  In addn., it was generally found that antibacterial activity coincided with hemolytic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryykoLGgL-J7Vg90H21EOLACvtfcHk0lhNXqlFdzYp9w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvFKmt7w%253D&md5=1393be628124813dc7891df81b81ba43</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fpsc.598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpsc.598%26sid%3Dliteratum%253Aachs%26aulast%3DIfrah%26aufirst%3DD.%26aulast%3DDoisy%26aufirst%3DX.%26aulast%3DRyge%26aufirst%3DT.%2BS.%26aulast%3DHansen%26aufirst%3DP.%2BR.%26atitle%3DStructure-activity%2520relationship%2520study%2520of%2520anoplin%26jtitle%3DJ.%2520Pept.%2520Sci.%26date%3D2005%26volume%3D11%26spage%3D113%26epage%3D121%26doi%3D10.1002%2Fpsc.598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luan, X.</span></span> <span> </span><span class="NLM_article-title">Advances in the study of structural modification and biological activities of anoplin</span>. <i>Front. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">519</span>, <span class="refDoi">Â DOI: 10.3389/fchem.2020.00519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.3389%2Ffchem.2020.00519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=32733845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitFWitrvF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2020&pages=519&author=Y.+Wuauthor=R.+Huangauthor=J.+M.+Jinauthor=L.+J.+Zhangauthor=H.+Zhangauthor=H.+Z.+Chenauthor=L.+L.+Chenauthor=X.+Luan&title=Advances+in+the+study+of+structural+modification+and+biological+activities+of+anoplin&doi=10.3389%2Ffchem.2020.00519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the study of structural modification and biological activities of anoplin</span></div><div class="casAuthors">Wu, Ye; Huang, Rui; Jin, Jin-Mei; Zhang, Li-Jun; Zhang, Hong; Chen, Hong-Zhuan; Chen, Li-Li; Luan, Xin</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Chemistry (Lausanne, Switzerland)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">519</span>CODEN:
                <span class="NLM_cas:coden">FCLSAA</span>;
        ISSN:<span class="NLM_cas:issn">2296-2646</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  Anoplin is an amphipathic, Î±-helical bioactive peptide from wasp venom.  In recent years, pharmaceutical and org. chemists discovered that anoplin and its derivs. showed multiple pharmacol. activities in antibacterial, antitumor, antifungal, and antimalarial activities.  Owing to the simple and unique structure and diverse biol. activities, anoplin has attracted considerable research interests.  This review highlights the advances in structural modification, biol. activities, and the outlook of anoplin in order to provide a basis for new drug design and delivery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCDIxfNFo-QrVg90H21EOLACvtfcHk0lhNXqlFdzYp9w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitFWitrvF&md5=d0a43e9ac1fd1617d206570cab9eed0c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.3389%2Ffchem.2020.00519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffchem.2020.00519%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DR.%26aulast%3DJin%26aufirst%3DJ.%2BM.%26aulast%3DZhang%26aufirst%3DL.%2BJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DH.%2BZ.%26aulast%3DChen%26aufirst%3DL.%2BL.%26aulast%3DLuan%26aufirst%3DX.%26atitle%3DAdvances%2520in%2520the%2520study%2520of%2520structural%2520modification%2520and%2520biological%2520activities%2520of%2520anoplin%26jtitle%3DFront.%2520Chem.%26date%3D2020%26volume%3D8%26spage%3D519%26doi%3D10.3389%2Ffchem.2020.00519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Da
Silva, A. M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva-GonÃ§alves, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcisio-Miranda, M.</span></span> <span> </span><span class="NLM_article-title">Pro-necrotic activity of cationic mastoparan peptides in human glioblastoma multiforme cells via membranolytic action</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5490</span>â <span class="NLM_lpage">5504</span>, <span class="refDoi">Â DOI: 10.1007/s12035-017-0782-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1007%2Fs12035-017-0782-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=28965321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A280%3ADC%252BC1M%252FktVeqtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2018&pages=5490-5504&author=A.+M.+B.+Da%0ASilvaauthor=L.+C.+Silva-Gon%C3%A7alvesauthor=F.+A.+Oliveiraauthor=M.+Arcisio-Miranda&title=Pro-necrotic+activity+of+cationic+mastoparan+peptides+in+human+glioblastoma+multiforme+cells+via+membranolytic+action&doi=10.1007%2Fs12035-017-0782-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pro-necrotic Activity of Cationic Mastoparan Peptides in Human Glioblastoma Multiforme Cells Via Membranolytic Action</span></div><div class="casAuthors">da Silva Annielle Mendes Brito; Silva-Goncalves Laiz Costa; Arcisio-Miranda Manoel; Oliveira Fernando Augusto</div><div class="citationInfo"><span class="NLM_cas:title">Molecular neurobiology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">5490-5504</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Glioblastoma multiforme is the most common and lethal malignant brain tumor.  Because of its complexity and heterogeneity, this tumor has become resistant to conventional therapies and the available treatment produces multiple side effects.  Here, using multiple experimental approaches, we demonstrate that three mastoparan peptides-Polybia-MP1, Mastoparan X, and HR1-from solitary wasp venom exhibit potent anticancer activity toward human glioblastoma multiforme cells.  Importantly, the antiglioblastoma action of mastoparan peptides occurs by membranolytic activity, leading to necrosis.  Our data also suggest a direct relation between mastoparan membranolytic potency and the presence of negatively charged phospholipids like phosphatidylserine.  Collectively, these data may warrant additional studies for mastoparan peptides as new agents for the treatment of glioblastoma multiforme brain tumor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSOnt_sG1bsqS-bLEOO4dYpfW6udTcc2eZPXq3XAupAW7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M%252FktVeqtg%253D%253D&md5=e0cfbc1e0c066c67fac4a752d36e3934</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs12035-017-0782-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-017-0782-1%26sid%3Dliteratum%253Aachs%26aulast%3DDa%2BSilva%26aufirst%3DA.%2BM.%2BB.%26aulast%3DSilva-Gon%25C3%25A7alves%26aufirst%3DL.%2BC.%26aulast%3DOliveira%26aufirst%3DF.%2BA.%26aulast%3DArcisio-Miranda%26aufirst%3DM.%26atitle%3DPro-necrotic%2520activity%2520of%2520cationic%2520mastoparan%2520peptides%2520in%2520human%2520glioblastoma%2520multiforme%2520cells%2520via%2520membranolytic%2520action%26jtitle%3DMol.%2520Neurobiol.%26date%3D2018%26volume%3D55%26spage%3D5490%26epage%3D5504%26doi%3D10.1007%2Fs12035-017-0782-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span> <span> </span><span class="NLM_article-title">Effects of linker amino acids on the potency and selectivity of dimeric antimicrobial peptides</span>. <i>Chin. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1163</span>â <span class="NLM_lpage">1166</span>, <span class="refDoi">Â DOI: 10.1016/j.cclet.2018.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1016%2Fj.cclet.2018.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotlClt74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=1163-1166&author=M.+Kaiauthor=W.+Zhangauthor=H.+Xieauthor=L.+Liuauthor=S.+Huangauthor=X.+Liauthor=Z.+Zhangauthor=Y.+Liuauthor=B.+Zhangauthor=J.+Songauthor=R.+Wang&title=Effects+of+linker+amino+acids+on+the+potency+and+selectivity+of+dimeric+antimicrobial+peptides&doi=10.1016%2Fj.cclet.2018.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of linker amino acids on the potency and selectivity of dimeric antimicrobial peptides</span></div><div class="casAuthors">Kai, Ming; Zhang, Wei; Xie, Huan; Liu, Liwei; Huang, Sujie; Li, Xiao; Zhang, Zhengzheng; Liu, Yuyang; Zhang, Bangzhi; Song, Jingjing; Wang, Rui</div><div class="citationInfo"><span class="NLM_cas:title">Chinese Chemical Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1163-1166</span>CODEN:
                <span class="NLM_cas:coden">CCLEE7</span>;
        ISSN:<span class="NLM_cas:issn">1001-8417</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dimerization is an effective strategy for designing antimicrobial peptides that combine the advantages of different native peptides.  In this study, the authors explored the effects of different linker amino acids, including leucine, proline and aminocaproic acid, on the anticancer, antimicrobial and hemolytic activities of the heteromeric antimicrobial peptides AM-1, AM-2, and AM-3.  Proline and aminocaproic acid are ideal linkers for increasing the potency and selectivity of heteromeric antimicrobial peptides.  The results of MD simulations provided a rationalization for this observation.  Both AM-2, which had a proline linker, and AM-3, which had an aminocaproic acid linker, adopted a compact conformation in water and a bent conformation in membranes.  This change in the flexible structures of AM-2 and AM-3 could have resulted in decreased binding of these peptides to zwitterionic lipid bilayers and increased damage to mixed lipid bilayers contg. acidic phospholipids.  In short, these findings obtained via assessing the effects of linker amino acids will contribute to the design of ideal heteromeric antimicrobial peptides with high selectivity and potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPoHPlD1ZAerVg90H21EOLACvtfcHk0lhBho0afkae_g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotlClt74%253D&md5=78a668c6b87e5c411a5028e77855d8c6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.cclet.2018.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cclet.2018.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKai%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DEffects%2520of%2520linker%2520amino%2520acids%2520on%2520the%2520potency%2520and%2520selectivity%2520of%2520dimeric%2520antimicrobial%2520peptides%26jtitle%3DChin.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D29%26spage%3D1163%26epage%3D1166%26doi%3D10.1016%2Fj.cclet.2018.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, M.-f.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.-y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.-f.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, H.-l.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and antiproliferative activities of stapled melittin peptides</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">17514</span>â <span class="NLM_lpage">17518</span>, <span class="refDoi">Â DOI: 10.1039/c6ra26427a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1039%2Fc6ra26427a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC2sXksVyjt7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=17514-17518&author=Y.+Wuauthor=M.-f.+Hanauthor=C.+Liuauthor=T.-y.+Liuauthor=Y.-f.+Fengauthor=Y.+Zouauthor=B.+Liauthor=H.-l.+Liao&title=Design%2C+synthesis%2C+and+antiproliferative+activities+of+stapled+melittin+peptides&doi=10.1039%2Fc6ra26427a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and antiproliferative activities of stapled melittin peptides</span></div><div class="casAuthors">Wu, Ye; Han, Meng-fei; Liu, Chao; Liu, Tai-yu; Feng, Yu-fei; Zou, Yan; Li, Bai; Liao, Hong-li</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">17514-17518</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Melittin is a 26-residue, amphipathic, cell-penetrating, Î±-helical anti-hepatoma peptide isolated from bee venom.  However, the application of melittin as a drug is limited owing to its original conformational flexibility and low stability.  In this study, we designed, synthesized, and tested a series of hydrocarbon-stapled analogs of melittin, of which, some analogs showed remarkable enhancement not only in anti-hepatoma activity, but also in Î±-helicity and protease resistance when compared to the parent melittin.  These results disclosed the important impact of all-hydrocarbon crosslinking on the biol. activity, stability, and hemolytic activity of melittin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBrPFO9bCuFLVg90H21EOLACvtfcHk0lhBho0afkae_g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXksVyjt7c%253D&md5=4e312f1adb811ef13d772443481a6142</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1039%2Fc6ra26427a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc6ra26427a%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DM.-f.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DT.-y.%26aulast%3DFeng%26aufirst%3DY.-f.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DLiao%26aufirst%3DH.-l.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520antiproliferative%2520activities%2520of%2520stapled%2520melittin%2520peptides%26jtitle%3DRSC%2520Adv.%26date%3D2017%26volume%3D7%26spage%3D17514%26epage%3D17518%26doi%3D10.1039%2Fc6ra26427a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walensky, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, G. H.</span></span> <span> </span><span class="NLM_article-title">Hydrocarbon-stapled peptides: principles, practice, and progress</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">6275</span>â <span class="NLM_lpage">6288</span>, <span class="refDoi">Â DOI: 10.1021/jm4011675</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4011675" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC2cXislensbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6275-6288&author=L.+D.+Walenskyauthor=G.+H.+Bird&title=Hydrocarbon-stapled+peptides%3A+principles%2C+practice%2C+and+progress&doi=10.1021%2Fjm4011675"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrocarbon-Stapled Peptides: Principles, Practice, and Progress</span></div><div class="casAuthors">Walensky, Loren D.; Bird, Gregory H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6275-6288</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Protein structure underlies essential biol. processes and provides a blueprint for mol. mimicry that drives drug discovery.  Although small mols. represent the lion's share of agents that target proteins for therapeutic benefit, there remains no substitute for the natural properties of proteins and their peptide subunits in the majority of biol. contexts.  The peptide Î±-helix represents a common structural motif that mediates communication between signaling proteins.  Because peptides can lose their shape when taken out of context, developing chem. interventions to stabilize their bioactive structure remains an active area of research.  The all-hydrocarbon staple has emerged as one such soln., conferring Î±-helical structure, protease resistance, cellular penetrance, and biol. activity upon successful incorporation of a series of design and application principles.  Here, we describe our more than decade-long experience in developing stapled peptides as biomedical research tools and prototype therapeutics, highlighting lessons learned, pitfalls to avoid, and keys to success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC-4FlhgczWbVg90H21EOLACvtfcHk0lgIqbFtnmP_0A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXislensbs%253D&md5=a2d11fd1668df5707099b94d2932d352</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm4011675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4011675%26sid%3Dliteratum%253Aachs%26aulast%3DWalensky%26aufirst%3DL.%2BD.%26aulast%3DBird%26aufirst%3DG.%2BH.%26atitle%3DHydrocarbon-stapled%2520peptides%253A%2520principles%252C%2520practice%252C%2520and%2520progress%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6275%26epage%3D6288%26doi%3D10.1021%2Fjm4011675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lau, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Andrade, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">Peptide stapling techniques based on different macrocyclisation chemistries</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">91</span>â <span class="NLM_lpage">102</span>, <span class="refDoi">Â DOI: 10.1039/c4cs00246f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1039%2Fc4cs00246f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=25199043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2mtb%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2015&pages=91-102&author=Y.+H.+Lauauthor=P.+de+Andradeauthor=Y.+Wuauthor=D.+R.+Spring&title=Peptide+stapling+techniques+based+on+different+macrocyclisation+chemistries&doi=10.1039%2Fc4cs00246f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide stapling techniques based on different macrocyclization chemistries</span></div><div class="casAuthors">Lau, Yu Heng; de Andrade, Peterson; Wu, Yuteng; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-102</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Peptide stapling is a strategy for constraining short peptides typically in an alpha-helical conformation.  Stapling is carried out by covalently linking the side-chains of two amino acids, thereby forming a peptide macrocycle.  There is an expanding repertoire of stapling techniques based on different macrocyclization chemistries.  In this tutorial review, the authors categorize and analyze key examples of peptide stapling in terms of their synthesis and applicability to biol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkqQ6yGsikIbVg90H21EOLACvtfcHk0lgIqbFtnmP_0A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2mtb%252FL&md5=0efb31241f9809b61a81474131a54de3</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1039%2Fc4cs00246f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc4cs00246f%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DY.%2BH.%26aulast%3Dde%2BAndrade%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DPeptide%2520stapling%2520techniques%2520based%2520on%2520different%2520macrocyclisation%2520chemistries%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2015%26volume%3D44%26spage%3D91%26epage%3D102%26doi%3D10.1039%2Fc4cs00246f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cabrea, M. P. D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcisio-Miranda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, S. T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konno, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggiero, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Procopio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neto, J. R.</span></span> <span> </span><span class="NLM_article-title">Study of the mechanism of action of anoplin, a helical antimicrobial decapeptide with ion channel-like activity, and the role of the amidated C-terminus</span>. <i>J. Pept. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">661</span>â <span class="NLM_lpage">669</span>, <span class="refDoi">Â DOI: 10.1002/psc.960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1002%2Fpsc.960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=17994639" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=661-669&author=M.+P.+D.+S.+Cabreaauthor=M.+Arcisio-Mirandaauthor=S.+T.+B.+Costaauthor=K.+Konnoauthor=J.+R.+Ruggieroauthor=J.+Procopioauthor=J.+R.+Neto&title=Study+of+the+mechanism+of+action+of+anoplin%2C+a+helical+antimicrobial+decapeptide+with+ion+channel-like+activity%2C+and+the+role+of+the+amidated+C-terminus&doi=10.1002%2Fpsc.960"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fpsc.960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpsc.960%26sid%3Dliteratum%253Aachs%26aulast%3DCabrea%26aufirst%3DM.%2BP.%2BD.%2BS.%26aulast%3DArcisio-Miranda%26aufirst%3DM.%26aulast%3DCosta%26aufirst%3DS.%2BT.%2BB.%26aulast%3DKonno%26aufirst%3DK.%26aulast%3DRuggiero%26aufirst%3DJ.%2BR.%26aulast%3DProcopio%26aufirst%3DJ.%26aulast%3DNeto%26aufirst%3DJ.%2BR.%26atitle%3DStudy%2520of%2520the%2520mechanism%2520of%2520action%2520of%2520anoplin%252C%2520a%2520helical%2520antimicrobial%2520decapeptide%2520with%2520ion%2520channel-like%2520activity%252C%2520and%2520the%2520role%2520of%2520the%2520amidated%2520C-terminus%26jtitle%3DJ.%2520Pept.%2520Sci.%26date%3D2008%26volume%3D14%26spage%3D661%26epage%3D669%26doi%3D10.1002%2Fpsc.960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leung, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Won, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ianoul, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholl, A.</span></span> <span> </span><span class="NLM_article-title">Imaging interactions of cationic antimicrobial peptides with model lipid monolayers using X-ray spectromicroscopy</span>. <i>Eur. Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">805</span>â <span class="NLM_lpage">810</span>, <span class="refDoi">Â DOI: 10.1007/s00249-011-0690-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1007%2Fs00249-011-0690-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=21380600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlslChsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=805-810&author=B.+O.+Leungauthor=A.+P.+Hitchcockauthor=A.+Wonauthor=A.+Ianoulauthor=A.+Scholl&title=Imaging+interactions+of+cationic+antimicrobial+peptides+with+model+lipid+monolayers+using+X-ray+spectromicroscopy&doi=10.1007%2Fs00249-011-0690-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging interactions of cationic antimicrobial peptides with model lipid monolayers using X-ray spectromicroscopy</span></div><div class="casAuthors">Leung, Bonnie O.; Hitchcock, Adam P.; Won, Amy; Ianoul, Anatoli; Scholl, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">European Biophysics Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">805-810</span>CODEN:
                <span class="NLM_cas:coden">EBJOE8</span>;
        ISSN:<span class="NLM_cas:issn">0175-7571</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The interaction of antimicrobial peptide anoplin with 1,2-dipalmitoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] lipid monolayers was imaged with at. force microscopy, scanning transmission X-ray microscopy, and X-ray photoemission electron microscopy.  X-ray absorption spectromicroscopy of the surface revealed the domains of the phase-segregated surface to be composed of 98(Â±5)% lipid while the matrix consisted of a â¼50:50 lipid-peptide mixt.  We show X-ray spectromicroscopy to be a valuable quant. tool for label-free imaging of lipid monolayers with antimicrobial peptides at a lateral spatial resoln. below 80 nm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxaJQb9OmLs7Vg90H21EOLACvtfcHk0liCnlB6Z_1QWg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlslChsL0%253D&md5=4ac25425e6c59d826fbd86f5fb0caec1</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs00249-011-0690-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00249-011-0690-7%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DB.%2BO.%26aulast%3DHitchcock%26aufirst%3DA.%2BP.%26aulast%3DWon%26aufirst%3DA.%26aulast%3DIanoul%26aufirst%3DA.%26aulast%3DScholl%26aufirst%3DA.%26atitle%3DImaging%2520interactions%2520of%2520cationic%2520antimicrobial%2520peptides%2520with%2520model%2520lipid%2520monolayers%2520using%2520X-ray%2520spectromicroscopy%26jtitle%3DEur.%2520Biophys.%2520J.%26date%3D2011%26volume%3D40%26spage%3D805%26epage%3D810%26doi%3D10.1007%2Fs00249-011-0690-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bird, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opoku-Nsiah, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lammert, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuberg, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walensky, L. D.</span></span> <span> </span><span class="NLM_article-title">Biophysical determinants for cellular uptake of hydrocarbon-stapled peptide helices</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">845</span>â <span class="NLM_lpage">852</span>, <span class="refDoi">Â DOI: 10.1038/nchembio.2153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1038%2Fnchembio.2153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=27547919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlyqsbbP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=845-852&author=G.+H.+Birdauthor=E.+Mazzolaauthor=K.+Opoku-Nsiahauthor=M.+A.+Lammertauthor=M.+Godesauthor=D.+S.+Neubergauthor=L.+D.+Walensky&title=Biophysical+determinants+for+cellular+uptake+of+hydrocarbon-stapled+peptide+helices&doi=10.1038%2Fnchembio.2153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Biophysical determinants for cellular uptake of hydrocarbon-stapled peptide helices</span></div><div class="casAuthors">Bird, Gregory H.; Mazzola, Emanuele; Opoku-Nsiah, Kwadwo; Lammert, Margaret A.; Godes, Marina; Neuberg, Donna S.; Walensky, Loren D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">845-852</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hydrocarbon-stapled peptides are a class of bioactive alpha-helical ligands developed to dissect and target protein interactions.  While there is consensus that stapled peptides can be effective chem. tools for investigating protein regulation, their broader utility for therapeutic modulation of intracellular interactions remains an active area of study.  In particular, the design principles for generating cell-permeable stapled peptides are empiric, yet consistent intracellular access is essential to in vivo application.  Here, we used an unbiased statistical approach to det. which biophys. parameters dictate the uptake of stapled-peptide libraries.  We found that staple placement at the amphipathic boundary combined with optimal hydrophobic and helical content are the key drivers of cellular uptake, whereas excess hydrophobicity and pos. charge at isolated amino acid positions can trigger membrane lysis at elevated peptide dosing.  Our results provide a design roadmap for maximizing the potential to generate cell-permeable stapled peptides with on-mechanism cellular activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowcU10JcijIbVg90H21EOLACvtfcHk0liCnlB6Z_1QWg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlyqsbbP&md5=f31d10106beebfe08f69ec9a1b215ec1</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2153%26sid%3Dliteratum%253Aachs%26aulast%3DBird%26aufirst%3DG.%2BH.%26aulast%3DMazzola%26aufirst%3DE.%26aulast%3DOpoku-Nsiah%26aufirst%3DK.%26aulast%3DLammert%26aufirst%3DM.%2BA.%26aulast%3DGodes%26aufirst%3DM.%26aulast%3DNeuberg%26aufirst%3DD.%2BS.%26aulast%3DWalensky%26aufirst%3DL.%2BD.%26atitle%3DBiophysical%2520determinants%2520for%2520cellular%2520uptake%2520of%2520hydrocarbon-stapled%2520peptide%2520helices%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D845%26epage%3D852%26doi%3D10.1038%2Fnchembio.2153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muddineti, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torchilin, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswas, S.</span></span> <span> </span><span class="NLM_article-title">d-Î±-Tocopheryl succinate/phosphatidyl ethanolamine conjugated amphiphilic polymer-based nanomicellar system for the efficient delivery of curcumin and to overcome multiple drug resistance in cancer</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">16778</span>â <span class="NLM_lpage">16792</span>, <span class="refDoi">Â DOI: 10.1021/acsami.7b01087</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.7b01087" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC2sXns1aru74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=16778-16792&author=O.+S.+Muddinetiauthor=P.+Kumariauthor=B.+Ghoshauthor=V.+P.+Torchilinauthor=S.+Biswas&title=d-%CE%B1-Tocopheryl+succinate%2Fphosphatidyl+ethanolamine+conjugated+amphiphilic+polymer-based+nanomicellar+system+for+the+efficient+delivery+of+curcumin+and+to+overcome+multiple+drug+resistance+in+cancer&doi=10.1021%2Facsami.7b01087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">D-Î±-Tocopheryl Succinate/Phosphatidyl Ethanolamine Conjugated Amphiphilic Polymer-Based Nanomicellar System for the Efficient Delivery of Curcumin and To Overcome Multiple Drug Resistance in Cancer</span></div><div class="casAuthors">Muddineti, Omkara Swami; Kumari, Preeti; Ghosh, Balaram; Torchilin, Vladimir P.; Biswas, Swati</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">16778-16792</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nanomedicines have emerged as a promising treatment strategy for cancer.  Multiple drug resistance due to overexpression of various drug efflux transporters and upregulation of apoptotic inhibitory pathways in cancer cells are major barriers that limit the success of chemotherapy.  Here, we have developed a D-Î±-tocopherol (Î±-TOS)/lipid based copolymeric nanomicellar system (VPM) by conjugating phosphatidyl ethanolamine (PE) and Î±-TOS with poly(ethylene glycol) via an amino acid linkage.  The synthesis of polymer by multireaction steps was detd. by characterizing the polymers by FTIR, GPC, 1H and 13C NMR spectroscopy.  VPM exhibited mean hydrodynamic diam. of 141.0 Â± 0.94 nm with low crit. micelles concns. (CMC) of 15 Î¼M compared to plain PEG-PE micelles (PPM) with size of 23.9 Â± 0.34 nm and CMC 20 Î¼M.  The bigger hydrophobic compartment in VPM resulted in improved loading of a potent chemotherapeutic drug, Curcumin (Cur) and increased encapsulation efficiency (EE) (% drug loading 98.3 Â± 1.92, and 85.3 Â± 3.29; EE 14.8 Â± 0.16 and 12.8 Â± 0.09 for VPM and PPM, resp.).  C-VPM exhibited higher cytotoxicity compared to C-PPM in tested cancer cell lines.  C-VPM demonstrated â¼3.2 and â¼2.7fold higher ability to reverse multiple drug resistance compared to PPM and Verapamil (concn. used 30 Î¼M), resp.  In the in vivo study by using B16F10 implanted C57Bl6/J mice, C-VPM reduced the tumor vol. and wt. more efficiently than C-PPM by inducing apoptosis as analyzed by TUNEL assay on tumor cryo-sections.  The newly developed polymeric micelles, VPM with improved drug loadability and ability to reverse the drug resistance could successfully be utilized as a nanocarrier system for hydrophobic chemotherapeutic agents for the treatment of drug resistant solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRtVomZBezsbVg90H21EOLACvtfcHk0lhVN4VX6XIfHw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXns1aru74%253D&md5=af530bd7ed74b4afcf9f0596089664f5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facsami.7b01087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.7b01087%26sid%3Dliteratum%253Aachs%26aulast%3DMuddineti%26aufirst%3DO.%2BS.%26aulast%3DKumari%26aufirst%3DP.%26aulast%3DGhosh%26aufirst%3DB.%26aulast%3DTorchilin%26aufirst%3DV.%2BP.%26aulast%3DBiswas%26aufirst%3DS.%26atitle%3Dd-%25CE%25B1-Tocopheryl%2520succinate%252Fphosphatidyl%2520ethanolamine%2520conjugated%2520amphiphilic%2520polymer-based%2520nanomicellar%2520system%2520for%2520the%2520efficient%2520delivery%2520of%2520curcumin%2520and%2520to%2520overcome%2520multiple%2520drug%2520resistance%2520in%2520cancer%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2017%26volume%3D9%26spage%3D16778%26epage%3D16792%26doi%3D10.1021%2Facsami.7b01087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">pH-Sensitive nano-complexes overcome drug resistance and inhibit metastasis of breast cancer by silencing Akt expression</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">4204</span>â <span class="NLM_lpage">4216</span>, <span class="refDoi">Â DOI: 10.7150/thno.21516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.7150%2Fthno.21516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=29158820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFaitLbP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=4204-4216&author=J.+Yinauthor=T.+Langauthor=D.+Cunauthor=Z.+Zhengauthor=Y.+Huangauthor=Q.+Yinauthor=H.+Yuauthor=Y.+Li&title=pH-Sensitive+nano-complexes+overcome+drug+resistance+and+inhibit+metastasis+of+breast+cancer+by+silencing+Akt+expression&doi=10.7150%2Fthno.21516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">pH-sensitive nano-complexes overcome drug resistance and inhibit metastasis of breast cancer by silencing Akt expression</span></div><div class="casAuthors">Yin, Jieying; Lang, Tianqun; Cun, Dongmei; Zheng, Zhong; Huang, Yan; Yin, Qi; Yu, Haijun; Li, Yaping</div><div class="citationInfo"><span class="NLM_cas:title">Theranostics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4204-4216</span>CODEN:
                <span class="NLM_cas:coden">THERDS</span>;
        ISSN:<span class="NLM_cas:issn">1838-7640</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">The therapy of breast cancer is encumbered by drug resistance and metastasis, which can be due to a defective PI3K/AKT/mTOR signaling pathway.  This study was aimed at improving the anti-cancer effect of the chemotherapeutic agent paclitaxel (PTX) on the drug resistant and metastatic breast cancer by co-delivering PTX and a siRNA, siAkt, directed at silencing the Akt expression.  The pH-sensitive amphiphilic polymer, poly [(1,4-butanediol)-diacrylate-Î²-N, N-diisopropylethylenediamine]-polyethyleneimine (BDP) was synthesized.  The PTX-loaded BDP micelle/siAkt nano-complex (PMA) was prepd. and characterized.  The cellular uptake, cytotoxicity, RNA interference efficiency, biodistribution, pharmacokinetics, pharmacodynamics, and biocompatibility of PMA in the murine metastatic breast cancer 4T1 cells and the 4T1 tumor-bearing mice were evaluated.  Results: PMA was stable at the neutral as well as tumor extracellular pH and released the drugs in the intra-endo/lysosome acidic environment.  In 4T1 cells, the RNA interference against the Akt gene down-regulated the expression of Akt and P-glycoprotein and up-regulated the expression of Caspase-3.  The down-regulated P-gp inhibits the efflux of PTX thereby increasing its intracellular concn., improving the cytotoxicity, and inhibiting the migration and invasion of 4T1 cells.  In the 4T1 tumor-bearing mice, co-delivery of PTX and siAkt by PMA achieved a tumor inhibiting rate of 94.1% and suppressed 96.8% lung metastases.  PMA did not cause pathol. lesions in normal organs.  PMA, by virtue of overcoming drug resistance and simultaneously restraining lung metastasis, might be an efficient drug delivery system for the therapy of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwy14RdCM2prVg90H21EOLACvtfcHk0lhVN4VX6XIfHw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFaitLbP&md5=41175d135b4606b8e1dc0b38d12e77d1</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.7150%2Fthno.21516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.21516%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DLang%26aufirst%3DT.%26aulast%3DCun%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DYin%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DpH-Sensitive%2520nano-complexes%2520overcome%2520drug%2520resistance%2520and%2520inhibit%2520metastasis%2520of%2520breast%2520cancer%2520by%2520silencing%2520Akt%2520expression%26jtitle%3DTheranostics%26date%3D2017%26volume%3D7%26spage%3D4204%26epage%3D4216%26doi%3D10.7150%2Fthno.21516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">UggerhÃ¸j, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munk, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredborg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sondergaard, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frimodt-Moller, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wimmer, R.</span></span> <span> </span><span class="NLM_article-title">Rational design of alpha-helical antimicrobial peptides: doâs and donâts</span>. <i>Chembiochem</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">242</span>â <span class="NLM_lpage">253</span>, <span class="refDoi">Â DOI: 10.1002/cbic.201402581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1002%2Fcbic.201402581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=25530580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFamsLvJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=242-253&author=L.+E.+Uggerh%C3%B8jauthor=T.+J.+Poulsenauthor=J.+K.+Munkauthor=M.+Fredborgauthor=T.+E.+Sondergaardauthor=N.+Frimodt-Mollerauthor=P.+R.+Hansenauthor=R.+Wimmer&title=Rational+design+of+alpha-helical+antimicrobial+peptides%3A+do%E2%80%99s+and+don%E2%80%99ts&doi=10.1002%2Fcbic.201402581"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Alpha-Helical Antimicrobial Peptides: Do's and Don'ts</span></div><div class="casAuthors">Uggerhoj, Lars Erik; Poulsen, Tanja Juul; Munk, Jens Kristian; Fredborg, Marlene; Sondergaard, Teis Esben; Frimodt-Moller, Niels; Hansen, Paul Robert; Wimmer, Reinhard</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">242-253</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Antimicrobial peptides (AMPs) are promising candidates for battling multiresistant bacteria.  Despite extensive research, structure-activity relationships of AMPs are not fully understood, and there is a lack of structural data relating to AMPs in lipids.  Here we present the NMR structure of anoplin (GLLKRIKTLL-NH2) in a micellar environment.  A vast library of substitutions was designed and tested for antimicrobial and hemolytic activity, as well as for changes in structure and lipid interactions.  This showed that improvement of antimicrobial activity without concomitant introduction of strong hemolytic activity can be achieved through subtle increases in the hydrophobicity of the hydrophobic face or through subtle increases in the polarity of the hydrophilic face of the helix, or-most efficiently-a combination of both.  A set of guidelines based on the results is given, for assistance in how to modify cationic Î±-helical AMPs in order to control activity and selectivity.  The guidelines are finally tested on a different peptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHlWjS56lQL7Vg90H21EOLACvtfcHk0ljWlTwJbJ94Cg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFamsLvJ&md5=f55279a04afacd29ab9af091154e0fe3</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201402581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201402581%26sid%3Dliteratum%253Aachs%26aulast%3DUggerh%25C3%25B8j%26aufirst%3DL.%2BE.%26aulast%3DPoulsen%26aufirst%3DT.%2BJ.%26aulast%3DMunk%26aufirst%3DJ.%2BK.%26aulast%3DFredborg%26aufirst%3DM.%26aulast%3DSondergaard%26aufirst%3DT.%2BE.%26aulast%3DFrimodt-Moller%26aufirst%3DN.%26aulast%3DHansen%26aufirst%3DP.%2BR.%26aulast%3DWimmer%26aufirst%3DR.%26atitle%3DRational%2520design%2520of%2520alpha-helical%2520antimicrobial%2520peptides%253A%2520do%25E2%2580%2599s%2520and%2520don%25E2%2580%2599ts%26jtitle%3DChembiochem%26date%3D2015%26volume%3D16%26spage%3D242%26epage%3D253%26doi%3D10.1002%2Fcbic.201402581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MigoÅ, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubauer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamysz, W.</span></span> <span> </span><span class="NLM_article-title">Hydrocarbon stapled antimicrobial peptides</span>. <i>Protein J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">2</span>â <span class="NLM_lpage">12</span>, <span class="refDoi">Â DOI: 10.1007/s10930-018-9755-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1007%2Fs10930-018-9755-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=29330644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVKlsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2018&pages=2-12&author=D.+Migo%C5%84author=D.+Neubauerauthor=W.+Kamysz&title=Hydrocarbon+stapled+antimicrobial+peptides&doi=10.1007%2Fs10930-018-9755-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrocarbon Stapled Antimicrobial Peptides</span></div><div class="casAuthors">Migon, Dorian; Neubauer, Damian; Kamysz, Wojciech</div><div class="citationInfo"><span class="NLM_cas:title">Protein Journal</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-12</span>CODEN:
                <span class="NLM_cas:coden">PJROAH</span>;
        ISSN:<span class="NLM_cas:issn">1572-3887</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A Review.  Antimicrobial peptides are promising candidates for anti-infective pharmaceuticals.  Unfortunately, because of their low proteolytic and chem. stability, their usage is generally narrowed down to topical formulations.  Until now, numerous approaches to increase peptide stability have been proposed.  One of them, peptide hydrocarbon stapling, a modification based on stabilizing peptide secondary structure with a side-chain covalent hydrocarbon bridge, have been successfully applied to many peptides.  Moreover, constraining secondary structure of peptides have also been proven to increase their biol. activity.  This review article describes studies on hydrocarbon stapled antimicrobial peptides with respect to improved drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonkdLuAftqzLVg90H21EOLACvtfcHk0lh4AHnLsr9w_Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVKlsb8%253D&md5=d36884c57dfe17a152ec43d1b6a5b7f6</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2Fs10930-018-9755-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10930-018-9755-0%26sid%3Dliteratum%253Aachs%26aulast%3DMigo%25C5%2584%26aufirst%3DD.%26aulast%3DNeubauer%26aufirst%3DD.%26aulast%3DKamysz%26aufirst%3DW.%26atitle%3DHydrocarbon%2520stapled%2520antimicrobial%2520peptides%26jtitle%3DProtein%2520J.%26date%3D2018%26volume%3D37%26spage%3D2%26epage%3D12%26doi%3D10.1007%2Fs10930-018-9755-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stone, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deber, C. M.</span></span> <span> </span><span class="NLM_article-title">Influence of hydrocarbon-stapling on membrane interactions of synthetic antimicrobial peptides</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1189</span>â <span class="NLM_lpage">1196</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2017.10.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1016%2Fj.bmc.2017.10.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=29275987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVeht7fK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=1189-1196&author=T.+A.+Stoneauthor=G.+B.+Coleauthor=H.+Q.+Nguyenauthor=S.+Sharpeauthor=C.+M.+Deber&title=Influence+of+hydrocarbon-stapling+on+membrane+interactions+of+synthetic+antimicrobial+peptides&doi=10.1016%2Fj.bmc.2017.10.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of hydrocarbon-stapling on membrane interactions of synthetic antimicrobial peptides</span></div><div class="casAuthors">Stone, Tracy A.; Cole, Gregory B.; Nguyen, Huong Q.; Sharpe, Simon; Deber, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1189-1196</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cyclization has been recognized as a valuable technique for increasing the efficacy of small mol. and peptide therapeutics.  Here we report the application of a hydrocarbon staple to a rationally-designed cationic antimicrobial peptide (CAP) that acquires increased membrane targeting and interaction vs. its linear counterpart.  The previously-described CAP, 6K-F17 (KKKKKK-AAFAAWAAFAA-NH2) was used as the backbone for incorporation of an i to i + 4 helical hydrocarbon staple through olefin ring closing metathesis.  Stapled versions of 6K-F17 showed an increase in non-selective membrane interaction, where the staple itself enhances the degree of membrane interaction and rate of cell death while maintaining high potency against bacterial membranes.  However, the higher averaged hydrophobicity imparted by the staple also significantly increases toxicity to mammalian cells.  This deleterious effect is countered through stepwise redn. of the stapled 6K-F17's backbone hydrophobicity through polar amino acid substitutions.  CD assessment of secondary structure in various bacterial membrane mimetics reveals that a helical structure may improve - but is not an abs. requirement for - antimicrobial activity of 6K-F17.  Further, phosphorus-31 static solid state NMR spectra revealed that both non-toxic stapled and linear peptides bind bacterial membranes in a similar manner that does not involve a detergent-like mechanism of lipid removal.  The overall results suggest that the technique of hydrocarbon stapling can be readily applied to membrane-interactive CAPs to modulate how they interact and target biol. membranes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrF912vc6mnrVg90H21EOLACvtfcHk0lh4AHnLsr9w_Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVeht7fK&md5=af22818a24e2b7133c48e81f9e37a787</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.10.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.10.020%26sid%3Dliteratum%253Aachs%26aulast%3DStone%26aufirst%3DT.%2BA.%26aulast%3DCole%26aufirst%3DG.%2BB.%26aulast%3DNguyen%26aufirst%3DH.%2BQ.%26aulast%3DSharpe%26aufirst%3DS.%26aulast%3DDeber%26aufirst%3DC.%2BM.%26atitle%3DInfluence%2520of%2520hydrocarbon-stapling%2520on%2520membrane%2520interactions%2520of%2520synthetic%2520antimicrobial%2520peptides%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D1189%26epage%3D1196%26doi%3D10.1016%2Fj.bmc.2017.10.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mourtada, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herce, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moroco, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wales, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walensky, L. D.</span></span> <span> </span><span class="NLM_article-title">Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1186</span>â <span class="NLM_lpage">1197</span>, <span class="refDoi">Â DOI: 10.1038/s41587-019-0222-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1038%2Fs41587-019-0222-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=31427820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1WjurjP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2019&pages=1186-1197&author=R.+Mourtadaauthor=H.+D.+Herceauthor=D.+J.+Yinauthor=J.+A.+Morocoauthor=T.+E.+Walesauthor=J.+R.+Engenauthor=L.+D.+Walensky&title=Design+of+stapled+antimicrobial+peptides+that+are+stable%2C+nontoxic+and+kill+antibiotic-resistant+bacteria+in+mice&doi=10.1038%2Fs41587-019-0222-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice</span></div><div class="casAuthors">Mourtada, Rida; Herce, Henry D.; Yin, Daniel J.; Moroco, Jamie A.; Wales, Thomas E.; Engen, John R.; Walensky, Loren D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1186-1197</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The clin. translation of cationic Î±-helical antimicrobial peptides (AMPs) has been hindered by structural instability, proteolytic degrdn. and in vivo toxicity from nonspecific membrane lysis.  Although analyses of hydrophobic content and charge distribution have informed the design of synthetic AMPs with increased potency and reduced in vitro hemolysis, nonspecific membrane toxicity in vivo continues to impede AMP drug development.  Here, we analyzed a 58-member library of stapled AMPs (StAMPs) based on magainin II and applied the insights from structure-function-toxicity measurements to devise an algorithm for the design of stable, protease-resistant, potent and nontoxic StAMP prototypes.  We show that a lead double-stapled StAMP named Mag(i+4)1,15(A9K,B21A,N22K,S23K) can kill multidrug-resistant Gram-neg. pathogens, such as colistin-resistant Acinetobacter baumannii in a mouse peritonitis-sepsis model, without obsd. hemolysis or renal injury in murine toxicity studies.  Inputting the amino acid sequences alone, we further generated membrane-selective StAMPs of pleurocidin, CAP18 and esculentin, highlighting the generalizability of our design platform.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPEI2M6f3z2bVg90H21EOLACvtfcHk0lioZQlleuKnbw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1WjurjP&md5=48d439283037426cd8275d550bbbcd80</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fs41587-019-0222-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41587-019-0222-z%26sid%3Dliteratum%253Aachs%26aulast%3DMourtada%26aufirst%3DR.%26aulast%3DHerce%26aufirst%3DH.%2BD.%26aulast%3DYin%26aufirst%3DD.%2BJ.%26aulast%3DMoroco%26aufirst%3DJ.%2BA.%26aulast%3DWales%26aufirst%3DT.%2BE.%26aulast%3DEngen%26aufirst%3DJ.%2BR.%26aulast%3DWalensky%26aufirst%3DL.%2BD.%26atitle%3DDesign%2520of%2520stapled%2520antimicrobial%2520peptides%2520that%2520are%2520stable%252C%2520nontoxic%2520and%2520kill%2520antibiotic-resistant%2520bacteria%2520in%2520mice%26jtitle%3DNat.%2520Biotechnol.%26date%3D2019%26volume%3D37%26spage%3D1186%26epage%3D1197%26doi%3D10.1038%2Fs41587-019-0222-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, H.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bierer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.-G.</span></span> <span> </span><span class="NLM_article-title">A novel peptide stapling strategy enables the retention of ring-closing amino acid side chains for the Wnt/Î²-catenin signalling pathway</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">7368</span>â <span class="NLM_lpage">7373</span>, <span class="refDoi">Â DOI: 10.1039/c7sc02420g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1039%2Fc7sc02420g" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=29163887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVGjurzE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=7368-7373&author=Y.+Wuauthor=Y.-H.+Liauthor=X.+Liauthor=Y.+Zouauthor=H.-L.+Liaoauthor=L.+Liuauthor=Y.-G.+Chenauthor=D.+Biererauthor=H.-G.+Hu&title=A+novel+peptide+stapling+strategy+enables+the+retention+of+ring-closing+amino+acid+side+chains+for+the+Wnt%2F%CE%B2-catenin+signalling+pathway&doi=10.1039%2Fc7sc02420g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A novel peptide stapling strategy enables the retention of ring-closing amino acid side chains for the Wnt/Î²-catenin signalling pathway</span></div><div class="casAuthors">Wu, Ye; Li, Ye-Hua; Li, Xiang; Zou, Yan; Liao, Hong-Li; Liu, Lei; Chen, Ye-Guang; Bierer, Donald; Hu, Hong-Gang</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">7368-7373</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The all-hydrocarbon peptide stapling strategy has recently been extensively explored in drug discovery.  There remains the potential for improvement regarding the retention of the amino acid side chains at the stapled positions.  Herein, we describe a new series of amino acids that not only contain the native side chains, but also carry the alkenyl arms that are needed for the ring-closing stapling chem.  We incorporate the new amino acids into a Î²-catenin-binding domain of Axin (469-482) and develop a new category of stapled peptides with the retention of the native side chains.  These stapled peptides exhibit high Î±-helicity, strong proteolytic stability and good cell permeability.  Biochem. expts. demonstrate that these stapled peptides can activate Î²-catenin more efficiently than canonical stapled peptides due to the presence of extra side chains.  We expect that the new side-chain-retention stapling method would expand the scope of the all-hydrocarbon stapled peptide strategy by retaining some important peripheral residues for protein-protein interactions or preserving key hydrophilic side chains to improve soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzifiqUvr-37Vg90H21EOLACvtfcHk0lioZQlleuKnbw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVGjurzE&md5=1bc302b99fa3cd11177a7a9ed1d01e09</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1039%2Fc7sc02420g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc7sc02420g%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.-H.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DLiao%26aufirst%3DH.-L.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DY.-G.%26aulast%3DBierer%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DH.-G.%26atitle%3DA%2520novel%2520peptide%2520stapling%2520strategy%2520enables%2520the%2520retention%2520of%2520ring-closing%2520amino%2520acid%2520side%2520chains%2520for%2520the%2520Wnt%252F%25CE%25B2-catenin%2520signalling%2520pathway%26jtitle%3DChem.%2520Sci.%26date%3D2017%26volume%3D8%26spage%3D7368%26epage%3D7373%26doi%3D10.1039%2Fc7sc02420g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camilio, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berge, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravuri, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rekdal, Ã.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">SveinbjÃ¸rnsson, B.</span></span> <span> </span><span class="NLM_article-title">Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315</span>. <i>Cancer Immunol. Immunother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">601</span>â <span class="NLM_lpage">613</span>, <span class="refDoi">Â DOI: 10.1007/s00262-014-1540-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1007%2Fs00262-014-1540-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=24676901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFyjtLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2014&pages=601-613&author=K.+A.+Camilioauthor=G.+Bergeauthor=C.+S.+Ravuriauthor=%C3%98.+Rekdalauthor=B.+Sveinbj%C3%B8rnsson&title=Complete+regression+and+systemic+protective+immune+responses+obtained+in+B16+melanomas+after+treatment+with+LTX-315&doi=10.1007%2Fs00262-014-1540-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315</span></div><div class="casAuthors">Camilio, Ketil Andre; Berge, Gerd; Ravuri, Chandra Sekhar; Rekdal, Oeystein; Sveinbjoernsson, Baldur</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Immunotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">601-613</span>CODEN:
                <span class="NLM_cas:coden">CIIMDN</span>;
        ISSN:<span class="NLM_cas:issn">0340-7004</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Malignant melanoma is the most aggressive and deadliest form of skin cancer due to its highly metastatic potential, which calls for new and improved therapies.  Cationic antimicrobial peptides (CAPs) are naturally occurring mols. found in most species, in which they play a significant role in the first line of defense against pathogens, and several CAPs have shown promising potential as novel anticancer agents.  Structure-activity relationship studies on the CAP bovine lactoferricin allowed us to de novo design short chem. modified lytic anticancer peptides.  In the present study, we investigated the in vivo antitumor effects of LTX-315 against intradermally established B16 melanomas in syngeneic mice.  Intratumoral administration of LTX-315 resulted in tumor necrosis and the infiltration of immune cells into the tumor parenchyma followed by complete regression of the tumor in the majority of the animals.  LTX-315 induced the release of danger-assocd. mol. pattern mols. such as the high mobility group box-1 protein in vitro and the subsequent upregulation of proinflammatory cytokines such as interleukin (IL) 1Î², IL6 and IL18 in vivo.  Animals cured by LTX-315 treatment were protected against a re-challenge with live B16 tumor cells both intradermally and i.v.  Together, our data indicate that intratumoral treatment with LTX-315 can provide local tumor control followed by protective immune responses and has potential as a new immunotherapeutic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkrMTmNQJBzbVg90H21EOLACvtfcHk0lgSa0PMxF9aow"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFyjtLw%253D&md5=a998cae3a19f9dd5e5e7783ae1cff6a9</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs00262-014-1540-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00262-014-1540-0%26sid%3Dliteratum%253Aachs%26aulast%3DCamilio%26aufirst%3DK.%2BA.%26aulast%3DBerge%26aufirst%3DG.%26aulast%3DRavuri%26aufirst%3DC.%2BS.%26aulast%3DRekdal%26aufirst%3D%25C3%2598.%26aulast%3DSveinbj%25C3%25B8rnsson%26aufirst%3DB.%26atitle%3DComplete%2520regression%2520and%2520systemic%2520protective%2520immune%2520responses%2520obtained%2520in%2520B16%2520melanomas%2520after%2520treatment%2520with%2520LTX-315%26jtitle%3DCancer%2520Immunol.%2520Immunother.%26date%3D2014%26volume%3D63%26spage%3D601%26epage%3D613%26doi%3D10.1007%2Fs00262-014-1540-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camilio, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauseth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waagene, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kvalheim, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rekdal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sveinbjornsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maelandsmo, G. M.</span></span> <span> </span><span class="NLM_article-title">Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model</span>. <i>Breast Canc. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">9</span>, <span class="refDoi">Â DOI: 10.1186/s13058-018-1092-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1186%2Fs13058-018-1092-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=30670061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A280%3ADC%252BB3cjktV2mtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2019&pages=9&author=K.+A.+Camilioauthor=M.+Y.+Wangauthor=B.+Mausethauthor=S.+Waageneauthor=G.+Kvalheimauthor=O.+Rekdalauthor=B.+Sveinbjornssonauthor=G.+M.+Maelandsmo&title=Combining+the+oncolytic+peptide+LTX-315+with+doxorubicin+demonstrates+therapeutic+potential+in+a+triple-negative+breast+cancer+model&doi=10.1186%2Fs13058-018-1092-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model</span></div><div class="casAuthors">Camilio Ketil A; Wang Meng-Yu; Waagene Stein; Maelandsmo Gunhild M; Camilio Ketil A; Mauseth Brynjar; Rekdal Oystein; Sveinbjornsson Baldur; Camilio Ketil A; Mauseth Brynjar; Mauseth Brynjar; Kvalheim Gunnar; Rekdal Oystein; Sveinbjornsson Baldur; Maelandsmo Gunhild M</div><div class="citationInfo"><span class="NLM_cas:title">Breast cancer research : BCR</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Immunochemotherapy, the combined use of immunotherapy and chemotherapy, has demonstrated great promise in several cancers.  LTX-315 is an oncolytic peptide with potent immunomodulatory properties designed for the local treatment of solid tumors.  By inducing rapid immunogenic cell death through the release of danger-associated molecular pattern molecules (DAMPs), LTX-315 is capable of reshaping the tumor microenvironment, turning "cold" tumors "hot" through a significant increase in tumor-infiltrating lymphocytes.  METHODS:  We investigated the potential of LTX-315 to be used in combination with standard-of-care chemotherapy (doxorubicin, brand name CAELYXÂ®) against triple-negative breast cancer in an orthotopic 4 T1 mammary fat pad model.  Tumor growth curves were compared using one-way ANOVA analysis of variance and Tukey's multiple comparisons test, and animal survival curves were compared using the log-rank (Mantel-Cox) test.  We considered p values â¤0.05 to indicate statistical significance.  RESULTS:  We found that LTX-315 displayed a strong additive antitumoral effect when used in combination with CAELYXÂ®, and induced immune-mediated changes in the tumor microenvironment, followed by complete regression in the majority of animals treated.  Furthermore, imaging techniques and histological examination showed that the combination induced strong local necrosis, followed by an increase in the infiltration of CD4+ and CD8+ immune cells into the tumor parenchymal tissue.  CONCLUSIONS:  Our data demonstrate that LTX-315 is a promising combination partner with CAELYXÂ® for the treatment of triple-negative breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSndeaf3qStzFf1XRtfYM0dfW6udTcc2ebd5kzvnxyV97ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cjktV2mtw%253D%253D&md5=50f4fe9609cb4ef05f9a951a8427470e</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1186%2Fs13058-018-1092-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13058-018-1092-x%26sid%3Dliteratum%253Aachs%26aulast%3DCamilio%26aufirst%3DK.%2BA.%26aulast%3DWang%26aufirst%3DM.%2BY.%26aulast%3DMauseth%26aufirst%3DB.%26aulast%3DWaagene%26aufirst%3DS.%26aulast%3DKvalheim%26aufirst%3DG.%26aulast%3DRekdal%26aufirst%3DO.%26aulast%3DSveinbjornsson%26aufirst%3DB.%26aulast%3DMaelandsmo%26aufirst%3DG.%2BM.%26atitle%3DCombining%2520the%2520oncolytic%2520peptide%2520LTX-315%2520with%2520doxorubicin%2520demonstrates%2520therapeutic%2520potential%2520in%2520a%2520triple-negative%2520breast%2520cancer%2520model%26jtitle%3DBreast%2520Canc.%2520Res.%26date%3D2019%26volume%3D21%26spage%3D9%26doi%3D10.1186%2Fs13058-018-1092-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepp, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zitvogel, L.</span></span> <span> </span><span class="NLM_article-title">Immunogenic cell death in cancer therapy</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">51</span>â <span class="NLM_lpage">72</span>, <span class="refDoi">Â DOI: 10.1146/annurev-immunol-032712-100008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1146%2Fannurev-immunol-032712-100008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=23157435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsFClsL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=51-72&author=G.+Kroemerauthor=L.+Galluzziauthor=O.+Keppauthor=L.+Zitvogel&title=Immunogenic+cell+death+in+cancer+therapy&doi=10.1146%2Fannurev-immunol-032712-100008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Immunogenic cell death in cancer therapy</span></div><div class="casAuthors">Kroemer, Guido; Galluzzi, Lorenzo; Kepp, Oliver; Zitvogel, Laurence</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">51-72</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Depending on the initiating stimulus, cancer cell death can be immunogenic or nonimmunogenic.  Immunogenic cell death (ICD) involves changes in the compn. of the cell surface as well as the release of sol. mediators, occurring in a defined temporal sequence.  Such signals operate on a series of receptors expressed by dendritic cells to stimulate the presentation of tumor antigens to T cells.  We postulate that ICD constitutes a prominent pathway for the activation of the immune system against cancer, which in turn dets. the long-term success of anticancer therapies.  Hence, suboptimal regimens (failing to induce ICD), selective alterations in cancer cells (preventing the emission of immunogenic signals during ICD), or defects in immune effectors (abolishing the perception of ICD by the immune system) can all contribute to therapeutic failure.  We surmise that ICD and its subversion by pathogens also play major roles in antiviral immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruNjdkTvG-O7Vg90H21EOLACvtfcHk0lhKPw6vmywS4A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsFClsL8%253D&md5=bc000639067604e4d67bcdcaf766c00c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1146%2Fannurev-immunol-032712-100008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-immunol-032712-100008%26sid%3Dliteratum%253Aachs%26aulast%3DKroemer%26aufirst%3DG.%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DKepp%26aufirst%3DO.%26aulast%3DZitvogel%26aufirst%3DL.%26atitle%3DImmunogenic%2520cell%2520death%2520in%2520cancer%2520therapy%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2013%26volume%3D31%26spage%3D51%26epage%3D72%26doi%3D10.1146%2Fannurev-immunol-032712-100008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wargo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reuben, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, P.</span></span> <span> </span><span class="NLM_article-title">Monitoring immune responses in the tumor microenvironment</span>. <i>Curr. Opin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">23</span>â <span class="NLM_lpage">31</span>, <span class="refDoi">Â DOI: 10.1016/j.coi.2016.05.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1016%2Fj.coi.2016.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=27240055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC28XosFWgur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2016&pages=23-31&author=J.+A.+Wargoauthor=S.+M.+Reddyauthor=A.+Reubenauthor=P.+Sharma&title=Monitoring+immune+responses+in+the+tumor+microenvironment&doi=10.1016%2Fj.coi.2016.05.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Monitoring immune responses in the tumor microenvironment</span></div><div class="casAuthors">Wargo, Jennifer A.; Reddy, Sangeetha M.; Reuben, Alexandre; Sharma, Padmanee</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">23-31</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Immune monitoring in the tumor microenvironment allows for important insights into immune mechanisms of response and resistance to various cancer treatments; however clin. challenges exist using current strategies.  Significant questions remain regarding monitoring of archival vs. fresh tissue, assessment of static vs. dynamic markers, evaluation of limited tissue samples, and the translation of insights gained from immunol. 'hot' tumors such as melanoma to other 'cold' tumor microenvironments prevalent in other cancer types.  Current and emerging immune monitoring strategies will be examd. herein, and genomic-based assays complementing these techniques will also be discussed.  Finally, host genomic and external environmental factors influencing anti-tumor immune responses will be considered, including the role of the gut microbiome.  Though optimal immune monitoring techniques are in evolution, great promise exists in recent advances that will help guide patient selection as far as type, sequence, and combination of therapeutic regimens to enhance anti-tumor immunity and clin. responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpENBW-z9IiFrVg90H21EOLACvtfcHk0lhKPw6vmywS4A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosFWgur4%253D&md5=01ee546380bc39fe46e8d1f87853158c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.coi.2016.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coi.2016.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DWargo%26aufirst%3DJ.%2BA.%26aulast%3DReddy%26aufirst%3DS.%2BM.%26aulast%3DReuben%26aufirst%3DA.%26aulast%3DSharma%26aufirst%3DP.%26atitle%3DMonitoring%2520immune%2520responses%2520in%2520the%2520tumor%2520microenvironment%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D2016%26volume%3D41%26spage%3D23%26epage%3D31%26doi%3D10.1016%2Fj.coi.2016.05.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vareki, M. S.</span></span> <span> </span><span class="NLM_article-title">High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors</span>. <i>J. Immunother. Canc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">157</span>, <span class="refDoi">Â DOI: 10.1186/s40425-018-0479-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1186%2Fs40425-018-0479-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=30587233" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=157&author=M.+S.+Vareki&title=High+and+low+mutational+burden+tumors+versus+immunologically+hot+and+cold+tumors+and+response+to+immune+checkpoint+inhibitors&doi=10.1186%2Fs40425-018-0479-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1186%2Fs40425-018-0479-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40425-018-0479-7%26sid%3Dliteratum%253Aachs%26aulast%3DVareki%26aufirst%3DM.%2BS.%26atitle%3DHigh%2520and%2520low%2520mutational%2520burden%2520tumors%2520versus%2520immunologically%2520hot%2520and%2520cold%2520tumors%2520and%2520response%2520to%2520immune%2520checkpoint%2520inhibitors%26jtitle%3DJ.%2520Immunother.%2520Canc.%26date%3D2018%26volume%3D6%26spage%3D157%26doi%3D10.1186%2Fs40425-018-0479-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routh, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pullikuth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoadley, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Print, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knowlton, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demaria, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedognetti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatza, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perou, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triozzi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, L. D.</span></span> <span> </span><span class="NLM_article-title">Tumor mutational burden is a determinant of immune-mediated survival in breast cancer</span>. <i>Oncoimmunology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e1490854</span> <span class="refDoi">Â DOI: 10.1080/2162402x.2018.1490854</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1080%2F2162402x.2018.1490854" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=30386679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVCqurjE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2018&author=A.+Thomasauthor=E.+D.+Routhauthor=A.+Pullikuthauthor=G.+Jinauthor=J.+Suauthor=J.+W.+Chouauthor=K.+A.+Hoadleyauthor=C.+Printauthor=N.+Knowltonauthor=M.+A.+Blackauthor=S.+Demariaauthor=E.+Wangauthor=D.+Bedognettiauthor=W.+D.+Jonesauthor=G.+A.+Mehtaauthor=M.+L.+Gatzaauthor=C.+M.+Perouauthor=D.+B.+Pageauthor=P.+Triozziauthor=L.+D.+Miller&title=Tumor+mutational+burden+is+a+determinant+of+immune-mediated+survival+in+breast+cancer&doi=10.1080%2F2162402x.2018.1490854"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor mutational burden is a determinant of immune-mediated survival in breast cancer</span></div><div class="casAuthors">Thomas, Alexandra; Routh, Eric D.; Pullikuth, Ashok; Jin, Guangxu; Su, Jing; Chou, Jeff W.; Hoadley, Katherine A.; Print, Cristin; Knowlton, Nick; Black, Michael A.; Demaria, Sandra; Wang, Ena; Bedognetti, Davide; Jones, Wendell D.; Mehta, Gaurav A.; Gatza, Michael L.; Perou, Charles M.; Page, David B.; Triozzi, Pierre; Miller, Lance D.</div><div class="citationInfo"><span class="NLM_cas:title">OncoImmunology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e1490854/1-e1490854/12</span>CODEN:
                <span class="NLM_cas:coden">ONCOGX</span>;
        ISSN:<span class="NLM_cas:issn">2162-402X</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Mounting evidence supports a role for the immune system in breast cancer outcomes.  The ability to distinguish highly immunogenic tumors susceptible to anti-tumor immunity from weakly immunogenic or inherently immune-resistant tumors would guide development of therapeutic strategies in breast cancer.  Genomic, transcriptomic and clin. data from The Cancer Genome Atlas (TCGA) and Mol. Taxonomy of Breast Cancer International Consortium (METABRIC) breast cancer cohorts were used to examine statistical assocns. between tumor mutational burden (TMB) and the survival of patients whose tumors were assigned to previously-described prognostic immune subclasses reflecting favorable, weak or poor immune-infiltrate dispositions (FID, WID or PID, resp.).  Tumor immune subclasses were assocd. with survival in patients with high TMB (TMB-Hi, P < 0.001) but not in those with low TMB (TMB-Lo, P = 0.44).  This statistical relationship was confirmed in the METABRIC cohort (TMB-Hi, P = 0.047; TMB-Lo, P = 0.39), and also found to hold true in the more-indolent Luminal A tumor subtype (TMB-Hi, P = 0.011; TMB-Lo, P = 0.91).  In TMB-Hi tumors, the FID subclass was assocd. with prolonged survival independent of tumor stage, mol. subtype, age and treatment.  Copy no. anal. revealed the reproducible, preferential amplification of chromosome 1q immune-regulatory genes in the PID immune subclass.  These findings demonstrate a previously unappreciated role for TMB as a determinant of immune-mediated survival of breast cancer patients and identify candidate immune-regulatory mechanisms assocd. with immunol. cold tumors.  Immune subtyping of breast cancers may offer opportunities for therapeutic stratification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo20EcT1j7GMbVg90H21EOLACvtfcHk0lgpA6a4mpW4OQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVCqurjE&md5=b2d3c90c131475ebfa2eb5ec0928027b</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1080%2F2162402x.2018.1490854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F2162402x.2018.1490854%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DA.%26aulast%3DRouth%26aufirst%3DE.%2BD.%26aulast%3DPullikuth%26aufirst%3DA.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DSu%26aufirst%3DJ.%26aulast%3DChou%26aufirst%3DJ.%2BW.%26aulast%3DHoadley%26aufirst%3DK.%2BA.%26aulast%3DPrint%26aufirst%3DC.%26aulast%3DKnowlton%26aufirst%3DN.%26aulast%3DBlack%26aufirst%3DM.%2BA.%26aulast%3DDemaria%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DBedognetti%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DW.%2BD.%26aulast%3DMehta%26aufirst%3DG.%2BA.%26aulast%3DGatza%26aufirst%3DM.%2BL.%26aulast%3DPerou%26aufirst%3DC.%2BM.%26aulast%3DPage%26aufirst%3DD.%2BB.%26aulast%3DTriozzi%26aufirst%3DP.%26aulast%3DMiller%26aufirst%3DL.%2BD.%26atitle%3DTumor%2520mutational%2520burden%2520is%2520a%2520determinant%2520of%2520immune-mediated%2520survival%2520in%2520breast%2520cancer%26jtitle%3DOncoimmunology%26date%3D2018%26volume%3D7%26doi%3D10.1080%2F2162402x.2018.1490854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, H.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garris, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfirschke, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickelt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arlauckas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siwicki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohler, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissleder, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundvold-Gjerstad, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">SveinbjÃ¸rnsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rekdal, Ã.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pittet, M. J.</span></span> <span> </span><span class="NLM_article-title">LTX-315 sequentially promotes lymphocyte-independent and lymphocyte-dependent antitumor effects</span>. <i>Cell Stress</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">348</span>â <span class="NLM_lpage">360</span>, <span class="refDoi">Â DOI: 10.15698/cst2019.11.204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.15698%2Fcst2019.11.204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=31799501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVCjsr3M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2019&pages=348-360&author=H.-W.+Liaoauthor=C.+Garrisauthor=C.+Pfirschkeauthor=S.+Rickeltauthor=S.+Arlauckasauthor=M.+Siwickiauthor=R.+H.+Kohlerauthor=R.+Weisslederauthor=V.+Sundvold-Gjerstadauthor=B.+Sveinbj%C3%B8rnssonauthor=%C3%98.+Rekdalauthor=M.+J.+Pittet&title=LTX-315+sequentially+promotes+lymphocyte-independent+and+lymphocyte-dependent+antitumor+effects&doi=10.15698%2Fcst2019.11.204"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">LTX-315 sequentially promotes lymphocyte-independent and lymphocyte-dependent antitumor effects</span></div><div class="casAuthors">Liao, Hsin-Wei; Garris, Christopher; Pfirschke, Christina; Rickelt, Steffen; Arlauckas, Sean; Siwicki, Marie; Kohler, Rainer H.; Weissleder, Ralph; Sundvold-Gjerstad, Vibeke; Sveinbjoernsson, Baldur; Rekdal, Oeystein; Pittet, Mikael J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Stress</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">348-360</span>CODEN:
                <span class="NLM_cas:coden">CSETBO</span>;
        ISSN:<span class="NLM_cas:issn">2523-0204</span>.
    
            (<span class="NLM_cas:orgname">Shared Science Publishers OG</span>)
        </div><div class="casAbstract">LTX-315 is an oncolytic peptide that has antitumor efficacy in mice grafted with various tumor cell lines and is currently being tested in phase II clin. trials.  Here we aimed to further evaluate LTX-315 in conditional genetic mouse models of cancer that typically resist current treatment options and to better understand the drug's mode of action in vivo.  We report LTX-315 mediates profound antitumor effects against Braf- and Pten-driven melanoma and delays the progression of Kras- and P53-driven soft tissue sarcoma in mice.  Addnl., we show in melanoma that LTX-315 triggers two sequential phases of antitumor response.  The first phase of response, which begins within minutes of drug delivery into tumors, is defined by disrupted tumor vasculature and decreased tumor burden and occurs independently of lymphocytes.  The second phase of response, which continues over weeks, is defined by long-term alteration of the tumor microenvironment; the changes induced by LTX-315 are most notably characterized by CD8+ T cell infiltration.  We further show that these CD8+ T cells are involved in suppressing melanoma outgrowth in mice and report similar CD8+ T cell infiltration following LTX-315 treatment in melanoma and sarcoma patients.  Taken together, these findings reveal LTX-315's multiple antitumor effects, including disrupting the tumor vasculature and promoting the conversion of poorly immunogenic tumors into ones that display antitumor T cell immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVsfysai3b3LVg90H21EOLACvtfcHk0lgpA6a4mpW4OQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVCjsr3M&md5=a10cec9c564ee71fe8bcbd74405cd255</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.15698%2Fcst2019.11.204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15698%252Fcst2019.11.204%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DH.-W.%26aulast%3DGarris%26aufirst%3DC.%26aulast%3DPfirschke%26aufirst%3DC.%26aulast%3DRickelt%26aufirst%3DS.%26aulast%3DArlauckas%26aufirst%3DS.%26aulast%3DSiwicki%26aufirst%3DM.%26aulast%3DKohler%26aufirst%3DR.%2BH.%26aulast%3DWeissleder%26aufirst%3DR.%26aulast%3DSundvold-Gjerstad%26aufirst%3DV.%26aulast%3DSveinbj%25C3%25B8rnsson%26aufirst%3DB.%26aulast%3DRekdal%26aufirst%3D%25C3%2598.%26aulast%3DPittet%26aufirst%3DM.%2BJ.%26atitle%3DLTX-315%2520sequentially%2520promotes%2520lymphocyte-independent%2520and%2520lymphocyte-dependent%2520antitumor%2520effects%26jtitle%3DCell%2520Stress%26date%3D2019%26volume%3D3%26spage%3D348%26epage%3D360%26doi%3D10.15698%2Fcst2019.11.204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Correction to redox-activated porphyrin-based liposome remote-loaded with indoleamine 2,3-dioxygenase (IDO) inhibitor for synergistic photoimmunotherapy through induction of immunogenic cell death and blockage of IDO pathway</span>. <i>Nano Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1476</span>, <span class="refDoi">Â DOI: 10.1021/acs.nanolett.0c00113</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.nanolett.0c00113" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtVKls7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2020&pages=1476&author=D.+Liuauthor=B.+Chenauthor=Y.+Moauthor=Z.+Wangauthor=T.+Qiauthor=Q.+Zhangauthor=Y.+Wang&title=Correction+to+redox-activated+porphyrin-based+liposome+remote-loaded+with+indoleamine+2%2C3-dioxygenase+%28IDO%29+inhibitor+for+synergistic+photoimmunotherapy+through+induction+of+immunogenic+cell+death+and+blockage+of+IDO+pathway&doi=10.1021%2Facs.nanolett.0c00113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Correction to Redox-Activated Porphyrin-Based Liposome Remote-Loaded with Indoleamine 2,3-Dioxygenase (IDO) Inhibitor for Synergistic Photoimmunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway</span></div><div class="casAuthors">Liu, Dechun; Chen, Binlong; Mo, Yulin; Wang, Zenghui; Qi, Tong; Zhang, Qiang; Wang, Yiguang</div><div class="citationInfo"><span class="NLM_cas:title">Nano Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1476</span>CODEN:
                <span class="NLM_cas:coden">NALEFD</span>;
        ISSN:<span class="NLM_cas:issn">1530-6984</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQJ9VruPivJ7Vg90H21EOLACvtfcHk0liDnwEf1g97sw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtVKls7o%253D&md5=c2ac2ab8663eeb2d5d15330d8110ec31</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.nanolett.0c00113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.nanolett.0c00113%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DMo%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DQi%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DCorrection%2520to%2520redox-activated%2520porphyrin-based%2520liposome%2520remote-loaded%2520with%2520indoleamine%25202%252C3-dioxygenase%2520%2528IDO%2529%2520inhibitor%2520for%2520synergistic%2520photoimmunotherapy%2520through%2520induction%2520of%2520immunogenic%2520cell%2520death%2520and%2520blockage%2520of%2520IDO%2520pathway%26jtitle%3DNano%2520Lett.%26date%3D2020%26volume%3D20%26spage%3D1476%26doi%3D10.1021%2Facs.nanolett.0c00113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span> <span> </span><span class="NLM_article-title">Tumors and their microenvironment dual-targeting chemotherapy with local immune adjuvant therapy for effective antitumor immunity against breast cancer</span>. <i>Adv. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1801868</span>, <span class="refDoi">Â DOI: 10.1002/advs.201801868</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1002%2Fadvs.201801868" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A280%3ADC%252BB3M%252Fgs12rsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2019&pages=1801868&author=C.+Dengauthor=Q.+Zhangauthor=M.+Jiaauthor=J.+Zhaoauthor=X.+Sunauthor=T.+Gongauthor=Z.+Zhang&title=Tumors+and+their+microenvironment+dual-targeting+chemotherapy+with+local+immune+adjuvant+therapy+for+effective+antitumor+immunity+against+breast+cancer&doi=10.1002%2Fadvs.201801868"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Tumors and Their Microenvironment Dual-Targeting Chemotherapy with Local Immune Adjuvant Therapy for Effective Antitumor Immunity against Breast Cancer</span></div><div class="casAuthors">Deng Caifeng; Jia Mengdi; Zhao Jin; Sun Xun; Gong Tao; Zhang Zhirong; Zhang Quan</div><div class="citationInfo"><span class="NLM_cas:title">Advanced science (Weinheim, Baden-Wurttemberg, Germany)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1801868</span>
        ISSN:<span class="NLM_cas:issn">2198-3844</span>.
    </div><div class="casAbstract">Chemotherapy turns tumor cells into "tumor vaccines" by immunogenic cell death (ICD).  However, it remains a challenge to exploit chemotherapy-induced "tumor vaccines" for solid cancer immunotherapy due to the inefficient effector T cells activation and tumor microenvironment immunosuppression.  Here, a matrix metalloprotease 2 responsive liposome (PEG-FA-Lip) composed of cleavable PEG chains covering the folate (FA)-modified liposome is developed to deliver ICD inducer doxorubicin.  In breast cancer-bearing mice, PEG-FA-Lip targets both 4T1 breast cancer cells and M2-tumor associated macrophages (M2-TAMs) via FA-receptor mediated endocytosis, resulting in abundant "tumor vaccines" and efficient elimination of M2-TAMs.  The combination of local cytosine-phosphate-guanine (CpG) therapy facilitates PEG-FA-Lip induced "tumor vaccines" to effectively arouse systematic effector T cells immune response through promoting dendritic cell maturation and immunostimulatory cytokines secretion.  The simultaneous elimination of M2-TAMs ensures the activated effector T cells exert antitumor immunity within tumor via decreasing immunosuppressive cytokines secretion and tumor infiltration of Treg cells.  After receiving the combined treatment, 30.1% of breast cancer-bearing mice (initial tumor volume > 100 mm(3)) achieves the goal of tumor eradication.  Remarkably, this combination therapy greatly inhibits lung metastasis and controls the growth of already metastasized breast cancers (initial tumor volume > 100 mm(3)).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9omYqtS42lsrRqEXsZufAfW6udTcc2eaaIR9a2TPr5bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M%252Fgs12rsQ%253D%253D&md5=3e49e26828fd5463bfe7ed2becda69cf</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fadvs.201801868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadvs.201801868%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DJia%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DGong%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DZ.%26atitle%3DTumors%2520and%2520their%2520microenvironment%2520dual-targeting%2520chemotherapy%2520with%2520local%2520immune%2520adjuvant%2520therapy%2520for%2520effective%2520antitumor%2520immunity%2520against%2520breast%2520cancer%26jtitle%3DAdv.%2520Sci.%26date%3D2019%26volume%3D6%26spage%3D1801868%26doi%3D10.1002%2Fadvs.201801868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Nanomedicine-based immunotherapy for the treatment of cancer metastasis</span>. <i>Adv. Mater.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1904156</span>, <span class="refDoi">Â DOI: 10.1002/adma.201904156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1002%2Fadma.201904156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=31566275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVKkur3I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2019&pages=1904156&author=P.+Zhangauthor=Y.+Zhaiauthor=Y.+Caiauthor=Y.+Zhaoauthor=Y.+Li&title=Nanomedicine-based+immunotherapy+for+the+treatment+of+cancer+metastasis&doi=10.1002%2Fadma.201904156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Nanomedicine-Based Immunotherapy for the Treatment of Cancer Metastasis</span></div><div class="casAuthors">Zhang, Pengcheng; Zhai, Yihui; Cai, Ying; Zhao, Yuliang; Li, Yaping</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Materials (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">1904156</span>CODEN:
                <span class="NLM_cas:coden">ADVMEW</span>;
        ISSN:<span class="NLM_cas:issn">0935-9648</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Metastasis is the leading cause of cancer-assocd. death, with poor prognosis even after extensive treatment.  The dormancy of metastatic cancer cells during dissemination or after colony formation is one major reason for treatment failure, as most drugs target cells of active proliferation.  Immunotherapy has shown great potential in cancer therapy because the activity of effector cells is less affected by the metabolic status of cancer cells.  In addn., metastatic cells out of immunosuppressive tumor microenvironment (TME) are more susceptible to immune clearance, although these cells can achieve immune surveillance evasion via strategies such as platelet and macrophage recruitment.  Since nanomaterials themselves or their carried drugs have the capability to modulate the immune system, a great amt. of focus has been placed on nanomedicine strategies that leverage immune cells participating the metastatic cascade.  These nanomedicines successfully inhibit the tumor metastasis and prolong the survival of model animals.  Immune cells that are involved in the metastasis cascade are first summarized and then recent and inspiring strategies and nanomaterials in this growing field are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAdL8c5wwN2LVg90H21EOLACvtfcHk0liDnwEf1g97sw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVKkur3I&md5=f0e75d502455119a7504dc7094475cde</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fadma.201904156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadma.201904156%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DNanomedicine-based%2520immunotherapy%2520for%2520the%2520treatment%2520of%2520cancer%2520metastasis%26jtitle%3DAdv.%2520Mater.%26date%3D2019%26volume%3D31%26spage%3D1904156%26doi%3D10.1002%2Fadma.201904156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holohan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Schaeybroeck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longley, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, P. G.</span></span> <span> </span><span class="NLM_article-title">Cancer drug resistance: an evolving paradigm</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">714</span>â <span class="NLM_lpage">726</span>, <span class="refDoi">Â DOI: 10.1038/nrc3599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1038%2Fnrc3599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=24060863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVyqurnE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=714-726&author=C.+Holohanauthor=S.+Van+Schaeybroeckauthor=D.+B.+Longleyauthor=P.+G.+Johnston&title=Cancer+drug+resistance%3A+an+evolving+paradigm&doi=10.1038%2Fnrc3599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer drug resistance: an evolving paradigm</span></div><div class="casAuthors">Holohan, Caitriona; Van Schaeybroeck, Sandra; Longley, Daniel B.; Johnston, Patrick G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">714-726</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Resistance to chemotherapy and molecularly targeted therapies is a major problem facing current cancer research.  The mechanisms of resistance to 'classical' cytotoxic chemotherapeutics and to therapies that are designed to be selective for specific mol. targets share many features, such as alterations in the drug target, activation of prosurvival pathways and ineffective induction of cell death.  With the increasing arsenal of anticancer agents, improving preclin. models and the advent of powerful high-throughput screening techniques, there are now unprecedented opportunities to understand and overcome drug resistance through the clin. assessment of rational therapeutic drug combinations and the use of predictive biomarkers to enable patient stratification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrykBEUSgvv7Vg90H21EOLACvtfcHk0lhnBIvjUhfuQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVyqurnE&md5=b497a823bbd968904ce1591b918d0679</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnrc3599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3599%26sid%3Dliteratum%253Aachs%26aulast%3DHolohan%26aufirst%3DC.%26aulast%3DVan%2BSchaeybroeck%26aufirst%3DS.%26aulast%3DLongley%26aufirst%3DD.%2BB.%26aulast%3DJohnston%26aufirst%3DP.%2BG.%26atitle%3DCancer%2520drug%2520resistance%253A%2520an%2520evolving%2520paradigm%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2013%26volume%3D13%26spage%3D714%26epage%3D726%26doi%3D10.1038%2Fnrc3599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Russo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crisafulli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sogari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arena, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamba, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amodio, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MagrÃ¬, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novara, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarotto, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagel, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piett, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amatu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sartore-Bianchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siena, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trusolino, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corigliano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gherardi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagomarsino, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Nicolantonio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardelli, A.</span></span> <span> </span><span class="NLM_article-title">Adaptive mutability of colorectal cancers in response to targeted therapies</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>366</i></span>,  <span class="NLM_fpage">1473</span>â <span class="NLM_lpage">1480</span>, <span class="refDoi">Â DOI: 10.1126/science.aav4474</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1126%2Fscience.aav4474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=31699882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVGhtLvN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2019&pages=1473-1480&author=M.+Russoauthor=G.+Crisafulliauthor=A.+Sogariauthor=N.+M.+Reillyauthor=S.+Arenaauthor=S.+Lambaauthor=A.+Bartoliniauthor=V.+Amodioauthor=A.+Magr%C3%ACauthor=L.+Novaraauthor=I.+Sarottoauthor=Z.+D.+Nagelauthor=C.+G.+Piettauthor=A.+Amatuauthor=A.+Sartore-Bianchiauthor=S.+Sienaauthor=A.+Bertottiauthor=L.+Trusolinoauthor=M.+Coriglianoauthor=M.+Gherardiauthor=M.+C.+Lagomarsinoauthor=F.+Di+Nicolantonioauthor=A.+Bardelli&title=Adaptive+mutability+of+colorectal+cancers+in+response+to+targeted+therapies&doi=10.1126%2Fscience.aav4474"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Adaptive mutability of colorectal cancers in response to targeted therapies</span></div><div class="casAuthors">Russo, Mariangela; Crisafulli, Giovanni; Sogari, Alberto; Reilly, Nicole M.; Arena, Sabrina; Lamba, Simona; Bartolini, Alice; Amodio, Vito; Magri, Alessandro; Novara, Luca; Sarotto, Ivana; Nagel, Zachary D.; Piett, Cortt G.; Amatu, Alessio; Sartore-Bianchi, Andrea; Siena, Salvatore; Bertotti, Andrea; Trusolino, Livio; Corigliano, Mattia; Gherardi, Marco; Lagomarsino, Marco Cosentino; Di Nicolantonio, Federica; Bardelli, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">6472</span>),
    <span class="NLM_cas:pages">1473-1480</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">1095-9203</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The emergence of drug resistance limits the efficacy of targeted therapies in human tumors.  The prevalent view is that resistance is a fait accompli: when treatment is initiated, cancers already contain drug-resistant mutant cells.  Bacteria exposed to antibiotics transiently increase their mutation rates (adaptive mutability), thus improving the likelihood of survival.  We investigated whether human colorectal cancer (CRC) cells likewise exploit adaptive mutability to evade therapeutic pressure.  We found that epidermal growth factor receptor (EGFR)/BRAF inhibition down-regulates mismatch repair (MMR) and homologous recombination DNA-repair genes and concomitantly up-regulates error-prone polymerases in drug-tolerant (persister) cells. MMR proteins were also down-regulated in patient-derived xenografts and tumor specimens during therapy.  EGFR/BRAF inhibition induced DNA damage, increased mutability, and triggered microsatellite instability.  Thus, like unicellular organisms, tumor cells evade therapeutic pressures by enhancing mutability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH-BSjnOzI0LVg90H21EOLACvtfcHk0lhnBIvjUhfuQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVGhtLvN&md5=8b5ac7f79d2b4e97a1134a827a946a3d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1126%2Fscience.aav4474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aav4474%26sid%3Dliteratum%253Aachs%26aulast%3DRusso%26aufirst%3DM.%26aulast%3DCrisafulli%26aufirst%3DG.%26aulast%3DSogari%26aufirst%3DA.%26aulast%3DReilly%26aufirst%3DN.%2BM.%26aulast%3DArena%26aufirst%3DS.%26aulast%3DLamba%26aufirst%3DS.%26aulast%3DBartolini%26aufirst%3DA.%26aulast%3DAmodio%26aufirst%3DV.%26aulast%3DMagr%25C3%25AC%26aufirst%3DA.%26aulast%3DNovara%26aufirst%3DL.%26aulast%3DSarotto%26aufirst%3DI.%26aulast%3DNagel%26aufirst%3DZ.%2BD.%26aulast%3DPiett%26aufirst%3DC.%2BG.%26aulast%3DAmatu%26aufirst%3DA.%26aulast%3DSartore-Bianchi%26aufirst%3DA.%26aulast%3DSiena%26aufirst%3DS.%26aulast%3DBertotti%26aufirst%3DA.%26aulast%3DTrusolino%26aufirst%3DL.%26aulast%3DCorigliano%26aufirst%3DM.%26aulast%3DGherardi%26aufirst%3DM.%26aulast%3DLagomarsino%26aufirst%3DM.%2BC.%26aulast%3DDi%2BNicolantonio%26aufirst%3DF.%26aulast%3DBardelli%26aufirst%3DA.%26atitle%3DAdaptive%2520mutability%2520of%2520colorectal%2520cancers%2520in%2520response%2520to%2520targeted%2520therapies%26jtitle%3DScience%26date%3D2019%26volume%3D366%26spage%3D1473%26epage%3D1480%26doi%3D10.1126%2Fscience.aav4474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Genovese, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assaraf, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colotti, G.</span></span> <span> </span><span class="NLM_article-title">Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins</span>. <i>Drug Resist. Updates</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">23</span>â <span class="NLM_lpage">46</span>, <span class="refDoi">Â DOI: 10.1016/j.drup.2017.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1016%2Fj.drup.2017.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=29145976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A280%3ADC%252BC1M3itVaqtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2017&pages=23-46&author=I.+Genoveseauthor=A.+Ilariauthor=Y.+G.+Assarafauthor=F.+Faziauthor=G.+Colotti&title=Not+only+P-glycoprotein%3A+Amplification+of+the+ABCB1-containing+chromosome+region+7q21+confers+multidrug+resistance+upon+cancer+cells+by+coordinated+overexpression+of+an+assortment+of+resistance-related+proteins&doi=10.1016%2Fj.drup.2017.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins</span></div><div class="casAuthors">Genovese Ilaria; Ilari Andrea; Assaraf Yehuda G; Fazi Francesco; Colotti Gianni</div><div class="citationInfo"><span class="NLM_cas:title">Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">23-46</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The development of drug resistance continues to be a dominant hindrance toward curative cancer treatment.  Overexpression of a wide-spectrum of ATP-dependent efflux pumps, and in particular of ABCB1 (P-glycoprotein or MDR1) is a well-known resistance mechanism for a plethora of cancer chemotherapeutics including for example taxenes, anthracyclines, Vinca alkaloids, and epipodopyllotoxins, demonstrated by a large array of published papers, both in tumor cell lines and in a variety of tumors, including various solid tumors and hematological malignancies.  Upon repeated or even single dose treatment of cultured tumor cells or tumors in vivo with anti-tumor agents such as paclitaxel and doxorubicin, increased ABCB1 copy number has been demonstrated, resulting from chromosomal amplification events at 7q11.2-21 locus, leading to marked P-glycoprotein overexpression, and multidrug resistance (MDR).  Clearly however, additional mechanisms such as single nucleotide polymorphisms (SNPs) and epigenetic modifications have shown a role in the overexpression of ABCB1 and of other MDR efflux pumps.  However, notwithstanding the design of 4 generations of ABCB1 inhibitors and the wealth of information on the biochemistry and substrate specificity of ABC transporters, translation of this vast knowledge from the bench to the bedside has proven to be unexpectedly difficult.  Many studies show that upon repeated treatment schedules of cell cultures or tumors with taxenes and anthracyclines as well as other chemotherapeutic drugs, amplification, and/or overexpression of a series of genes genomically surrounding the ABCB1 locus, is observed.  Consequently, altered levels of other proteins may contribute to the establishment of the MDR phenotype, and lead to poor clinical outcome.  Thus, the genes contained in this ABCB1 amplicon including ABCB4, SRI, DBF4, TMEM243, and RUNDC3B are overexpressed in many cancers, and especially in MDR tumors, while TP53TG1 and DMTF1 are bona fide tumor suppressors.  This review describes the role of these genes in cancer and especially in the acquisition of MDR, elucidates possible connections in transcriptional regulation (co-amplification/repression) of genes belonging to the same ABCB1 amplicon region, and delineates their novel emerging contributions to tumor biology and possible strategies to overcome cancer MDR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTlGWXKBPOQGvtos8R3JUhXfW6udTcc2eZhaYzrM9vEXrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3itVaqtQ%253D%253D&md5=60a54c7bae87c6f4ccffdaa242138de3</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2017.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2017.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DGenovese%26aufirst%3DI.%26aulast%3DIlari%26aufirst%3DA.%26aulast%3DAssaraf%26aufirst%3DY.%2BG.%26aulast%3DFazi%26aufirst%3DF.%26aulast%3DColotti%26aufirst%3DG.%26atitle%3DNot%2520only%2520P-glycoprotein%253A%2520Amplification%2520of%2520the%2520ABCB1-containing%2520chromosome%2520region%25207q21%2520confers%2520multidrug%2520resistance%2520upon%2520cancer%2520cells%2520by%2520coordinated%2520overexpression%2520of%2520an%2520assortment%2520of%2520resistance-related%2520proteins%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2017%26volume%3D32%26spage%3D23%26epage%3D46%26doi%3D10.1016%2Fj.drup.2017.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aronson, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonson, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orchard, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LlinÃ¡s, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, S. H.</span></span> <span> </span><span class="NLM_article-title">Lipopeptisomes: Anticancer peptide-assembled particles for fusolytic oncotherapy</span>. <i>Acta Biomater.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">269</span>â <span class="NLM_lpage">277</span>, <span class="refDoi">Â DOI: 10.1016/j.actbio.2018.09.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1016%2Fj.actbio.2018.09.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=30240951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslyqsr3O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2018&pages=269-277&author=M.+R.+Aronsonauthor=A.+W.+Simonsonauthor=L.+M.+Orchardauthor=M.+Llin%C3%A1sauthor=S.+H.+Medina&title=Lipopeptisomes%3A+Anticancer+peptide-assembled+particles+for+fusolytic+oncotherapy&doi=10.1016%2Fj.actbio.2018.09.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Lipopeptisomes: Anticancer peptide-assembled particles for fusolytic oncotherapy</span></div><div class="casAuthors">Aronson, Matthew R.; Simonson, Andrew W.; Orchard, Lindsey M.; Llinas, Manuel; Medina, Scott H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Biomaterialia</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">269-277</span>CODEN:
                <span class="NLM_cas:coden">ABCICB</span>;
        ISSN:<span class="NLM_cas:issn">1742-7061</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Anticancer peptides (ACPs) are cationic amphiphiles that preferentially kill cancer cells through folding-dependent membrane disruption.  Although ACPs represent attractive therapeutic candidates, particularly against drug-resistant cancers, their successful translation into clin. practice has gone unrealized due to their poor bioavailability, serum instability and, most importantly, severe hemolytic toxicity.  Here, we exploit the membrane-specific interactions of ACPs to prep. a new class of peptide-lipid particle, we term a lipopeptisome (LP).  This design sequesters loaded ACPs within a lipid lamellar corona to avoid contact with red blood cells and healthy tissues, while affording potent lytic destruction of cancer cells following LP-membrane fusion.  Biophys. studies show ACPs rapidly fold at, and integrate into, liposomal membranes to form stable LPs with high loading efficiencies (>80%).  Rational design of the particles to possess lipid combinations mimicking that of the aberrant cancer cell outer leaflet allows LPs to rapidly fuse with tumor cell membranes and afford localized assembly of loaded ACPs within the bilayer.  This leads to preferential fusolytic killing of cancer cells with minimal collateral toxicity towards non-cancerous cells and erythrocytes, thereby imparting clin. relevant therapeutic indexes to otherwise toxic ACPs.  Thus, integration of ACPs into self-assembled LPs represents a new delivery strategy to improve the therapeutic utility of oncolytic agents, and suggests this technol. may be added to targeted combinatorial approaches in precision medicine.  Despite their significant clin. potential, the therapeutic utility of many ACPs has been limited by their collateral hemolysis during administration.  Leveraging the membrane-specific interactions of ACPs, here we prep. self-assembled peptide-lipid nanoparticles, or 'lipopeptisomes' (LPs), capable of preferentially fusing with and lysing cancer cell membranes.  Key to this fusolytic action is the construction of LPs from lipids simulating the cancer cell outer leaflet.  This design recruits the oncolytic peptide payload into the carrier lamella and allows for selective destruction of cancer cells without disrupting healthy cells.  Consequently, LPs impart clin. relevant therapeutic indexes to previously toxic ACPs, and thus open new opportunities to improve the clin. translation of oncolytics challenged by narrow therapeutic windows.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrms7QPSxD_ArVg90H21EOLACvtfcHk0ljv3dNTsbadyQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslyqsr3O&md5=91d468632aa4cc288649daa595fc62db</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.actbio.2018.09.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.actbio.2018.09.025%26sid%3Dliteratum%253Aachs%26aulast%3DAronson%26aufirst%3DM.%2BR.%26aulast%3DSimonson%26aufirst%3DA.%2BW.%26aulast%3DOrchard%26aufirst%3DL.%2BM.%26aulast%3DLlin%25C3%25A1s%26aufirst%3DM.%26aulast%3DMedina%26aufirst%3DS.%2BH.%26atitle%3DLipopeptisomes%253A%2520Anticancer%2520peptide-assembled%2520particles%2520for%2520fusolytic%2520oncotherapy%26jtitle%3DActa%2520Biomater.%26date%3D2018%26volume%3D80%26spage%3D269%26epage%3D277%26doi%3D10.1016%2Fj.actbio.2018.09.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vitale, I.</span>; <span class="NLM_string-name">Yamazaki, T.</span>; <span class="NLM_string-name">Wennerberg, E.</span>; <span class="NLM_string-name">SveinbjÃ¸rnsson, B.</span>; <span class="NLM_string-name">Rekdal, Ã.</span>; <span class="NLM_string-name">Demaria, S.</span>; <span class="NLM_string-name">Galluzzi, L.</span></span> <span> </span><span class="NLM_article-title">Targeting cancer heterogeneity with immune responses driven by oncolytic peptides</span>.  <i>Trends Cancer</i>. <span class="NLM_year" style="font-weight: bold;">2021</span>, <span class="refDoi">Â DOI: 10.1016/j.trecan.2020.12.012</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1016%2Fj.trecan.2020.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=33446447" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2021&author=I.+Vitale&author=T.+Yamazaki&author=E.+Wennerberg&author=B.+Sveinbj%C3%B8rnsson&author=%C3%98.+Rekdal&author=S.+Demaria&author=L.+Galluzzi&title=Targeting+cancer+heterogeneity+with+immune+responses+driven+by+oncolytic+peptides&doi=10.1016%2Fj.trecan.2020.12.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.trecan.2020.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trecan.2020.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DVitale%26aufirst%3DI.%26atitle%3DTargeting%2520cancer%2520heterogeneity%2520with%2520immune%2520responses%2520driven%2520by%2520oncolytic%2520peptides%26jtitle%3DTrends%2520Cancer%26date%3D2021%26doi%3D10.1016%2Fj.trecan.2020.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashmi, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Activatable protein nanoparticles for targeted delivery of therapeutic peptides</span>. <i>Adv. Mater.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">1705383</span>, <span class="refDoi">Â DOI: 10.1002/adma.201705383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1002%2Fadma.201705383" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2018&pages=1705383&author=X.+Yuauthor=X.+Gouauthor=P.+Wuauthor=L.+Hanauthor=D.+Tianauthor=F.+Duauthor=Z.+Chenauthor=F.+Liuauthor=G.+Dengauthor=A.+T.+Chenauthor=C.+Maauthor=J.+Liuauthor=S.+M.+Hashmiauthor=X.+Guoauthor=X.+Wangauthor=H.+Zhaoauthor=X.+Liuauthor=X.+Zhuauthor=K.+Shethauthor=Q.+Chenauthor=L.+Fanauthor=J.+Zhou&title=Activatable+protein+nanoparticles+for+targeted+delivery+of+therapeutic+peptides&doi=10.1002%2Fadma.201705383"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fadma.201705383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadma.201705383%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DX.%26aulast%3DGou%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DHan%26aufirst%3DL.%26aulast%3DTian%26aufirst%3DD.%26aulast%3DDu%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DDeng%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DA.%2BT.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DHashmi%26aufirst%3DS.%2BM.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DSheth%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DActivatable%2520protein%2520nanoparticles%2520for%2520targeted%2520delivery%2520of%2520therapeutic%2520peptides%26jtitle%3DAdv.%2520Mater.%26date%3D2018%26volume%3D30%26spage%3D1705383%26doi%3D10.1002%2Fadma.201705383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiedmann, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galloway, W. R. J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sore, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chattopadhyay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, T. T.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Andrade, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janecek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arumugam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itzhaki, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">Toolbox of diverse linkers for navigating the cellular efficacy landscape of stapled peptides</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">526</span>â <span class="NLM_lpage">533</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.9b00063</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.9b00063" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFyqu7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=526-533&author=Y.+Wuauthor=A.+Kaurauthor=E.+Fowlerauthor=M.+M.+Wiedmannauthor=R.+Youngauthor=W.+R.+J.+D.+Gallowayauthor=L.+Olsenauthor=H.+F.+Soreauthor=A.+Chattopadhyayauthor=T.+T.-L.+Kwanauthor=W.+Xuauthor=S.+J.+Walshauthor=P.+de+Andradeauthor=M.+Janecekauthor=S.+Arumugamauthor=L.+S.+Itzhakiauthor=Y.+H.+Lauauthor=D.+R.+Spring&title=Toolbox+of+diverse+linkers+for+navigating+the+cellular+efficacy+landscape+of+stapled+peptides&doi=10.1021%2Facschembio.9b00063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Toolbox of Diverse Linkers for Navigating the Cellular Efficacy Landscape of Stapled Peptides</span></div><div class="casAuthors">Wu, Yuteng; Kaur, Amandeep; Fowler, Elaine; Wiedmann, Mareike M.; Young, Reginald; Galloway, Warren R. J. D.; Olsen, Lasse; Sore, Hannah F.; Chattopadhyay, Anasuya; Kwan, Terence T.-L.; Xu, Wenshu; Walsh, Stephen J.; de Andrade, Peterson; Janecek, Matej; Arumugam, Senthil; Itzhaki, Laura S.; Lau, Yu Heng; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">526-533</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Stapled peptides have great potential as modulators of protein-protein interactions (PPIs).  However, there is a vast landscape of chem. features that can be varied for any given peptide, and identifying a set of features that maximizes cellular uptake and subsequent target engagement remains a key challenge.  Herein, we present a systematic anal. of staple functionality on the peptide bioactivity landscape in cellular assays.  Through application of a "toolbox" of diversified dialkynyl linkers to the stapling of MDM2-binding peptides via a double-click approach, we conducted a study of cellular uptake and p53 activation as a function of the linker.  Minor changes in the linker motif and the specific pairing of linker with peptide sequence can lead to substantial differences in bioactivity, a finding which may have important design implications for peptide-based inhibitors of other PPIs.  Given the complexity of the structure-activity relationships involved, the toolbox approach represents a generalizable strategy for optimization when progressing from in vitro binding assays to cellular efficacy studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMk22wTNrvLLVg90H21EOLACvtfcHk0liF9o4RyQ85CA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFyqu7w%253D&md5=f22fff1cabf65589d182961382b9339e</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Facschembio.9b00063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.9b00063%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DKaur%26aufirst%3DA.%26aulast%3DFowler%26aufirst%3DE.%26aulast%3DWiedmann%26aufirst%3DM.%2BM.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGalloway%26aufirst%3DW.%2BR.%2BJ.%2BD.%26aulast%3DOlsen%26aufirst%3DL.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DChattopadhyay%26aufirst%3DA.%26aulast%3DKwan%26aufirst%3DT.%2BT.-L.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DWalsh%26aufirst%3DS.%2BJ.%26aulast%3Dde%2BAndrade%26aufirst%3DP.%26aulast%3DJanecek%26aufirst%3DM.%26aulast%3DArumugam%26aufirst%3DS.%26aulast%3DItzhaki%26aufirst%3DL.%2BS.%26aulast%3DLau%26aufirst%3DY.%2BH.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DToolbox%2520of%2520diverse%2520linkers%2520for%2520navigating%2520the%2520cellular%2520efficacy%2520landscape%2520of%2520stapled%2520peptides%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2019%26volume%3D14%26spage%3D526%26epage%3D533%26doi%3D10.1021%2Facschembio.9b00063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Won, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pripotnev, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruscito, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ianoul, A.</span></span> <span> </span><span class="NLM_article-title">Effect of point mutations on the secondary structure and membrane interaction of antimicrobial peptide anoplin</span>. <i>J. Phys. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">2371</span>â <span class="NLM_lpage">2379</span>, <span class="refDoi">Â DOI: 10.1021/jp108343g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp108343g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVWmsLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2011&pages=2371-2379&author=A.+Wonauthor=S.+Pripotnevauthor=A.+Ruscitoauthor=A.+Ianoul&title=Effect+of+point+mutations+on+the+secondary+structure+and+membrane+interaction+of+antimicrobial+peptide+anoplin&doi=10.1021%2Fjp108343g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of point mutations on the secondary structure and membrane interaction of antimicrobial peptide anoplin</span></div><div class="casAuthors">Won, Amy; Pripotnev, Stahs; Ruscito, Annamaria; Ianoul, Anatoli</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2371-2379</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1520-5207</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Anoplin (GLLKRIKTLL-NH2) is the smallest linear Î±-helical antimicrobial peptide found naturally to date.  Antibacterial and hemolytic properties of anoplin depend strongly on physicochem. properties.  Two anoplin derivs., anoplin-8K (Ano8K, GLLKRIKKLL-NH2) and anoplin-1K5 V8K (Ano1K5 V8K, KLLKVIKKLL-NH2), were found to have increased bacterial and low hemolytic activity.  In the present work physicochem. properties of these three peptides were studied by UV resonance Raman (UVRR) spectroscopy, Langmuir-Blodgett monolayer technique, and carboxyfluorescein (CF) leakage assay.  UVRR data indicated that all three peptides adopt predominantly unordered conformation in aq. buffer soln.  In membrane-mimicking trifluoroethanol, the Î±-helical content increases for all three peptides with Ano1K5 V8K having the highest Î±-helix percentage, followed by Ano8K and anoplin.  Crit. micelle concns. were found to be similar for all three peptides, and the satn. pressure decreases in the sequence Ano1K5 V8K, anoplin, Ano8K.  Crit. pressure of insertion was found to be greater for anionic lipid monolayer DPPG than for zwitterionic lipid DPPC, indicating preferential adsorption of all three peptides to DPPG.  Finally, membrane lytic activities of all three peptides toward various model lipid vesicles were compared through CF leakage assay.  Overall the data indicate that antimicrobial activity of anoplin increases with charge, whereas membrane lytic activity correlates with peptide helicity and amphipathicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq86WnKqef97LVg90H21EOLACvtfcHk0liF9o4RyQ85CA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVWmsLs%253D&md5=134f41a25422180e5cd8e632060958b3</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjp108343g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp108343g%26sid%3Dliteratum%253Aachs%26aulast%3DWon%26aufirst%3DA.%26aulast%3DPripotnev%26aufirst%3DS.%26aulast%3DRuscito%26aufirst%3DA.%26aulast%3DIanoul%26aufirst%3DA.%26atitle%3DEffect%2520of%2520point%2520mutations%2520on%2520the%2520secondary%2520structure%2520and%2520membrane%2520interaction%2520of%2520antimicrobial%2520peptide%2520anoplin%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2011%26volume%3D115%26spage%3D2371%26epage%3D2379%26doi%3D10.1021%2Fjp108343g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinn, Y. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">Peptidomimetic inhibitors of APC-Asef interaction block colorectal cancer migration</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">994</span>â <span class="NLM_lpage">1001</span>, <span class="refDoi">Â DOI: 10.1038/nchembio.2442</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1038%2Fnchembio.2442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=28759015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1WrtLfE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=994-1001&author=H.+Jiangauthor=R.+Dengauthor=X.+Yangauthor=J.+Shangauthor=S.+Luauthor=Y.+Zhaoauthor=K.+Songauthor=X.+Liuauthor=Q.+Zhangauthor=Y.+Chenauthor=Y.+E.+Chinnauthor=G.+Wuauthor=J.+Liauthor=G.+Chenauthor=J.+Yuauthor=J.+Zhang&title=Peptidomimetic+inhibitors+of+APC-Asef+interaction+block+colorectal+cancer+migration&doi=10.1038%2Fnchembio.2442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidomimetic inhibitors of APC-Asef interaction block colorectal cancer migration</span></div><div class="casAuthors">Jiang, Haiming; Deng, Rong; Yang, Xiuyan; Shang, Jialin; Lu, Shaoyong; Zhao, Yanlong; Song, Kun; Liu, Xinyi; Zhang, Qiufen; Chen, Yu; Chinn, Y. Eugene; Wu, Geng; Li, Jian; Chen, Guoqiang; Yu, Jianxiu; Zhang, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">994-1001</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The binding of adenomatous polyposis coli (APC) to its receptor Asef relieves the neg. intramol. regulation of Asef and leads to aberrant cell migration in human colorectal cancer.  Because of its crucial role in metastatic dissemination, the interaction between APC and Asef is an attractive target for anti-colorectal-cancer therapy.  We rationally designed a series of peptidomimetics that act as potent inhibitors of the APC interface.  Crystal structures and biochem. and cellular assays showed that the peptidomimetics in the APC pocket inhibited the migration of colorectal cells by disrupting APC-Asef interaction.  By using the peptidomimetic inhibitor as a chem. probe, we found that CDC42 was the downstream GTPase involved in APC-stimulated Asef activation in colorectal cancer cells.  Our work demonstrates the feasibility of exploiting APC-Asef interaction to regulate the migration of colorectal cancer cells, and provides what to our knowledge is the first class of protein-protein interaction inhibitors available for the development of cancer therapeutics targeting APC-Asef signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQtEFrIZd5_rVg90H21EOLACvtfcHk0liF9o4RyQ85CA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1WrtLfE&md5=03e378e877cc84646882a68f982a1ec4</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2442%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DDeng%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DShang%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DChinn%26aufirst%3DY.%2BE.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DPeptidomimetic%2520inhibitors%2520of%2520APC-Asef%2520interaction%2520block%2520colorectal%2520cancer%2520migration%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2017%26volume%3D13%26spage%3D994%26epage%3D1001%26doi%3D10.1038%2Fnchembio.2442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Q. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z. H.</span></span> <span> </span><span class="NLM_article-title">Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1110</span>, <span class="refDoi">Â DOI: 10.1038/s41467-020-14906-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=10.1038%2Fs41467-020-14906-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=32111828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtVGmsbjK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=1110&author=X.+Yuauthor=Y.+F.+Daiauthor=Y.+F.+Zhaoauthor=S.+H.+Qiauthor=L.+Liuauthor=L.+S.+Luauthor=Q.+M.+Luoauthor=Z.+H.+Zhang&title=Melittin-lipid+nanoparticles+target+to+lymph+nodes+and+elicit+a+systemic+anti-tumor+immune+response&doi=10.1038%2Fs41467-020-14906-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response</span></div><div class="casAuthors">Yu, Xiang; Dai, Yanfeng; Zhao, Yifan; Qi, Shuhong; Liu, Lei; Lu, Lisen; Luo, Qingming; Zhang, Zhihong</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1110</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Targeted delivery of a nanovaccine loaded with a tumor antigen and adjuvant to the lymph nodes (LNs) is an attractive approach for improving cancer immunotherapy outcomes.  However, the application of this technique is restricted by the paucity of suitable tumor-assocd. antigens (TAAs) and the sophisticated technol. required to identify tumor neoantigens.  Here, we demonstrate that a self-assembling melittin-lipid nanoparticle (Î±-melittin-NP) that is not loaded with extra tumor antigens promotes whole tumor antigen release in situ and results in the activation of antigen-presenting cells (APCs) in LNs.  Compared with free melittin, Î±-melittin-NPs markedly enhance LN accumulation and activation of APCs, leading to a 3.6-fold increase in antigen-specific CD8+ T cell responses.  Furthermore, in a bilateral flank B16F10 tumor model, primary and distant tumor growth are significantly inhibited by Î±-melittin-NPs, with an inhibition rate of 95% and 92%, resp.  Thus, Î±-melittin-NPs induce a systemic anti-tumor response serving as an effective LN-targeted whole-cell nanovaccine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2cSmtqon3nLVg90H21EOLACvtfcHk0ljbPJDbYm5g3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtVGmsbjK&md5=9fd42905787485f0ec7551e8b7b744b1</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fs41467-020-14906-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-020-14906-9%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DX.%26aulast%3DDai%26aufirst%3DY.%2BF.%26aulast%3DZhao%26aufirst%3DY.%2BF.%26aulast%3DQi%26aufirst%3DS.%2BH.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DL.%2BS.%26aulast%3DLuo%26aufirst%3DQ.%2BM.%26aulast%3DZhang%26aufirst%3DZ.%2BH.%26atitle%3DMelittin-lipid%2520nanoparticles%2520target%2520to%2520lymph%2520nodes%2520and%2520elicit%2520a%2520systemic%2520anti-tumor%2520immune%2520response%26jtitle%3DNat.%2520Commun.%26date%3D2020%26volume%3D11%26spage%3D1110%26doi%3D10.1038%2Fs41467-020-14906-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shepherd, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbenante, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, D. P.</span></span> <span> </span><span class="NLM_article-title">Single turn peptide alpha helices with exceptional stability in water</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">2974</span>â <span class="NLM_lpage">2983</span>, <span class="refDoi">Â DOI: 10.1021/ja0456003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0456003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yhsrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=2974-2983&author=N.+E.+Shepherdauthor=H.+N.+Hoangauthor=G.+Abbenanteauthor=D.+P.+Fairlie&title=Single+turn+peptide+alpha+helices+with+exceptional+stability+in+water&doi=10.1021%2Fja0456003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Single Turn Peptide Alpha Helices with Exceptional Stability in Water</span></div><div class="casAuthors">Shepherd, Nicholas E.; Hoang, Huy N.; Abbenante, Giovanni; Fairlie, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2974-2983</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclic pentapeptides are not known to exist in Î±-helical conformations.  CD and NMR spectra show that specific 20-membered cyclic pentapeptides, Ac-(cyclo-1,5)-[KXXXD]-NH2 (X = Ala, Arg) and Ac-(cyclo-2,6)-R[KXXXD]-NH2 (X = Ala, Leu, Met, Gln, Phe, Gly, Ser) are highly Î±-helical structures in water and independent of concn., TFE, denaturants, and proteases.  These are the smallest Î±-helical peptides in water.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKJhSsJ2TgQLVg90H21EOLACvtfcHk0ljbPJDbYm5g3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yhsrY%253D&md5=5fc515610f290300af1be167a1446798</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fja0456003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0456003%26sid%3Dliteratum%253Aachs%26aulast%3DShepherd%26aufirst%3DN.%2BE.%26aulast%3DHoang%26aufirst%3DH.%2BN.%26aulast%3DAbbenante%26aufirst%3DG.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DSingle%2520turn%2520peptide%2520alpha%2520helices%2520with%2520exceptional%2520stability%2520in%2520water%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D2974%26epage%3D2983%26doi%3D10.1021%2Fja0456003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2MJQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2MJQ','PDB','2MJQ'); return false;">PDB: 2MJQ</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i30"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02237">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_87032"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c02237?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02237</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings with IC<sub>50</sub> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02237/suppl_file/jm0c02237_si_001.csv">CSV</a>)</p></li><li><p class="inline">HPLC, HR-Q-TOF-MS, CD, and NMR characterization; antitumor activity of all compounds; LDH release of 4T1 cells following treatment with anoplin; 4T1 cells after treatment with anoplin and stained with the LIVE/DEAD cell viability/cytotoxicity kit; protease stability of peptides; and immunohistochemical staining images and quantitative analysis of CD4+ T cells and CD8+ T cells in the 4T1 tumor slices (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02237/suppl_file/jm0c02237_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02237/suppl_file/jm0c02237_si_001.csv">jm0c02237_si_001.csv (2.99 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02237/suppl_file/jm0c02237_si_002.pdf">jm0c02237_si_002.pdf (1.85 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c02237&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-9%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c02237%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c02237" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67997852ec453ce8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
